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ABSTRACT 
Porphyrins are of exceptional importance in nature, science and technology: for instance, 
as ligands for metals in supramolecular synthesis, as photosensitizers in photodynamic therapy 
(PDT), and as building blocks for electronic devices. In addition to their application in cancer 
therapy, porphyrin species also exhibit antiviral activity. New meso-tetraarylporphyrins (TArP, 
Ar = -C6H4-) of the general formula, T(R1R2NSO2Ar)P, with R1 = N-py-n-CH2 (n = 2, 3 or 4) or 
SO3- and R2 = H or CH3 were synthesized. These groups were linked to the 4-position of the 
phenylene group of the porphyrin by a secondary (SO2NHR) or tertiary (SO2NR2) sulfonamide 
group. The sulfonamide group was found to be a versatile way of expanding the porphyrin. The 
presence of a tertiary sulfonamide group instead of a dissociable proton improved the solubility 
of the new class of porphyrin compounds synthesized. 
Adducts having four methylcobaloxime units (CH3Co(DH)2) bound to the pyridyl 
nitrogens of T(N-py-4-CH2(CH3)NSO2Ar)P or TpyP(4) were synthesized for the first time and 
their solution properties studied by 1H NMR spectroscopy. The 1H NMR signal of the axial 
methyl of CH3Co(DH)2L complexes shifts upfield with increasing L basicity, but the signal of 
the equatorial methyl is insensitive to L basicity. The axial methyl signal was used to examine 
the effect of coordination of the CH3Co(DH)2 moiety to the N-pyridyl group of the TpyP(4) and 
of the newly synthesized porphyrin, T(N-py-4-CH2(CH3)NSO2Ar)P.  
A new class of water-soluble porphyrins meso-tetraarylporphyrins and some metal 
derivatives were synthesized from the above class of compounds by simple alkylation and 
metallation with copper and zinc salt. Interactions of selected porphyrins and metalloporphyrins 
(Cu(II), Zn(II)) with calf thymus DNA were investigated by visible circular dichroism, 
absorption, and fluorescence spectroscopies. The main aim of studying this class of compounds 
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was to assess whether N-methylpyridinium (N-Mepy) groups must be directly attached to the 
porphyrin core in order for intercalative binding to DNA to occur. 
 Porphyrins have been known for some years to show antiviral activity against human 
immunodeficiency virus (HIV) infection in assays that measured inhibition of virus replication. 
One promising approach receiving increasing attention is the development of microbicides 
which, when applied topically, can prevent viral infection. These compounds could directly 
interact with HIV virions to decrease or prevent infectivity, thus providing a defense against 
sexual transmission of the virus. Sulfonated derivatives of tetraarylporphyrin have also been 
shown to exhibit activity HIV. A new class of porphyrins containing sulfonamide links was 
synthesized and characterized by 1H NMR spectroscopy and mass spectrometry. 
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CHAPTER 1. INTRODUCTION 
 
Porphyrins are a class of macrocyclic compounds, which contain four pyrrole rings linked 
by four methine bridges and their parent molecule is known as porphine (Figure 1.1). 
Substitution of some or all of the hydrogens on the pyrrole rings or at the methine bridge of the 
porphine results in β-substituted and meso-substituted (Figure 1.1) porphyrins.1 Porphyrins and 
related compounds are the basic chromophores for a large number of biologically important 
natural products such as cytochromes, haemoproteins, chlorophylls and bacteriophylls.2 
Porphyrins are being studied widely because of their intriguing physical, chemical and biological 
properties.1 
 
Figure 1.1. Structures of porphine, β-substitued and meso-subsituted porphyrins. 
Porphyrins and their derivatives are highly colored and absorb strongly in the visible region 
near 400 nm (molar extinction coefficients are about 105 mol-1L), characteristic of the 
macrocyclic conjugation and several weaker absorption bands (Q bands) between 450-700 nm.3 
The main intense absorption band is known as the Soret band, named after the biochemist who 
first observed it in hemoglobin.4 The Soret band is a major characteristic of the optical spectrum 
of the porphyrin macrocycle as it disappears with the disruption of the macrocycle.3 The 
intensity and wavelength of the absorption bands changes with variations in the peripheral 
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positions of the porphyrin macrocycle. Protonation of two of the inner nitrogen atoms or 
insertion of a metal into the porphyrin cavity changes the visible absorption spectrum.3 The 1H 
NMR spectrum of the aromatic porphyrin ring shows anisotropic effects.5-7 The highly shielded 
NH protons in the porphyrins appear at very high field (-2 to -4 ppm), whereas the outer meso 
protons (shielded by the aromatic ring current) appear at very low field (8 to 10 ppm).8,9  
The porphyrin macrocycle is very stable to concentrated acids (e.g. sulfuric acid ), and can 
exhibit characteristics of both acids and bases.2 The nitrogen atoms at the centre of the porphyrin 
core are responsible for this interesting characteristic.2 In the free-base porphyrins, the central 
nitrogen atoms are free and the NHs (pKb~ 9) can be protonated easily with acids such as 
trifluoroacetic acid.1 Strong base such as alkoxides can remove the protons (pKa~16) from the 
inner nitrogen atoms of the porphyrin to form a dianion.1 The inner protons can also be replaced 
by a metal. Various types of metals (e.g., Zn, Cu, Ni, Sn etc) can be inserted into the porphyrin 
cavity by using various metal salts.10 Removal of the metal can be achieved by treatment of the 
metallated porphyrins with acids, and different types of acids are required for the removal of the 
different metals. 
1.1 Meso-tetra(4-pyridyl)porphyrin (TpyP(4)) 
 
The development of new multiporphyrin assemblies is a subject of current research because 
of their potential applications in material science, reaction catalysis and energy transfer 
molecular devices for advanced technological tasks. 11-14 Porphyrins offer a variety of appealing 
features: rigid, planar geometries, high stability, intense electronic absorption bands in the visible 
region, a relatively long fluorescence decay time, facile tunability of their physicochemical 
properties by metallation or functionalization of the peripheral substituents.15 
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The metal-driven construction of multi-porphyrin assemblies exploits the formation of 
coordination bonds between peripheral basic site(s) on the porphyrins and metal centers. This has 
recently allowed the design and preparation of sophisticated supramolecular architectures.12 
Particularly attractive porphyrin arrays are those based on TpyP(4) (Figure 1.2). The electronic 
properties and solubility of TpyP(4) can be tuned by functionalization of the phenyl rings or the 
β-pyrrolic positions.16 TpyP(4) or related compounds can provide geometrically well-defined 
connections to as many as four metal centers by the coordinating ability of the peripheral pyridyl 
groups.17,18 4-meso pyridyl groups can be coordinated to metal-containing fragments of various 
coordination numbers and geometries.19 Adducts obtained by peripheral coordination of 
pyridylporphyrins to singly unsaturated metal centers have shown new, interesting photophysical 
properties.20,21 Similarly, when polyunsaturated metal fragments are used to bridge two or more 
TpyP(4) units, supramolecular species of considerable structural and photophysical interest are 
obtained.18 
 
Figure 1.2. Meso-tetra(4-pyridyl)porphyrin. 
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1.2 Cationic Porphyrins 
Most derivatives of cationic meso-tetraphenylporphyrins (TPPs) are based either on the 
pyridine or aniline structures, TpyP(4) and TMAP (Figure 1.3). The interaction of cationic 
porphyrins with DNA is of considerable interest due to their potential applications in medicine. 
The special properties of porphyrins such as high optical absorption, relatively high quantum 
yields of triplet state and fluorescence, or paramagnetism of some metal complexes provide the 
use of porphyrins in medicine, for instance, as active compounds in radiological therapy,22,23 and 
magnetic resonance imaging of cancer detection24 and as photosenstizers in photodynamic 
therapy (PDT) of cancer.22,23,25  
 
 
Figure 1.3. Structures of cationic porphyrins mentioned in this study. 
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Other work has demonstrated that cationic porphyrins can exhibit PDT against psoriasis 
atheromatous plaque, antiviral and antibacterial activity or act as artificial nucleases.26-31 
Porphyrins have been found to selectively accumulate in cancer cells more than in normal 
cells.32-34 The ability of porphyrins to selectively accumulate in tumors, in addition to the 
characteristic red fluorescence has led to use of porphyrins in tumor diagnosis.35 Interest in 
porphyrins and metalloporphyrins as photosensitizers and the need to understand their effect on 
DNA has led to extensive studies of porphyrin-DNA binding. From early studies of meso-tetra(4-
N-methylpyridiniumyl)porphyrin(TMpyP(4)) and several of its derivatives, Fiel et al. proposed 
three major binding modes for the classification of porphyrin-DNA interactions: intercalation, 
outside binding with self-stacking of the porphyrin and simple outside binding (Figure 1.4).36 
The interaction of cationic porphyrins with synthetic or natural DNA has been widely studied 
using visible and fluorescence37spectroscopy, circular dichroism (CD)36,38-40, Raman,41-43 
Nuclear Magnetic Resonance (NMR),31,41,42 Electron Spin Resonance (ESR),44 viscometry,42,45 
footprinting,46 kinetic methods47 and X-ray crystallography.48 
One motivation for these spectroscopic investigations has been to establish reliable criteria 
for differentiating between intercalative and outside binding modes of porphyrins with various 
synthetic and natural DNAs. A thorough investigation conducted in Pasternak’s laboratory 
showed that intercalating porphyrins are characterized by: (i) large red (Δλ ≥ 15 nm) and 
hypochromic (%H ≥ 35) shifts of their Soret maxima, (ii) negative induced CD activity in the 
Soret region, and (iii) high selectivity for the GC-rich DNA regions.40 In contrast outside binding 
porphyrins displayed: (i) much smaller red shifts (Δλ ≥ 8 nm) and little hypochromicity (%H ≤ 
10) and sometimes hyperchromicity) of their Soret maxima, (ii) positive induced CD bands in 
the Soret region, and (iii) a distinct selectivity for AT-rich DNA regions.40 
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The binding mode or modes of a specific porphyrin-DNA system are highly dependent on 
the location of the substituent groups of the porphyrin, the nature of the metal ion, and the type 
of DNA. In order to achieve intercalation, it has been proposed that the porphyrin must have a 
limited effective thickness. For example, the four planar N-methylpyridinium substituents of 
TMpyP(4) (Figure 1.3) allow intercalative binding,36,45,49,50 whereas a similar porphyrin, TMAP, 
with non-planar N-trimethylammonium substituents, is an outside binder.36,49 Metalloporphyrin 
derivatives of TMpyP(4) (MTMpyP(4)) having no axial ligands such as Au(III), Ni(II), Pt(II) 
and Cu(II) are also known to intercalate with calf thymus DNA (CT DNA) and poly(dG-dC)-
poly(dG-dC) (abbreviated as [poly(dG-dC)]2).40,45,51-55 In contrast, MTMpyP(4) that maintain 
axial ligands (Zn(II), Co(III), Fe(III), and Mn(III) do not intercalate but bind preferentially to 
poly(dA-dT)-poly(dA-dT) (abbreviated as [poly(dA-dT)]2) over poly [poly(dG-dC)]2.56-60 It’s 
believed that intercalation does not occur because the axial ligands sterically prevent the 
insertion of the porphyrin ring between DNA base pairs. Interestingly, none of the 
metalloporphyin derivatives of TMpyP(4), regardless of ligation, intercalate into [poly(dA-dT)]2. 
This finding has led to the conclusion that porphyrins selectively intercalate in regions of DNA 
with a high percentage of GC base pairs and undergo outside binding in regions high in AT base 
pairs.31,59,61  
Fiel and co-workers presented a systematic study of position isomers of TMpyP(4), 
including meso-tetra(3-N-methylpyridiniumyl)porphyrin (TMpyP(3), TMpyP(2).36,62 The 
absorbance, circular dichroism, and viscometric results indicated that TMpyP(3) could 
intercalate into CT DNA but that TMpyP(2) could not. 36 The metal-free porphyrin, meso-
tetra(2-N-methylpyridiniumyl)porphyrin (TMpyP(2)), in which the rotation of the N-methyl 
pyridyl group is prevented because of steric hindrance does not intercalate, but rather binds 
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externally to DNA and shows high specificity for AT-rich regions of DNA.36,40A comprehensive 
study of the DNA binding characteristics of 33 porphyrins by Sari et al. has evaluated the effect 
of the number of charges and their position on the porphyrin.37 All porphyrins were of the 
formula [meso-[N-methyl-4(or 3 or 2)-pyridiniuml]n(aryl)4-nPorphyrin]. From competitive 
binding assays with ethidium bromide, apparent binding constants were calculated for each of 
the porphyrins with CT DNA. The binding affinity was found to increase linearly with the 
increase in number of positive charges on the porphyrin.37 In addition, it was determined that the 
minimum requirement for intercalation was two freely rotating groups in a cis position. This 
result suggested that only half of the porphyrin needs to be in a planar conformation inorder to 
intercalate.37  
Over the years multiple steric issues have come to light in the quest to understand the 
DNA-binding interactions of the TMpyP (4) and its related compounds. Recent studies have 
shown that intercalation versus outside binding may also be influenced by charge on the 
porphyrin core63,64 and the ionic strength of the medium, which affects self association of the 
porphyrin.65,66 For instance, when the n-butyl group is attached to the periphery of the 
pyridinium ring, the porphyrin intercalates between the DNA base pairs,67 but when replaced by 
the tri-methyl group, the porphyrin exhibits an outside self-stacking binding mode,45 therefore 
indicating the importance of the steric effect of the periphery of the pyridinium ring. Fiel et al. 
found that TMAP binds to CT DNA in a self-stacking manner, characterized by a conservative 
induced CD signal.36 Pasternack and Gibbs et al. discovered extensive self-stacking of cis-bis(4-
N-methylpyridyl)diphenylporphyrin (cis-P(4) (Figure 1.3) and trans-bis(4-N-
methylpyridyl)diphenylporphyrin (trans-P(4) (Figure 1.3) along the DNA backbone.51,66,68 Our 
laboratory has studied the interaction of three tentacle porphyrins; (meso-tetra[2,3,5,6-
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tetrafluoro-4-(2-trimethylammoniumethylamine)phenyl]porphyrin (TθF4TAP), meso-tetra[4-[3-
trimethylammoniumpropyl)oxy]phenyl]porphyrin (TθOPP), meso-tetra[4-N-(3-
(trimethylammonio)-propyl)pyridyl]porphyrin (TθpyP) (Figure 1.3) with natural and synthetic 
DNA. These tentacle porphyrins all have similar size and shape but differ in electronic 
properties. The electron-withdrawing fluoro substituents on the aromatic rings make the 
porphyrin ring of TθF4TAP more electron deficient than that of TθOPP (electron-donating 
ability of the phenoxy aromatic substituents of TθOPP makes it more electron rich) and more 
like that of TθpyP which is electron deficient owing to the electron-withdrawing effect of the 
pyridinium groups.64 Spectroscopic and viscometric studies indicated that TθpyP (Figure 1.3) is 
an intercalator, whereas TθOPP and TθF4TAP are outside binders with self stacking along the 
backbone of CT DNA, [poly(dA-dT)]2 and [poly(dG-dC)]2 DNA.38,69,70 The electron-richness of 
the core of TθOPP may act to stabilize the self-stacked, outside bound DNA adduct, disfavoring 
intercalation.38 Sterically less demanding porphyrins 5-15-di(N-methylpyridinium-4-yl)porphyrin 
(D4) and 5-15-di(N-methylpyridinium-3-yl)porphyrin (D3) (Figure 1.4) have been synthesized 
by the McMillin group and the interaction of these porphyrins with DNA indicated that both 
porphyrins bind as intercalators, regardless of the base composition of the DNA host.71 
Many porphyrins form dimers and higher order aggregates in aqueous solution. Generally, 
anionic porphyrins (carboxy- and sulfonato-porphyrins) have shown a stronger tendency to self-
stack than cationic porphyrins. This behavior may be the result of a greater localized electron 
density in the core region, which would promote stronger van der Waals interactions in a face-
face dimer.72 Similarly, electron-donating substituents on cationic porphyrins, which produce 
relatively electron rich cores, also tend to promote the formation of dimers and higher order 
aggregates.73 For example, TMAP is electron rich, as indicated by the relatively high pKa values 
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of its pyrrolic nitrogens, and it aggregates in aqueous solution;74 TθOPP also has an electronic 
rich core due to the electron-donating ability of the phenoxy aromatic substituents (pKa = 4.6)64 
and exhibits aggregation properties similar to those of TMAP.64 Aggregation of these porphyrins 
is promoted at high salt concentrations, where repulsions of like charges are reduced. 
Cationic porphyrins aggregate quite readily in aqueous solution. Pasternack et al. first 
proposed72 the idea that TMpyP(4) exists only as a monomer in aqueous solution. The original 
conclusion was based on a straight-line Beer’s law plot over the concentration range 1-60 mM.72 
However, Kano et al., using mainly fluorescence techniques, argued that TMpyP(4) dimerizes 
very strongly even at concentrations below 0.1 μM.75 They observed unresolved fluorescence 
bands which tended to separate upon dilution and with increasing temperature.75 In 1H NMR 
studies, a broad singlet corresponding to the pyrrole protons of TMpyP(4) was interpreted as 
evidence for face-to face dimer.76 In contrast, other tetracationic porphyrins such as TMAP, 
TOpyP(4) (meso-tetra(4-N-octylpyridinium)porphyrin) aggregate spontaneously in aqueous 
solution in both the presence and absence of NaCl.74 Moreover two dicationic porphyrin 
derivatives (cis-P(4) and trans-P(4)) are known to form self aggregates.66,74 In particular, trans-
P(4) readily forms large aggregate assemblies. McMillin and co-workers have synthesized less 
sterically demanding porphyrin having less bulk at the periphery (tMe2D4) (Figure 1.3).71 The 
tMe2D4 system makes an interesting contrast with trans-P(4), tMe2D4 is a less hydrophobic 
porphyrin and generally is less prone to aggregation than trans-P(4).71 tMe2D4 (Figure 1.3) was 
found to intercalate into DNA, in contrast to reports on trans-P(4), which binds externally, 
forming long-range stacked structures.51,66,71  
The aggregation behavior of a porphyrin has a direct effect on its DNA-binding mode; 
porphyrins which aggregate strongly have a greater tendency to undergo outside binding with 
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self-stacking. Several porphyrins have been recognized as binding to DNA in this manner. 
TMAP binds to DNA in an outside binding with self-stacking mode and forms aggregates on 
DNA under higher ionic strength that differs from those that are formed under low ionic 
strength.77 Fe(II) form of TMAP outside bind to DNA under low ionic strength but at higher 
ionic strength the binding mode is outside binding with self-stacking.77 Other porphyrins which 
bind to DNA by this mode include cis-and trans-P(4), two dicationic porphyrins that exhibit 
intense conservative CD signals with CT DNA.51,66 Cu(II)TMpyP(4) is an outside binder with 
self-stacking with [poly(dA-dT)]2 at high porphyrin/DNA ratios, even though it can also 
intercalate at GC sites.78 TθOPP has positive charges on the side chains off the TPP.38,69 TθOPP 
bind to CT DNA with stacking of the porphyrin along the exterior of the DNA.38,69 
1.3 Porphyrins Containing Sulfonamide Links 
In this dissertation, the synthesis and applications of porphyrins containing sulfonamide 
groups (Figure 1.5) will be discussed. Part one of this dissertation presents the synthesis of new 
porphyrin derivatives of meso-tetraarylporphyrins (TArP) of the general formula 
T(R1R2NSO2Ar)P with R1 = N-py-CH2, in which n = 2 or 4 and R2 = H or CH3. These porphyrins 
are neutral, bearing pyridy groups linked to the 4-position of the phenylene group of the 
porphyrin by secondary (-SO2NHR) or tertiary (-SO2NR2) sulfonamide groups. The reaction of 
T(N-py-4-CH2(CH)3NSO2Ar)P and its model porphyrin, meso-tetra(4-pyridyl)porphyrin 
(TpyP(4)), with methylcobaloxime (CH3Co(DH)2H2O will be discussed. The newly synthesized 
porphyrin (T(N-py-4-CH2(CH)3NSO2Ar)P) contain a 4-pyridyl group attached to the aryl group 
of the porphyrin at the meso position through a sulfonamide link, and a methine group links the 
sulfonamide group and the pyridyl group; as a result, the pyridyl group is insulated from the 
porphyrin core. The effect of coordination of the methylcobaloxime (CH3Co(DH)2) to the N-
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pyridyl moeity of TpyP(4) and of the newly synthesized porphyrin (T(N-py-4-
CH2(CH3)NSO2Ar)P) has been examined by 1H NMR, visible, and fluorescence spectroscopic 
techniques.  
In part two of this dissertation, the synthesis, solution properties and the DNA-binding 
characteristics of the alkylated derivatives of the porphyrin with the general formula 
[MT(R2R1NSO2Ar)P]X4/8 are presented (where M = 2H, Cu(II) or Zn(II); R1 = CH3 or H and R2 
= N-Mepy-n-CH2- (N-Mepy = N-methylpyridinium group and n = 2, 3 or 4) or R1 = R2 = 
Et3NCH2CH2; and Ar = 4-C6H4-). The DNA binding modes of both the free base and the selected 
metalloporphyrins derivatives have been evaluated by absorbance, circular dichroism, and 
fluorescence spectroscopy for the metal-free derivatives. The main goal of the second part of this 
dissertation was to assess if N-Mepy groups must be directly attached to the porphyrin core in 
order for intercalative binding of porphyrins to DNA to take place. 
 
 
Figure 1.4. Three modes of porphyrin-DNA binding. Edge-on view of the porphyrin is 
represented as the dark rectangle, while the face on view is the pyrrole-shaped figure in 
the center. 
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Figure 1.5. General structure of the newly synthesized porphyrins. 
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CHAPTER 2. NEW PORPHYRINS BEARING PYRIDYL PERIPHERAL GROUPS 
LINKED BY SECONDARY OR TERTIARY SULFONAMIDE GROUPS: SYNTHESIS 
AND STRUCTURAL CHARACTERIZATION 
 
2.1 Introduction 
The special characteristics of porphyrins have led to numerous studies and applications both by 
nature and by mankind.1-3 Pyridylporphyrins (PyPs) in which the pyridine ring is directly 
attached to the porphyrin core have been used in supramolecular systems, usually with metal 
centers providing the linking group.4-6 A number of complexes with different coordination 
numbers involving ruthenium, rhenium and platinum have been coordinated symmetrically to N 
atoms of the peripheral pyridyl groups of meso-tetrapyridylporphyrins (TpyPs).5,7-10 Most studies 
have involved the meso-tetra(4-pyridyl)porphyrin (TpyP(4)) isomer, Chart 2.1. It has been shown 
that coordination of the different metal fragments to N atoms of the peripheral pyridyl groups not 
only solubilizes the porphyrin but also introduces useful functionalities into the system.6 For 
example, Alessio and co-workers recently reported adducts between a TpyP(4) pyridyl group and 
either one or four Re(I) bipyridine tricarbonyl units, and they have compared their photophysical 
properties to those of the parent TpyP(4).11  
A second type of application for PyPs, such as TpyP(4), is to convert them into water-soluble 
N-alkylpyridinium derivatives. These compounds have been shown to possess interesting 
biomedical properties such as antiviral activity, anticancer activity, etc. and to interact with DNA 
by a variety of binding modes.12-16 In many cases, metals bound to the center of the porphyrin 
influence the DNA binding mode.17-21 Organometallic complexes such as areneruthenium(II) 
compounds (e.g., [Ru(η6-C6H5CH3)(μ-Cl)Cl]2) have been coordinated to the pyridyl groups of 
TpyP(4) in order to combine the photodynamic action of the porphyrin with the cytotoxicity 
effect of the areneruthenium complexes.22 These PyPs are generally relatively rigid, a property 
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that may be helpful in constructing supramolecular systems,23,24 but it would be interesting to 
examine less rigid systems, particularly after the pyridines are converted to N-alkyl pyridinium 
groups. As a first step in this direction, we wanted to overcome some of the problems in 
constructing suitable porphyrins, chiefly the low-yield syntheses that hamper porphyrin 
chemistry and the poor solubility of such PyPs as TpyP(4). PyPs reported here were prepared 
from the simple meso-tetraphenylporphyrin (TPP). TPP can be modified by connecting to it 
different peripheral substituents, changing the central metal, or expanding the size of the 
macrocycle. In this initial report, we describe a very useful strategy to meet our goals of finding 
a versatile synthetic approach to preparing soluble PyPs. Good solubility allows facile addition 
of the metal to either the inner core of the porphyrin or to a peripheral pyridyl group.  
Furthermore, we report a method of making poorly soluble porphyrins (e.g., TpyP(4)) more 
soluble by using a dissociable metal-protecting group such as an organocobaloxime moiety, 
RCo(DH)2 (DH = the monoanion of dimethylglyoxime).  
Organocobaloximes (RCo(DH)2L), in which L is an N-donor ligand such as pyridine, have 
been used extensively to understand the fundamental chemistry related to the organocobalt B12 
coenzymes.25-31 In this work we exploit the lability and the well-understood NMR properties to 
explore the new porphyrins we have prepared. In particular, we describe the synthesis of new 
pyridyl porphyrins containing sulfonamide groups of the general formula, MT(R1R2NSO2Ar)P. 
Using 1H NMR, visible absorption and fluorescence spectroscopic techniques, we have 
examined the effect of coordination of the methylcobaloxime (CH3Co(DH)2) moiety to the N-
pyridyl group of TpyP(4) and of the newly synthesized porphyrin, T(N-py-4-
CH2(CH3)NSO2Ar)P. 
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2.2 Experimental Section 
2.2.1 Materials and Methods. 4-Cyanopyridine (4-CNpy), pyridine (py), 3,5-lutidine (3,5-
lut), 4-dimethylaminopyridine (4-Me2Npy), n-pyridylcarboxaldehyde (n = 2 or 4), n-
pyridylmethylamine (n = 2 or 4),Methyl sulfonyl chloride (CH3SO2Cl), methylamine (CH3NH2), 
meso-tetra(4-pyridyl)porphyrin (TpyP(4)), and all solvents were obtained from Sigma-Aldrich. 
5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (TClSO2PP (1), Scheme 2.1) was synthesized 
by a known method, and the 1H NMR chemical shifts in CDCl3 matched the reported values. 32 
CH3Co(DH)2H2O was prepared as previously reported.30 
All 1H NMR spectra were recorded on a 400 MHz Bruker NMR spectrometer. Peak positions 
are relative to TMS or solvent residual peak, with TMS as reference. Visible absorption spectra 
were recorded with a Cary 3 spectrophotometer. Excitation and fluorescence spectra of 5.0 μM 
porphyrin solutions (CH2Cl2) were recorded on a Fluorolog-3 spectrofluorimeter (Horiba Jobin 
Yvon) at room temperature. 
2.2.2 X-ray Data Collection and Structure Determination. All single crystals suitable for X-
ray crystallography were obtained by slow diffusion of methanol into dichloromethane solution. 
Single crystals were placed in a cooled nitrogen gas stream at 90 K on a Nonius Kappa CCD 
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα (λ 
= 0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan 
method, with HKL SCALEPACK.33 All X-ray structures were determined by direct methods and 
difference Fourier techniques and refined by full-matrix least squares, using SHELXL97.34 All 
hydrogen atoms were visible in difference maps, but were placed in idealized positions. A 
torsional parameter was refined for each methyl group.  
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Scheme 2.1. Synthesis of porphyrin ligands and PMMS.  
2.2.3 Synthesis of T(N-py-2-CH2(H)NSO2Ar)P (2) and T(N-py-4-CH2(H)NSO2Ar)P (3). A 
suspension of 1 (0.1 g, 0.1 mmol) in acetonitrile (15 mL) was treated with a solution of the 
respective amine in acetonitrile (0.5 mmol in 5 mL) at RT overnight. The suspension was 
filtered, and the purplish solid collected on the filter was washed with water several times (3 × 15 
mL), followed by diethyl ether, and then air-dried.  
T(N-py-2-CH2(H)NSO2Ar)P (2). Treatment of 1 (0.1 g, 0.1 mmol) with 2-
pyridylmethylamine (50 μL, 0.5 mmol) as described above afforded porphyrin 2 as a purple 
powder (0.128 g, 83% yield). 1H NMR (ppm) in DMSO-d6: 8.80 (8H, s, β-pyrrole), 8.54 (4H, br, 
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NH-sulfonamide), 8.36 (8H, d, ArH), 8.18 (8H, d, ArH), 7.86 (4H, t, pyH), 7.52 (4H, d, pyH), 
7.35 (4H, t, pyH), 8.17-8.13 (4H, t, pyH), 4.45 (8H, d, CH2), -2.99 (2H, br, NH).  
T(N-py-4-CH2(H)NSO2Ar)P (3) Treatment of 1 (0.1 g, 0.1 mmol) with 4-pyridylmethylamine 
(50 μL, 0.5 mmol) as described above afforded porphyrin 3 as a purple powder (0.11 g, 76% 
yield). 1H NMR (ppm) in DMSO-d6: 8.76 (12H, s, β-pyrrole and NH-sulfonamide), 8.60 (8H, d, 
pyH), 8.36 (8H, d, ArH), 8.19 (8H, d, ArH), 7.43 (8H, d, pyH), 4.42 (8H, d, CH2), -3.01 (2H, br, 
NH).  
2.2.4 Synthesis of T(N-py-n-CH2(CH3)NSO2Ar)P Porphyrins (n = 2 or 4). Porphyrins 4 and 
5 (below) were synthesized from secondary amines, prepared by a slight modification of a 
published procedure.35 A solution of 1.0 g (9.34 mmol) of n-pyridylcarboxaldehyde (n = 2 or 4) 
in water (5 mL) was saturated with methylamine gas until the solution was cloudy. The resulting 
solution was stirred at RT for 2 h. Solvent removal under vacuum left a pale yellow oil of the 
Schiff base (~1.0 g); Schiff base formation was confirmed by a characteristic 1H NMR imine 
signal (N-(4-pyridylmethylene)methylamine at 8.16 ppm, N-(2-pyridylmethylene)methylamine at 
8.35 ppm). The yellow oil (9.34 mmol) was dissolved in 10 mL of methanol, 0.472 g of NaBH4 
was added, and the reaction mixture then left stirring at RT for 30 min. The solvent was 
evaporated under vacuum; the residue was dissolved in water (10 mL) and extracted into CH2Cl2 
(3 × 10 mL). The organic phase was dried over anhydrous Na2SO4 and the solvent evaporated 
under vacuum to yield pale yellow oils that were characterized by 1H NMR spectroscopy. These 
oils were used to synthesize porphyrins 4 and 5 as follows: a solution of 1 (0.2 g, 0.198 mmol) in 
CH2Cl2 (20 mL) was treated with 0.11 g (0.89 mmol) of N-methyl-N-(n-pyridylmethyl)amine (n 
= 2 or 4) in CH2Cl2 (5 mL). The reaction mixture was stirred at RT overnight, and the precipitate 
that formed was removed by filtration. The filtrate was washed with water (3 × 15 mL), dried 
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over anhydrous Na2SO4, and the solvent removed under vacuum. The residue was recrystallized 
from CH2Cl2/methanol. 
T(N-py-2-CH2(CH3)NSO2Ar)P (4). The general method described above, starting with 2-
pyridylcarboxaldehyde (9.34 mmol, 1 g) and CH3NH2, yielded N-methyl-N-(2-
pyridylmethyl)amine as a pale yellow oil (0.89 g, 76% yield). 1H NMR (ppm) in CDCl3: 8.53 
(1H, d, ArH), 7.66 (1H, t, ArH), 7.28 (1H, d, ArH), 7.16 (1H, s, ArH), 3.83 (2H, s, CH2), 2.50 
(3H, s, CH3).1.86 (1H, br, NH). GC-MS(m/z): M+ = 123.2. Calcd for M+ = 123.17. Treatment of 
1 (0.2 g, 0.198 mmol) with N-methyl-N-(2-pyridylmethyl)amine (0.11g, 0.89 mmol) as described 
above afforded porphyrin 4 as a purple powder (0.16 g, 59% yield). 1H NMR (ppm) in DMSO-
d6: 8.90 (8H, s, β-pyrrole), 8.59 (4H, d, pyH), 8.47 (8H, d, ArH), 8.25 (8H, d, ArH), 7.90 (4H, m, 
pyH), 7.56 (4H, d, pyH), 7.39 (4H, m, pyH), 4.60 (8H, s, CH2), 2.99 (12H, CH3), -2.94 (2H, br, 
NH). ESI-MS(m/z): [M + H]+ = 1351.4077, [M + 2H]+2 = 676.2076, [M + 3H]+3 = 451.1437. 
Calcd for [M + H]+ = 1351.3775, [M + 2H]+2 = 676.1926, [M + 3H]+3 = 451.1310. 
T(N-py-4-CH2(CH3)NSO2Ar)P (5). The general method described above, starting with 4-
pyridylcarboxaldehyde (9.34 mmol, 1 g) and CH3NH2, yielded N-methyl-N-(4-
pyridylmethyl)amine as a pale yellow oil (0.94 g, 83% yield). The 1H NMR spectrum in CDCl3 
matches that reported in the literature.36 1H NMR (ppm) in CDCl3: 8.53 (2H, d, ArH), 7.24 (2H, 
d, ArH), 3.77 (2H, s, CH2), 2.46 (3H, s, CH3), 1.98 (1H, br, NH). GC-MS(m/z): M+ = 123.0. 
Calcd for M+ = 123.17. Treatment of 1 (0.2 g, 0.198 mmol) with N-methyl-N-(4-
pyridylmethyl)amine (0.11g, 0.89 mmol) as described above afforded porphyrin 5 as a purple 
powder (0.15 g, 55% yield). 1H NMR (ppm) in DMSO-d6: 8.92 (8H, s, β-pyrrole), 8.65 (8H, d, 
pyH), 8.51 (8H, d, ArH), 8.30 (8H, d, ArH), 7.46 (8H, d, pyH), 4.54 (8H, s, CH2), 2.93 (12H, s, 
CH3), -2.92 (2H, br, NH). ESI-MS(m/z): [M + H]+ = 1351.4107, [M + 2H]+2 = 676.2096, [M + 
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3H]+3 = 451.1451. Calcd for [M + H]+ = 1351.3775, [M + 2H]+2 = 676.1926, [M + 3H]+3 = 
451.1310. 
Table 2.1. Characteristic Absorption and Emission Maxima of Methylcobaloxime–Porphyrin 
Adducts and of the Porphyrin Models in CH2Cl2 
compound absorption (λmax/nm) emission 
 Soret band  Q bands  λem (nm)a 
T(N-py-4-CH2(CH3)NSO2Ar)P (5) 420 514, 548, 
589, 644 
650 714 
Cu(II)5 416 540   
Zn(II)5 424 550, 596 603 649 
[CH3Co(DH)2]4Por5 (6) 420 514, 548 
589, 644 
650 714 
[CH3Co(DH)2]4Cu(II)5 (7) 416 540   
[CH3Co(DH)2]4Zn(II)5 (8) 424 550, 596 599 648 
TpyP(4) 416 510, 544,  
587, 642 
649 712 
Cu(II)TpyP(4) 418 538   
Zn(II)TpyP(4) 424 550, 596 602 652 
[CH3Co(DH)2]4TpyP(4) (9) 422 515, 550, 590, 
646 
652 714 
[CH3Co(DH)2]4Cu(II)TpyP(4) (10) 418 540   
[CH3Co(DH)2]4Zn(II)TpyP(4) (11) 424 551, 594 603 646 
a λexc = 420 nm. 
Cu(II)T(N-py-4-CH2(CH3)NSO2Ar)P (Cu(II)5). A solution of 5 (50 mg, 0.037 mmol) in 
CH2Cl2 (10 mL) was treated with copper(II) acetate (6.4 mg, 0.037 mmol) in methanol (5 mL). 
The solution was left stirring at RT for about 1 h. Completion of the reaction was indicated by 
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the collapse of the four Q bands of the free base to one Q band (Table 2.1). The reaction mixture 
was reduced in volume to about 1 mL, and acetone was added to precipitate Cu(II)5 as a red 
powder. (48 mg, 92% yield). 1H NMR (ppm) in CDCl3: 8.74 (8H, br, pyH), 8.05 (8H, br ArH), 
7.49 (8H, d, pyH), 4.46 (8H, br, CH2), 2.92 (12H, br, CH3).  
Zn(II)T(N-py-4-CH2(CH3)NSO2Ar)P (Zn(II)5). A solution of 5 (50 mg, 0.037 mmol) in 
CH2Cl2 (10 mL) was treated with zinc(II) acetate (40 mg, 0.19 mmol) in methanol (2 mL). The 
solution was left stirring at RT for 2 h, after which an aliquot of the reaction mixture was 
analyzed by using visible spectroscopy. The metal insertion was complete, as indicated by the 
collapse of the four Q bands to two Q bands (Table 2.1). After the CH2Cl2 was removed by 
rotary evaporation, the purple precipitate that formed was collected on a filter and washed with 
methanol to remove the excess of zinc acetate and air dried to afford Zn(II)5 (30 mg, 58% yield). 
1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole), 8.64 (8H, d, pyH), 8.46 (8H, d, ArH), 8.28 
(8H, d, ArH), 7.46 (8H, d, pyH), 4.55 (8H, d, CH2), 2.93 (12H, s, CH3). 
2.2.5 Synthesis of ([CH3Co(DH)2])4T(N-py-4-CH2(CH3)NSO2Ar)P (6). CH3Co(DH)2H2O 
(95 mg, 0.30 mmol) was added to a solution of 5 (0.1 g, 0.074 mmol) in CH2Cl2 (20 mL) and 
stirred until a clear solution resulted (~5 min). The solution was filtered and treated with 5 mL of 
ethyl acetate. After partial evaporation of the solution, a brownish precipitate was collected on a 
filter, washed with diethyl ether, and vacuum dried to afford 6 (Chart 2.1) as a brown precipitate 
(0.17 g, 92% yield). 1H NMR (ppm) in CDCl3: 18.34 (8H, s, OH), 8.85 (8H, s, β-pyrrole), 8.67 
(8H, d, pyH), 8.44 (8H, d, ArH), 8.26 (8H, d, ArH), 7.44 (8H, d, pyH), 4.54 (8H, d, CH2), 3.00 
(12H, CH3), 2.15 (48H, s, CH3), 0.82 (12H, d, Co-CH3), -2.79 (2H, br, NH).  
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Chart 2.1 
 
[CH3Co(DH)2]4Cu(II)T(N-py-4-CH2(CH3)NSO2Ar)P (7). The general method described 
above with CH3Co(DH)2H2O (45 mg, 0.14 mmol) and Cu(II)5 (50 mg, 0.035 mmol) afforded 7 
(Chart 2.1) as a red precipitate (65 mg, 69% yield). 1H NMR (ppm) in CDCl3: 18.30, (8H, s, 
OH), 8.62 (8H, br, pyH), 8.02 (8H, br ArH), 7.38 (8H, d, pyH), 4.44 (8H, d, CH2), 2.90 (12H, 
CH3), 2.14 (48H, s, CH3), 0.81 (12H, d, Co-CH3).  
[CH3Co(DH)2]4Zn(II)T(N-py-4-CH2(CH3)NSO2Ar)P (8). The general method described 
above with CH3Co(DH)2H2O (45 mg, 0.14 mmol) and Zn(II)5 (50 mg, 0.035 mmol) afforded 8 
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(Chart 2.1) as a purple precipitate (50 mg, 53% yield). 1H NMR (ppm) in CDCl3: 18.18 (8H, s, 
OH), 8.94 (8H, s, β-pyrrole), 8.63 (8H, d, ArH), 8.44 (8H, d, ArH), 8.24 (8H, d, ArH), 7.41 (8H, 
d, pyH), 4.54 (8H, d, CH2), 3.01 (12H, CH3), 2.12 (48H, s, CH3), 0.77 (12H, d, Co-CH3).  
[CH3Co(DH)2]4TpyP(4) (9). CH3Co(DH)2H2O (0.21 g, 0.64 mmol) was added to a suspension 
of TpyP(4) (0.1 g, 0.16 mmol) in CH2Cl2 (10 mL). After stirring (~5 min), the suspension 
became a solution, which was then filtered and 5 mL of ethyl acetate was added. After partial 
evaporation of the solution, a reddish precipitate was collected on a filter, washed with diethyl 
ether, and vacuum dried to afford 9 (Chart 2.1, 0.28 g, 94% yield). 1H NMR (ppm) in CDCl3: 
18.53 (8H, s, OH), 9.03 (8H, d, pyH), 8.75 (8H, s, β-pyrrole), 8.15 (8H, d, pyH), 2.33 (48H, s, 
CH3), 1.03 (12H, s, Co-CH3), -3.04 (2H, br, NH).  
[CH3Co(DH)2]4Cu(II)TpyP(4) (10). A solution of 9 (50 mg, 0.027 mmol) in CH2Cl2 (10 mL) 
was treated with a methanol solution (5 mL) of Cu(II) acetate (8.2 mg, 0.041 mmol). The 
solution was stirred at RT for 2 h, then filtered and left standing at RT overnight. The precipitate 
that formed was collected on a filter and vacuum dried, affording 10 (Chart 2.1) as a red 
precipitate (43 mg, 85%). 1H NMR (ppm) in CDCl3: 18.23 (8H, s, OH), 8.79 (8H, br, pyH), 2.26 
(48H, s, CH3), 0.96 (12H, s, Co-CH3).  
[CH3Co(DH)2]4Zn(II)TpyP(4) (11). Treatment of a solution of 9 (50 mg, 0.027 mmol) with a 
methanol solution (5 mL) of Zn(II) acetate (8.9 mg, 0.041 mmol) as described for 10 above 
afforded 11 (Chart 2.1) as a purple precipitate (39 mg, 77% yield). 1H NMR (ppm) in CDCl3: 
18.42(8H, s, OH), 8.97 (8H, d, pyH), 8.82 (8H, s, β-pyrrole), 8.13 (8H, d, pyH), 2.29 (48H, s, 
CH3), 0.97 (12H, s, Co-CH3).  
N-Methyl-N-(4-pyridylmethyl)methanesulfonamide (PMMS). A solution of 0.57 g (5 
mmol) of CH3SO2Cl in CH2Cl2 (50 mL) was added dropwise over the course of ~0.5 h to a 
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solution of 1.12 g of N-methyl-N-(4-pyridylmethyl)amine (10 mmol) in of CH2Cl2 (50 mL). The 
reaction mixture was stirred at RT overnight.  The reaction mixture was filtered and washed with 
water (3 × 50 mL). The CH2Cl2 was dried over anhydrous Na2SO4 and the solvent evaporated 
under vacuum to yield a pale yellow oil (0.76 g, 68% yield). 1H NMR (ppm) in CDCl3: 8.60 (1H, 
d, ArH), 7.29 (1H, d, ArH), 4.32 (2H, s, CH2), 2.89 (3H, s, CH3), 2.80 (3H, s, CH3). 
Synthesis of [CH3Co(DH)2]PMMS. CH3Co(DH)2H2O (100 mg, 0.31 mmol) was added to a 
solution of PMMS (62 mg, 0.31 mmol) in CH2Cl2 (20 mL) and stirred until a clear solution 
resulted (~5 min). The solution was filtered and treated with 5 mL of ethyl acetate. After partial 
evaporation of the solution, an orange precipitate was collected on a filter, washed with diethyl 
ether, and vacuum dried to afford [CH3Co(DH)2]PMMS as an orange precipitate (0.14 g, 90% 
yield). 1H NMR (ppm) in CDCl3: 18.29, (8H, s, OH), 8.59 (8H, d, pyH), 7.31 (8H, d, pyH), 4.32 
(8H, d, CH2), 2.91 (3H, CH3), 2.84 (3H, s, CH3), 2.13 (12H, s, CH3), 0.83 (12H, d, Co-CH3).  
2.3 Results and Discussion  
2.3.1 Crystal Structures of T(N-py-4-CH2(CH3)NSO2Ar)P (5) and Cu(II)T(N-py-4-
CH2(CH3)NSO2Ar)P (Cu(II)5). X-ray quality crystals of porphyrin 5 and its copper complex 
were obtained by slow diffusion of methanol into a dichloromethane solution of the respective 
compound. Crystal data and structural refinement details are summarized in Table 2.2. ORTEP 
drawings of 5 and Cu(II)5 are shown in Figure 2.1; 5 and Cu(II)5 lie on an inversion center. The 
24-atom core of 5 is planar. The two distances (2.018 and 2.091 Å) from the centroid (Ct) of the 
pyrrole nitrogens to Npyrrole and NHpyrrole, respectively, in 5 are comparable to the respective 
values of 2.026 and 2.099 Å for TPP.37 The phenyl rings of 5 are almost perpendicular to the 
plane of the porphyrin, with dihedral angles of 84.9(2)° and 73.3(2)°. Two of the pyridyl rings of 
5 are almost in the plane of the porphyrin, with a dihedral angle of 4.6(3)° and the other two 
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pyridyl rings are slightly out of the plane of the porphyrin with a dihedral angle of 36.1(3)°.The 
coordination about the copper atom of Cu(II)5 is square planar (Figure 2.1). The two Cu-N 
distances are 2.001(5) and 2.002(6) Å, which are comparable to that for Cu(II)TPP (1.995(2) 
Å).38 The phenyl rings of Cu(II)5 are almost perpendicular to the plane of the porphyrin with 
dihedral angles of 83.5(3)° and 84.0(3)°. Two of the pyridyl rings of Cu(II)5 are almost in the 
plane of the porphyrin with a dihedral angle of 3.7(4)°, while the dihedral angle for the other two 
pyridyl rings is 31.2(5)°.  
 
 
Figure 2.1. ORTEP drawings of T(N-py-4-CH2(CH3)NSO2Ar)P (5) and Cu(II)5 with 50% 
ellipsoids. 
 
The overlay of the porphyrin core of Cu(II)TPP and Cu(II)5 gave an RMS value of 0.0136 Å. 
This good fit implies that having substituents at the periphery of the porphyrin does not affect the 
planarity of the core. Preliminary X-ray results also confirmed the synthesis of 4 (Figure A1). 
 
 29
Table 2.2. Crystal Data and Structure Refinement for T(N-py-4-CH2(CH3)NSO2Ar)P (5), 
Cu(II)5, and [CH3Co(DH)2]4TpyP(4) (9) 
 5 Cu(II)5 9 
formula C72H62N12O8S4•4CH3OH C72H60CuN12O8S4•4CH3OH C76H94Co4N24O16•12CHCl3 
fw 
color 
1479.74 
red 
1541.27 
orange 
3267.89 
orange 
cryst syst 
space group 
monoclinic 
P21/c 
monoclinic 
P21/c 
triclinic 
1P  
unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
13.879(5) 
12.776(4) 
21.131(8) 
13.530(4) 
12.967(4) 
21.020(7) 
13.356(2) 
13.893(2) 
19.974(4) 
α (deg) 
β (deg) 
γ (deg) 
90 
99.184(15),  
90 
90 
97.227(14) 
90 
72.830(9) 
73.905(7) 
75.270(9) 
V (Å3) 3699(2) 3659(2) 3341.7(10) 
Z 2 2 1 
T (K) 90 90 90 
ρcalc (mg m–3) 1.329 1.399 1.624 
abs coeff (mm–1) 0.20 0.48 1.27 
2max (deg) 46.0 46.0 46.0 
R indicesa 
wR2 = [I > 2σ(I)]b 
0.090  
0.247 
0.096  
0.280 
0.051 
 0.136  
data/params 5081 / 471  5066 / 477 9107 / 795 
aR = (∑||Fο| - |Fc||)/∑|Fο|.  bwR2 = [∑[w(Fο2 – Fc2)2]/∑[w(Fο2)2]]1/2. 
2.3.2 Crystal Structure of [CH3Co(DH)2]4TpyP(4) (9). Crystals of porphyrin 9 were 
obtained by layering hexane in a chloroform solution of 9. The crystals permitted the first X-ray 
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structural determination of the TpyP(4) molecule with four CH3Co(DH)2 units, each bound to a 
pyridyl nitrogen (Table 2.2, Figure 2.2). In the crystal, the porphyrin has an inversion center. The 
planes of the pyridyl groups make dihedral angles of 78.1(2)° and 64.1(2)° with the plane of the 
porphyrin. The equatorial plane of the pseudo-octahedral methylcobaloxime units is nearly 
perpendicular to the plane of the porphyrin, with dihedral angles of 89.6(1)° and 81.4(1)°. The 
Co–Neq bond distances range from 1.882(4)–1.892(5) Å (Table A1), which is close to the range 
reported for CH3Co(DH)2py (1.877(2)–1.905(5) Å).39 The Co−N(axial) distances of 9 are 
2.055(4) and 2.079(4) Å (Table A1), in good agreement with the value reported for 
CH3Co(DH)2py (2.068(3) Å).39 The Co−CH3 bond lengths of 9 (1.999(5) and 2.002(5) Å) are 
very close to the value reported for CH3Co(DH)2py (1.998(5) Å).39 
 
Figure 2.2. ORTEP drawing of [CH3Co(DH)2]4TpyP(4) (9) with 50% ellipsoids. 
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2.3.3 Synthesis of the Porphyrins, Porphyrin-Cobaloxime Adducts, and Their Metal 
Complexes. Treatment of 1 (TClSO2PP, Scheme 2.1) with primary amines such as 2- or 4-
pyridylmethylamine generated porphyrins containing secondary sulfonamide groups (2 and 3). 
Metallation of such porphyrins resulted in an insoluble material, possibly because the metal 
coordinates to the sulfonamide group through both the sulfonyl oxygen and the deprotonated 
sulfonamide nitrogen.40-42 The potential for secondary sulfonamides to coordinate to metals led 
us to investigate the synthesis of porphyrins containing only tertiary sulfonamide groups. The 
presence of an N-Me group in place of the dissociable NH group allowed us to prepare 
porphyrins (4 and 5) that are very soluble in organic solvents; these were characterized by mass 
spectrometry and 1H NMR spectroscopy. Cu(II) and Zn(II) complexes of porphyrin 5 were also 
prepared.  
Methylcobaloxime complexes (CH3Co(DH)2L) are generally synthesized from 
CH3Co(DH)2H2O by substitution of water in the presence of an excess of L in methanol 
solution30 or in a CH2Cl2 suspension.29 Addition in a 4:1 ratio of CH3Co(DH)2H2O to L (L = 
T(N-py-4-CH2(CH3)NSO2Ar)P and TpyP(4)) in dichloromethane produced  [CH3Co(DH)2]4L 
adducts. The related metalloporphyrin adducts can be prepared by reaction of the 
metalloporphyrin with CH3Co(DH)2H2O or by insertion of the metal ion into the isolated 
[CH3Co(DH)2]4L adducts. Both methods were efficient and afforded the corresponding zinc and 
copper complexes in good yield. Because TpyP(4) is not very soluble in chloroform or 
dichloromethane and the adduct is soluble, metal insertion into the [CH3Co(DH)2]4TpyP(4) 
adduct (9) is the preferred method. Insertion of Zn(II) into ([CH3Co(DH)2]4T(N-py-4-
CH2(CH3)NSO2Ar)P) (6) and 9 led to two Q bands instead of four and a 2 nm red shift of the 
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Soret band, while insertion of Cu(II) led to one Q band and a 4 nm blue shift of the Soret band; 
these changes are similar to those found upon metallation of other porphyrins by these metals.43  
2.3.4 Solution Studies. Porphyrins 2 to 5 were characterized by 1H NMR spectroscopy in 
CDCl3 and DMSO-d6 (Tables 2.2 and A2). As a result of shielding by the porphyrin ring current, 
the β-pyrrole proton signals are downfield (~ 8.8 ppm) and the NH signals appear upfield (~-2.9 
to -3.0 ppm).  
The 1H NMR spectra of T(N-py-4-CH2(CH3)NSO2Ar)P (5) and [CH3Co(DH)2]4T(N-py-4-
CH2(CH3)NSO2Ar)P (6) are compared in Figure 2.3. The 1H NMR shifts of the β-pyrrole, H2,6, 
and H3,5 signals of 6 in CDCl3 are slightly upfield (by (0.02-0.03 ppm) to those of 5 (Table 2.3).  
 
Table 2.3. Selected 1H NMR Shifts (ppm) of Porphyrin and [CH3Co(DH)2]4–Porphyrin  
Signalsa  
compound O–H…O Hβb H3,5 (py) H2,6 (py) dmgH CH3–Co -NH 
T(N-py-4-CH2(CH3)NSO2Ar)P (5)  8.87 7.42 8.70   -2.79 
[CH3Co(DH)2]4Por5 (6) 18.34 8.85 7.44 8.67 2.15 0.82 -2.79 
[CH3Co(DH)2]4Cu(II)5 (7) 18.30  7.38 8.62 2.14 0.80  
[CH3Co(DH)2]4Zn(II)5 (8) 18.18 8.94 7.41 8.63 2.12 0.77  
TpyP(4)  8.87 8.16 9.06   -2.92 
[CH3Co(DH)2]4TpyP(4) (9) 18.53 8.75 8.15 9.03 2.33 1.03 -3.04 
[CH3Co(DH)2]4Cu(II)TpyP(4) (10) 18.23   8.79 2.26 0.96  
[CH3Co(DH)2]4Zn(II)TpyP(4) (11) 18.42 8.82 8.13 8.97 2.29 0.98  
py   7.29 8.61    
CH3Co(DH)2py 18.32  7.33 8.61 2.13 0.83  
a 5 mM in CDCl3. b β -pyrrole.  
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Figure 2.3. Comparison of the 1H NMR spectra of T(N-py-4-CH2(CH3)NSO2Ar)P (5) (bottom) 
and [CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P (6) (top) in CDCl3. 
 
Normally coordination of a metal would cause downfield shifts of such signals. The upfield shift 
of H2,6 arises from the anisotropic shielding by Co,27,28 which more than counteracts the 
deshielding typically resulting from the inductive effect of a metal. The sharp singlet for the 
equatorial DH methyls and the broad signal of the oxime O–H–O bridge of the CH3Co(DH)2 
moieties for 6 have shifts of 2.15 ppm and 18.34 ppm, respectively. These shifts are similar to 
the 2.13 ppm and 18.32 ppm values observed for CH3Co(DH)2py,27 as expected. For the axial 
methyls, a singlet was observed at 0.82 ppm for 6. Insertion of Cu(II) and Zn(II) into porphyrin 6 
resulted in a general upfield shift for the axial methyl signal (Table 2.4). The H3,5 and H2,6 1H 
NMR signals of TpyP(4) and [CH3Co(DH)2]4TpyP(4) (9) (shown in CDCl3 in Figure 2.4) are 
respectively ~0.7 and 0.35 downfield from those of 5 and 6. Such downfield shifts for TpyP(4) 
and 9, as well as the greater downfield shift of H3,5 vs. H2,6, could be explained either by an 
inductive or by an anisotropic effect of the porphyrin core.  
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Table 2.4. 1H NMR Chemical Shifts (ppm) for CH3Co(DH)2L Complexes in CDCl3  
L pKa CH3–Co DH methyls 
4-CNpya 1.9 0.90 2.13 
pya 5.9 0.83 2.13 
3,5-luta 6.2 0.77 2.13 
4-Me2Npya 9.7 0.72 2.13 
a Values from reference 27.  
 
Figure 2.4. Comparison of the 1H NMR spectra of TpyP(4) (bottom) and 
[CH3Co(DH)2]4TpyP(4) (9) (Top) in CDCl3. 
 
When compared to the shifts of the parent TpyP(4), several signals of 9 (Table 2.3) are 
moderately or slightly upfield (the β-pyrrole proton signal by 0.12 ppm, the pyridyl H2,6 signal 
by 0.03 ppm, and the H3,5 signal by 0.01 ppm). The upfield shifts of the pyridyl signals arise 
from the anisotropy of Co.27,28 In a previous study,5 coordination of four cis,cis,cis-
RuCl2(dimethylsulfoxide)2CO units to the pyridyl groups of TpyP(4) was found to cause 
downfield shifts of the β-pyrrole (0.07 ppm), H2,6 (0.45 ppm) and H3,5 (0.06 ppm) signals.5 
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This result is in contrast to the upfield-shifted porphyrin signals we have observed with 
[CH3Co(DH)2]4TpyP(4) (9). The NH signal of 9 (-3.04 ppm) is shifted upfield by 0.12 ppm, as 
compared to that of TpyP(4) (-2.92 ppm) (Table 2.3).  
Sharp singlets observed at 2.33 ppm and at 1.03 ppm for the equatorial and axial methyl 
protons of [CH3Co(DH)2]4TpyP(4) (9) are shifted downfield by 0.20 ppm when compared to the 
corresponding signals for CH3Co(DH)2py.27 The axial methyl signal of CH3Co(DH)2L shifts 
upfield with increasing L basicity;28 thus, the downfield shift of the axial methyl observed with L 
= TpyP(4) indicates either that TpyP(4) peripheral pyridyls are much less basic than pyridine or 
that the signal is shifted by porphyrin anisotropy. Unlike the axial methyl signal, the equatorial 
methyl signal of CH3Co(DH)2L compounds is insensitive to L basicity and tends not to vary 
much from compound to compound unless L is anisotropic.25 The usual value is ~2.15 ppm; the 
much further downfield signal for [CH3Co(DH)2]4TpyP(4) (9) indicates that anisotropy, not 
basicity, is responsible. Insertion of a metal into 9 to form the Cu(II) (10) and Zn(II) (11) 
derivatives resulted in a general upfield shift of the signals of the CH3Co(DH)2 and pyridyl 
moieties (Table 2.3). Previous studies have shown that insertion of Zn(II) into TpyP(4) increases 
the basicity of the pyridyl nitrogen.44-46 This increased basicity is confirmed by the more upfield 
shift of the axial methyl signal of 11 compared to 9. Nevertheless, the downfield shift position of 
the axial methyl signal of 9, 10, and 11 indicates either low pyridyl basicity or a porphyrin 
anisotropic effect extending out to this long distance. More basic L form more stable 
CH3Co(DH)2L compounds, and thus we assessed relative binding ability. 
A CDCl3 solution initially 10 mM in 3,5-lut and 5 mM in [CH3Co(DH)2]4TpyP(4) (9) gave a 
1H NMR spectrum (Figure 2.5) with signals for CH3Co(DH)2(3,5-lut), indicating some 
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displacement of the CH3Co(DH)2 moiety from 9. In addition to the NH signal for 9 at -3.04 ppm, 
NH signals for new species were observed at -3.01, -2.97, -2.94 and -2.92 ppm (Figure 2.5).  
 
 
Figure 2.5. Inner NH signals of the 1H NMR spectra of TpyP(4) (a); [CH3Co(DH)2]4TpyP(4) 
(b); [CH3Co(DH)2]4TpyP(4) : 3,5-lut = 1:2 (c); [CH3Co(DH)2]4TpyP(4) : 3,5-lut = 1:4 (d); 
[CH3Co(DH)2]4TpyP(4) : 3,5-lut = 1:8 (e) in CDCl3. 
 
In a similar study performed with 40 mM 3,5-lut, the relative size of the NH signals changed. 
This change and the relative shift trend (the NH signal shifted downfield as the number of 
CH3Co(DH)2 moieties displaced increased) allowed assignment of the NH signal to the different 
adducts. The distribution of the TpyP(4) adducts differing in the number of CH3Co(DH)2 
moieties is summarized in Table 2.5. The shifts for the NH and other signals are given in Table 
A3. 
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Table 2.5. Distributiona (%) of Various [CH3Co(DH)2] Adducts after Addition of Pyridines to a 
CDCl3 Solution of [CH3Co(DH)2]4TpyP(4) (9) 
9 : pyridine ratio number of coordinated [CH3Co(DH)2] units 
 0 1 2 3 4 
9 : 4-CNPy (1:2) 0 6 21 42 31 
9 : 4-CNPy (1:8) 6 22 37 27 8 
9 : 3,5-lut (1:2) 4 16 35 32 13 
9 : 3,5-lut (1:8) 49 36 12 3 0 
a Distribution determined from NH signals. 
 
Addition of a 40 mM solution of 3,5-lut led to considerable displacement of the porphyrin 
ligand, with 49% of the porphyrin completely lacking a CH3Co(DH)2 moiety (Table 2.5). Two 
DH methyl peaks were observed. One peak of the signal is for CH3Co(DH)2(3,5-lut) (2.13 ppm), 
a value similar to that observed previously.27,28 The second peak (2.33 ppm) is broad and arises 
from overlapping signals of [CH3Co(DH)2]nTpyP(4) adducts (n = 1, 2, 3 and 4). In solutions of 9 
containing 3,5-lut, two signals were observed for the axial methyls. The signal at 0.77 ppm 
matches that of CH3Co(DH)2(3,5-lut), while the other signal (1.03 ppm) is broad and matches 
that of the [CH3Co(DH)2]nTpyP(4) adducts (where n = 1, 2, 3 and 4). By integration of the axial 
methyl signals, the percentage of CH3Co(DH)2 moiety bound in TpyP(4) adducts and the 
percentage in CH3Co(DH)2(3,5-lut) could be determined (Table 2.6). In the experiment with 10 
mM 3,5-lut (9:3,5-lut = 1:2), 51% of the CH3Co(DH)2 was bound to 3,5-lut, while 49% was still 
bound to the porphyrin (Table 2.6); however, in the presence of 40 mM 3,5-lut (9:3,5-lut = 1:8), 
these values were 79% and 21%, respectively (Table 2.6). 
A procedure similar to that described above was used to assign the different adducts of 4-CNpy 
and 9. When 4-CNpy (40 mM) was added to a solution of 9 (5 mM) several TpyP(4) adducts 
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were observed. Only 6% of the porphyrin lacked a CH3Co(DH)2 moiety (Table 2.5). In the 9:4-
CNpy = 1:2 experiment, only 28% of the 4-CNpy was bound to CH3Co(DH)2 (Table 2.6).  
The pyridyl group is not directly linked to the porphyrin in [CH3Co(DH)2]Por5 (6); 
consequently, the NH signal of 6 is not shifted relative to that of 5. Also, the aromatic signals 
overlap. Hence, the distribution of the various [CH3Co(DH)2]nPor5 adducts after addition of 
pyridine ligands could not be assessed. By using the axial methyl signal the percent distribution 
of the CH3Co(DH)2 moiety between the porphyrin adduct and the CH3Co(DH)2(pyridine ligand) 
complex could be determined, and the results are summarized in Table 2.6. The distribution of 
the pyridine ligands between CH3Co(DH)2(pyridine ligand) and the [CH3Co(DH)2]nPor adducts 
is very similar for  Por = 5 or TpyP(4). Thus, these two porphyrins have similar basicity. 
The 1H NMR chemical shifts for the axial methyl group of CH3Co(DH)2(pyridine ligand)27 are 
summarized in Table 2.4. As mentioned, the axial methyl signal shifts upfield with greater 4-
substituted pyridine ligand basicity. The shifts when L = 5, TpyP(4), 4-CNpy, 3,5-lut and 4-
Me2Npy are given in Figure 2.6 and Table 2.4. When L = 5, the axial methyl shift at 0.82 ppm 
matches that of CH3Co(DH)2py. These results suggest that the basicity of the pyridyl groups of 5 
is close to that of pyridine. The similarity of the adduct distribution in Table 2.6 thus confirms 
that TpyP(4) has comparable basicity to 5. Without doubt the porphyrin ring anisotropy and not 
low porphyrin basicity is responsible for the downfield position of the signals in 
[CH3Co(DH)2]nTpyP(4) (9). 
2.3.5 Visible Absorption Spectra. Soret and Q bands for 5 and TpyP(4) and their respective 
methylcobaloxime adducts (6 and 9) were measured in CH2Cl2 (Table 2.1). The Q and Soret 
bands correspond respectively to the first and second excited singlet states of the porphyrins.47-49 
The change in the number of Q bands to two or one observed upon insertion of metals (zinc and 
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copper) into the porphyrin results from the increased molecular symmetry (C4v and D4h, 
respectively), and is typical of patterns observed for metalloporphyrins with the respective 
metals.47 The lower symmetry of the Zn porphyrin is attributable to one axial ligand, and X-ray 
results (although of crystals with less than desirable diffraction intensity) confirmed that an axial 
water is coordinated in [CH3Co(DH)2]4Zn(II)TpyP(4) (Figure A2). 
 
Figure 2.6. 1H NMR spectra (Co-CH3) region of CH3Co(DH)2L with L = T(N-py-4-
CH2(CH3)NSO2Ar)P (a); TpyP(4) (b); 4-CNpy (c); py (d); 3,5-lut (e) and 4-Me2Npy (f) in 
CDCl3. 
 
 Compared to the bands of the parent porphyrin (TpyP(4)), the Soret and Q bands of 9 show 6 
nm and ~4 nm red shifts, respectively (Table 2.1). The spectrum of 6 retains the characteristic 
Soret and Q bands of the parent porphyrin 5, with no shifts (Table 2.1). The red shift of the Soret 
band observed with the [CH3Co(DH)2]4TpyP(4) adduct (9) and its Cu and Zn complexes (Table 
2.1) suggests that there is a reduction of the electron density as a result of cobalt coordination to 
the pyridyl groups. In contrast, the lack of a shift for the [CH3Co(DH)2]4T(N-py-4-
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CH2(CH3)NSO2Ar)P adduct (6) is expected because the pyridyl groups are not directly linked to 
the porphyrin core. The blue shift (4 nm) of the Soret band and of one Q band (540 nm) observed 
for copper complexes 7 and 10 (Table 2.1) are consistent with observations reported for other 
copper porphyrins.50,51 In copper porphyrins the delocalized π bonding decreases the average 
electron density, which increases the energy needed for electronic transitions, and thus a blue 
shift of the Soret band is observed.52 Complexes 8 and of 11 show a red shift (< 10 nm) of the 
Soret band and two Q bands (550, 596 nm), as observed previously with other zinc porphyrins.51 
For zinc porphyrins the delocalized π bonding increases the average electron density of the 
porphyrin, thus lowering the energy for electronic transition and leading to a red shift of the 
Soret band.52  
2.3.6 Emission Spectra. The emission of T(N-py-4-CH2(CH3)NSO2Ar)P (5) and of TpyP(4) 
in dichloromethane is compared to that of the CH3Co(DH)2adducts (Table 2.1). The fluorescence 
intensity of 5 is comparable to that of TpyP(4) upon selective excitation at the Soret band (420 
nm) (Figure 2.7). The adducts ([CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P (6) and 
[CH3Co(DH)2]4TpyP(4) (9)) show typical porphyrin-based intense fluorescence spectra (Figure 
2.7) characterized by two bands at ~650 and ~714 nm (λexc = 420 or 515 nm).43 A small red shift 
(~3 nm) of the emission bands of 9 was observed with respect to the parent porphyrin (TpyP(4)). 
Insertion of zinc (8 and 11) changed the general shape of the emission spectra and led to a blue 
shift (50 nm, λexc = 420 nm) of the emission bands (~600 and 650 nm) (Table 2.1) compared to 
those of the metal-free porphyrins (6 and 9). The intensity of spectra obtained on optically 
matched (λexc = 420 nm) solutions showed that the emission of 6 is slightly lower (25-35%) for 
both bands (650 and 714 nm) than that of 5. The fluorescence intensity of 9 (λexc = 420 nm) is 
generally much lower (90%, for both bands 652, 714 nm) than that of TpyP(4) (Figure 2.7).  
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Figure 2.7. Emission spectra of TpyP(4), T(N-py-4-CH2(CH3)NSO2Ar)P (5), 
[CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P (6) and [CH3Co(DH)2]4TpyP(4) (9) in       
CH2Cl2. 
 
The much greater effect of adduct formation on 9 than on 6 is attributable to the direct and 
indirect attachment of the pyridyl group to TpyP(4) and T(N-py-4-CH2(CH3)NSO2Ar)P, 
respectively, resulting from a much shorter distance of the methylcobaloxime moieties to the 
porphyrin in 9 than in 6. The quenching of the emission of 9 is attributed to the cobalt heavy 
atom effect. Heavy atoms enhance spin-orbit coupling of a formally spin-forbidden deactivation 
process of the singlet state of the porphyrin.11  
The titrations of 4-CNpy, 3,5-lut and 4-Me2Npy into 5 μM solutions of adducts 6 and 9 in 
dichloromethane were monitored by fluorescence spectroscopy; results for 4-CNpy and 4-
Me2Npy are shown for 6 and 9 in Figures A3, A4, 2.8. When a solution of 9 was titrated with 
these pyridine ligands, fluorescence intensity restoration was observed. Upon addition of 4-
Me2Npy (80 μM) (Figure 2.8), the restored fluorescence intensity at 650 nm was 12 times that of 
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the original solution of 9; the values obtained with 3,5-lut and 4-CNpy (80 μM) (Figure A4) 
were 11 and 5 times the original fluorescence, respectively. 
 
 
Figure 2.8. Emission spectra of [CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P (6) (left) and 
[CH3Co(DH)2]4TpyP(4) (9) (right) (5.0 μM) in CH2Cl2 with increasing amounts (6/9 : pyridine 
ratio) of 4-Me2Npy. 
 
The titration of TpyP(4) with 4-Me2Npy resulted in an intensity ~1.2 times that of the original 
value of TpyP(4). These results support the conclusion that restoration of fluorescence intensity 
upon addition of the different pyridine ligands is caused by the displacement of the CH3Co(DH)2 
moieties, releasing the TpyP(4).  
The fluorescence intensity of 6 increased by 1.5 times upon the addition of 4-CNpy (Figure 
A3), 3,5-lut, or 4-Me2Npy (Figure 2.8) (80 μM). The titration of 5 with 4-Me2Npy led to a ~1.2 
times increase of the original fluorescence intensity. This higher intensity is similar to that 
observed upon titrating 6 with the different pyridine derivatives; as a result, we conclude that the 
increase in fluorescence intensity of solutions of 6 arises from a combined effect of the pyridine 
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ligands, which displace the CH3Co(DH)2 moieties and which then interact weakly with the 
displaced porphyrin.  
 
2.4 Conclusions 
The synthetic scheme developed in this work is useful and versatile for preparing 
metalloporphyrins having sulfonamides. However, it is necessary to employ a tertiary 
sulfonamide because otherwise intractable species are formed. New pyridyl-containing 
porphyrins with a sulfonamide linker have been synthesized and characterized by 1H NMR 
spectroscopy and mass spectrometry. Adducts with four methylcobaloxime units bound to 
pyridylporphyrins (TpyP(4) and T(N-py-4-CH2(CH3)NSO2Ar)P) have been synthesized and their 
photophysical properties investigated and compared to those of the parent porphyrin. Upon 
excitation of the porphyrin core, the typical porphyrin fluorescence is partially quenched for the 
([CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P adduct, whereas the fluorescence of the 
[CH3Co(DH)2]4TpyP(4) adduct is strongly quenched. These observations suggest that the 
porphyrin core of T(N-py-4-CH2(CH3)NSO2Ar)P is insulated from the pyridyl group, and 
consequently coordination of the methylcobaloxime moiety to the pyridyl group does not 
modulate greatly the photophysical properties of the porphyrin. A comparison of the 1H NMR 
signal of the axial methyl of the T(N-py-4-CH2(CH3)NSO2Ar)P and the TpyP(4) 
methylcobaloxime adducts with those of the other methylcobaloxime compounds with different 
pyridine ligands allows us to estimate the pKa of the pyridyl groups of T(N-py-4-
CH2(CH3)NSO2Ar)P) and of TpyP(4) to be close to that of pyridine.  
In summary, the additional linker insulates the porphyrin core from any effects of coordination 
of metals to the peripheral groups. Likewise, the linker extends the distance of the peripherally 
coordinated metals from the porphyrin core and this core does not affect the properties of the 
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peripheral metal. In contrast the core and the peripheral metals have mutual effects upon each 
other when adducts are prepared with the prototypical porphyrin, TpyP(4) . 
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CHAPTER 3. NEW PORPHYRINS BEARING POSITIVELY CHARGED PERIPHERAL 
GROUPS LINKED BY A SULFONAMIDE GROUP TO MESO-
TETRAPHENYLPORPHYRIN: INTERACTIONS WITH CALF THYMUS DNA 
 
3.1 Introduction 
The ability of cationic porphyrins to associate with DNA and RNA has prompted studies of 
medical and biological applications of porphyrins.1-3 Pioneering work by Fiel and co-workers 
demonstrating that TMpyP (meso-tetra(N-Mepy)porphyrin tetracation, N-Mepy = N-
methylpyridinium group, Figure 3.1) has a strong affinity for DNA3 stimulated many subsequent 
studies.4-8 TMpyP(4) (having the 4-Mepy group with the pyridinium moiety linked through the 
4- position) and its derivatives exhibit activity against human immunodeficiency virus, the virus 
responsible for AIDS.9 TMpyP(4) has also been used in various therapeutic applications, e.g., as 
photo-sensitizers in photodynamic therapy,2,3,10-13 inhibitors of telomerase DNA cleavage,14-16 
and anticancer agents.17,18 
 
Figure 3.1. Structures of porphyrins mentioned in this study. 
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Several types of noncovalent interactions of cationic porphyrins with DNA have been found, 
including intercalative binding, simple outside binding, and outside binding with self-stacking 
(Figure 3.2).5-7,19,20 The preferred binding mode and the distribution between modes are both 
highly dependent on the type of DNA and on the peripheral substituent groups on the 
porphyrin.21,22 In order to achieve intercalation, the porphyrin core must have a limited 
thickness.4,5,23 The metal-free porphyrin, TMpyP(4) (Figure 3.1), and its metal complexes 
constitute the porphyrin series most extensively studied for DNA binding; MTMpyP(4) with no 
axial ligands, such as Cu(II)TMpyP(4), generally intercalate into GC-rich DNA regions.1,19,24 
NMR spectral changes accompanying the binding of TMpyP(4) to oligodeoxyribonucleotides 
showed preferential insertion at the 5′-CG-3′ site.25 An X-ray structure shows Cu(II)TMpyP(4) 
bound to [d(CGATCG)]2 by intercalation between the C and the G of 5′-TCG-3′ accompanied by 
extrusion of the C of 5′-CGA-3′.26 Metalloporphyrins possessing axial ligands, such as 
MTMpyP(4), with M = Fe(III), Co(III), and Zn(II), do not intercalate.1,27 In general, these 
species bind preferentially to AT-rich DNA regions.27 Water-soluble cobalt porphyrins 
containing a covalent axial methyl ligand synthesized in our laboratory were also found to be 
outside-binders with AT selectivity.28  
In contrast to this clear understanding of how axial ligands influence intercalative vs. outside 
binding, the influences of the properties of the peripheral group and of the electronic properties 
of porphyrins with a thin core were not so well understood. Porphyrins that self-stack in aqueous 
solution (e.g., TMAP and cis- and trans-P4, Figure 3.1) are preferentially outside 
binders,4,5,20,29,30 and porphyrins that have a low propensity to self-stack (such as TMpyP(4), 
Figure 3.1) are intercalators.3,31 
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Figure 3.2. Binding modes of cationic porphyrins (represented by black bars in most cases). For 
outside binding without stacking, two subtypes are shown in the middle drawing. The upper left 
of this drawing illustrates how a tumbling porphyrin (shown side-on) such as TMpyP(2) might 
bind while its porphyrin core is maintained relatively far from the DNA. The other more 
commonly found subtype, shown both face-on (bottom) and side-on (upper right), allows the 
porphyrin core to approach the DNA more closely. 
 
Thus, the electron-richness of the core could possibly stabilize the self-stacked, outside-bound 
porphyrin-DNA adduct, disfavoring intercalation.32 To probe the influence of porphyrin 
properties on the DNA binding modes, we previously investigated the tentacle porphyrins 
depicted and defined in Figure 3.1. These studies revealed that only porphyrins possessing N-
alkylated pyridinium groups, such as TθpyP, intercalate into GC-rich regions of DNA.31 In 
contrast, TθF4TAP and TθOPP, which are similar in size and shape to TθpyP but with no N-
alkylated pyridinium groups, self-stacked along the DNA backbone and did not intercalate into 
DNA.31-34 The studies with tentacle porphyrins thus indicated that, while the influence of 
porphyrin electron richness on the binding mode of relatively thin porphyrins was not important, 
pyridinium groups appear to be necessary for intercalation. Furthermore, bulk and thickness of 
the N-alkyl groups attached to the pyridinium groups but projecting away from the porphyrin 
core do not appear to prevent intercalation.  
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Taking a different tack, McMillin et al. have been synthesizing less sterically demanding 
porphyrins having less bulk at the periphery; these investigators have found that relatively small 
porphyrins such as D4 and D3 (Figure 3.1) intercalate into B-form DNA, regardless of the base 
composition.35,36 In another study from the McMillin laboratory, the newly synthesized tMe2D4 
(Figure 3.1) was found to intercalate into DNA, in contrast to reports on trans-P(4), which binds 
externally, forming long-range stacked structures.29,30,37 In a recent study of the binding modes of 
two tricationic porphyrins having different steric size, McMillin et al. found that triD4 (Figure 
3.1) intercalates into [poly(dA-dT)]2 ((poly dA-dT)-(poly dA-dT)), whereas the larger MetriD4 
(Figure 3.1) binds externally, indicating that the presence of a fourth substituent destabilizes the 
intercalated form.38 In summary, the size of porphyrins with N-alkylpyridinium groups 
influences the extent of intercalation in GC and AT regions.  
In typical porphyrin intercalators, the N-alkylpyridinium group is attached to the porphyrin 
core, creating a common structural unit. This direct attachment allows the positive charges to 
delocalize onto the porphyrin ring39 and also restricts the distances between the pyridinium 
groups. We now take an approach different from that of McMillin et al. and also from that we 
used previously. In particular, we expand the size of the pyridinium-containing porphyrins by 
placing a linking group between the porphyrin core and the pyridinium group. The larger but 
flexible porphyrins used here can assume conformations such that the separations between the 
charge-bearing nitrogens of the N-Mepy groups encompass the distances [~11 Å (cis) and ~16 Å 
(trans)] between these nitrogens in known intercalators. Specifically, we describe here the 
synthesis of new porphyrins ([T(R2R1NSO2Ar)P]X4/8) and metalloporphyrins 
([MT(R2R1NSO2Ar)P]X4/8) bearing positively charged, peripheral N-Mepy or quaternary 
ammonium groups. These groups are linked to the 4-position of the phenylene group of the 
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porphyrin by secondary (-SO2NHR) or tertiary (-SO2NR2) sulfonamide groups (Figure 3.3).40 
These porphyrins were designed for us to determine whether the new porphyrins containing N-
Mepy groups would be intercalators and whether the new porphyrins lacking N-Mepy groups 
would allow us to gain some insight into factors that might influence outside binding 
interactions. The latter type of new porphyrins also serves as appropriate controls for comparison 
to the new porphyrins containing N-Mepy groups. We investigated the calf thymus (CT) DNA 
binding interactions of selected porphyrins by visible CD and other spectroscopic methods. We 
also assessed DNA binding of several new metalloporphyrins ([MT(R2R1NSO2Ar)P]X4/8) by 
viscometric methods.  
 
Figure 3.3. Structures of new porphyrins: (a) [MT(R2R1NSO2Ar)P]X4/8 (in 1 to 3, M = 2H and 
R1 = H and R2 = N-Mepy-n-CH2, with n = 2, 3 or 4, respectively; in 4, M = 2H and R1 = H and 
R2 = Me3NCH2CH2; 5 differs from 1 in that R1 = CH3; in 7 and Cu(II)7, R1 = R2 = Et3NCH2CH2 
and M = 2H and Cu(II), respectively; and (b) [MT(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (in 6, M 
= 2H; in Cu(II)6, M = Cu(II); and in Zn(II)6, M = Zn(II)). 
 
3.2 Experimental Section 
3.2.1 Materials and Methods. All compounds and reagents used in the synthetic chemistry 
were purchased from Aldrich. The chloride salts of Cu(II)TMpyP(4) and Cu(II)TMAP were 
obtained from MidCentury. The syntheses of the non-alkylated porphyrin precursors are 
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described elsewhere.40 The mean length of the DNA was ~5000 bp, established by gel 
electrophoresis on 1% agarose gel.41 All CT DNA solutions were stored at -20 °C and were 
allowed to warm to RT before sample preparation. Stock solutions of CT DNA (GE Amersham) 
were prepared in 10 and 100 mM NaCl at pH 7.0. The CT DNA concentration in base pairs was 
determined by UV spectroscopy by using ε260 = 1.32 × 104 M-1cm-1.42 The porphyrin 
concentration was 7.5 µM in titration studies employing visible absorption, fluorescence, and CD 
spectroscopies. 
All 1H NMR spectra were recorded on either a 300 MHz or 400 MHz Bruker NMR 
spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference. Visible absorption experiments were performed with a Cary 3 UV-visible 
spectrophotometer. CD spectra and titrations were recorded at 25 °C with a Jasco 710 
spectrophotometer. Fluorescence studies were performed on a Fluorolog-3 spectrofluorimeter 
(Horiba Jobin Yvon) at 25 °C. Excitation wavelengths were 412 nm in the absence of DNA and 
422 nm in the presence of DNA. Mass spectra for samples dissolved in methanol were obtained 
at the Mass Spectrometry Facility at LSU on a Hitachi MS-8000 3DQ LC-ion trap ESI mass 
spectrometer. 
Solutions for visible spectroscopy were prepared by diluting a 25 μL aliquot of 1.5 mM 
porphyrin stock solution in 5.0 mL of a 10 or 100 mM NaCl solution. An aliquot of CT DNA 
was then added to such dilute porphyrin solutions to obtain the desired value of R 
([porphyrin]/[DNA base pairs]). The pH of the solution was measured and readjusted to 7.0 with 
0.01 M NaOH or 0.01 M HCl before recording spectra. 
3.2.2 Viscosity Studies. Viscosity titrations were performed by using a Cannon-Ubbelohde 
semimicrodilution capillary viscometer in a circulating water bath maintained at 30.5 °C. Buffer 
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(1.0 mL of 100 mM NaCl at pH 7.0) was added to the viscometer, and the flow time was 
measured. Solution viscosity was determined by adding a small aliquot of CT DNA stock 
solution to a vial containing the buffer (~1 mL) to make the final concentration 75 μM in base 
pairs, and the pH was adjusted to 7.0. The flow time of the DNA solution was then obtained. An 
aliquot of the porphyrin stock solution (75 μM dissolved in CT DNA 75 μM) was then added to 
the viscometer in increments of 25 μL to give the desired value of R, while keeping the DNA 
concentration constant. Flow time measurements, obtained with a timer accurate to ±0.01 s, were 
recorded until three consecutive readings differed by less than ±0.1 s. The solution reduced 
viscosity (SRV) was presented as η/η0 versus R, where η/η0 = tc−t0/tD−t0 and t0 is the flow time 
of the buffer, tD is the flow time of the DNA in buffer, and tc is the flow time of the DNA 
solution containing porphyrin.43  
3.2.3 Competitive Binding Experiments. Solutions of Cu(II)TMpyP(4) (75 µM) and Cu(II)6 
(75 µM, Figure 3.3), both dissolved in 75 µM CT DNA, were prepared separately. Equal 
volumes of the two solutions were mixed and allowed to equilibrate for 1 h at room temperature. 
Aliquots of this 1:1 mixture were used as described above for viscosity measurements at 
different R values (where the porphyrin concentration equals the sum of the concentrations of the 
two Cu(II) porphyrins).  
3.2.4 Sodium Dodecyl Sulfate (SDS) Studies. SDS solutions were prepared by adding 
surfactant in water (e.g., for 1 M SDS (2.89 g) in 10 mL) and stirring for 15 min, when the 
solution became clear. An aliquot of the desired porphyrin stock solution (1.5 mM) was added to 
make a 7.5 μM solution, the pH was adjusted to 7.0, and the visible spectral changes were 
monitored with time. In one experiment, an aliquot of the porphyrin stock solution was diluted 
with water to 15 µM. After ~10 min this solution was added to an equal volume of a 2 M SDS 
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solution such that the final concentrations were 1 M SDS and 7.5 μM porphyrin. The pH was 
quickly readjusted to 7.0 and the visible spectrum recorded.  
3.2.5 General Synthesis for Alkylated [T(R2R1NSO2Ar)P]X4 Porphyrins 1 to 6. Alkylation 
was carried out by suspending the parent porphyrin in an excess of CH3I (10 mL) in a sealed 
flask and allowing the mixture to stir at RT overnight. The CH3I that did not react was allowed to 
evaporate; the residue was dried under vacuum for 3 h to yield the iodide salt of the product 
porphyrin. To prepare the chloride salt of porphyrins 1 to 6, a Dowex-1 (chloride form) anion-
exchange resin column was prewashed with 0.1 N HCl and then washed with water until the 
eluate was at pH 7.0; a slurry of the compound in water was made with the resin and loaded onto 
a short column, and then eluted with water. The water was removed by rotary evaporation and 
the purplish solid residue dried under vacuum. The product was obtained as a purple powder by 
dissolving it in methanol and adding ethyl acetate. All compounds were isolated as chloride salts 
and analyzed by 1H NMR spectroscopy and mass spectrometry.  
[T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4 (1). The general methylation method applied to the non-
alkylated parent porphyrin (0.12 g, 0.092 mmol) afforded 1 as a brown precipitate (0.115 g, 84% 
yield). 1H NMR (ppm) in DMSO-d6: 8.90 (8H, s, β-pyrrole), 9.36 (4H, br, NH-sulfonamide), 
9.12 (4H, d, pyH), 8.71 (4H, t, pyH), 8.49 (8H, d, ArH), 8.36 (8H, d, ArH), 8.31 (4H, d, pyH), 
8.14 (4H, t, pyH), 4.87 (8H, d, CH2), 4.44 (12H, s, CH3) -2.95 (2H, br, NH). UV-vis (methanol) 
λmax (ε) [nm (M-1cm-1)]: 416 (296,100), 512 (13,600), 546 (5300), 588 (4100), 642 (2300). ESI-
MS(m/z): [M+3H]3+ = 451.1344, [M+4H]4+ = 338.6032, calcd. for [M+3H]3+ = 451.1466, 
[M+4H]4+ = 338.5996. 
[T(N-Mepy-3-CH2(H)NSO2Ar)P]Cl4 (2). The general method using the non-alkylated parent 
(0.12 g, 0.092 mmol) afforded 2 as a brown precipitate (0.13 g, 96% yield). 1H NMR (ppm) in 
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DMSO-d6: 8.87 (8H, s, β-pyrrole), 9.46 (4H, t, NH-sulfonamide), 9.30 (4H, s, pyH), 9.08 (4H, t, 
pyH), 8.72 (4H, d, pyH), 8.45 (8H, d, ArH), 8.32 (8H, d, ArH), 8.24 (4H, t, pyH), 4.57 (8H, d, 
CH2), 4.42 (12H, s, CH3) -2.96 (2H, br, NH). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 416 
(292,800), 512 (14,000), 546 (5800), 588 (4400), 642 (2300). ESI-MS(m/z): [M+2H]2+ = 
676.7088, [M+3H]3+ = 451.1423, [M+4H]4+ = 338.6103, calcd. for [M+2H]2+ = 677.1994, 
[M+3H]3+ = 451.1466, [M+4H]4+ = 338.5996. 
[T(N-Mepy-4-CH2(H)NSO2Ar)P]Cl4 (3). The general method using the non-alkylated parent 
(0.12 g, 0.092 mmol) afforded 3 as a brown precipitate (0.12 g, 89% yield). 1H NMR (ppm) in 
DMSO-d6: 8.89 (8H, s, β-pyrrole), 9.20 (4H, br, NH-sulfonamide), 9.02 (8H, d, pyH), 8.49 (8H, 
d, ArH), 8.32 (8H, d, ArH), 8.20 (8H, d, pyH), 4.68 (8H, d, CH2), 4.35 (12H, s, CH3) -2.94 (2H, 
br, NH). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)], 416 (312,200), 512 (13,500), 546 (5200), 
588 (4000), 642 (1700). ESI-MS(m/z): [M+H]+ = 1354.4043, [M+2H]2+ = 676.2131, [M+3H]3+ 
= 451.14, [M+4H]4+ = 338.6097, calcd. for [M+H]+ = 1354.3987, [M+2H]2+ = 677.1994, 
[M+3H]3+ = 451.1466, [M+4H]4+ = 338.5996. 
[T(Me3NCH2CH2(H)NSO2Ar)P]Cl4 (4). The general method using the non-alkylated parent 
(0.12 g, 0.099 mmol) afforded 4 as a reddish precipitate (0.095 g, 69% yield). 1H NMR (ppm) in 
DMSO-d6: 8.88 (8H, s, β-pyrrole), 8.69 (4H, t, NH-sulfonamide), 8.48 (8H, d, ArH), 8.32 (8H, d, 
ArH), 3.63 (8H, d, CH2), 3.58 (8H, t, CH2), 3.23 (36H, s, CH3), -2.94 (2H, br, NH). UV-vis 
(methanol) λmax (ε) [nm (M-1cm-1)]: 416 (266,000), 512 (12,100), 546 (5000), 588 (3800), 642 
(1800). ESI-MS(m/z): [M+4H]4+ = 318.6365; calcd for [M+4H]4+ = 318.6309. 
[T(N-Mepy-2-CH2(CH3)NSO2Ar)P]Cl4 (5). The general method using the non-alkylated 
parent (0.116 g, 0.086 mmol) afforded 5 as a brown precipitate (0.125 g, 93% yield). 1H NMR 
(ppm) in DMSO-d6: 8.98 (8H, s, β-pyrrole), 9.18 (4H, d, pyH), 8.58 (8H, d, ArH), 8.42 (8H, d, 
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ArH), 8.74 (4H, t, pyH), 8.31 (4H, d, pyH), 8.16 (4H, t, pyH), 5.14 (8H, s, CH2), 4.46 (12H, s, 
CH3), 3.08 (12H, s CH3), -2.81 (2H, br, NH). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 416 
(359,600), 512 (16,700), 546 (6900), 588 (6400), 642 (2500). ESI-MS(m/z): [M + 4H]4+ = 
352.6276; calcd for [M+4H]4+ = 352.6177. 
[T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (6). The general method using the non-alkylated 
parent (0.108 g, 0.079 mmol) afforded 6 as a brown precipitate (0.11 g, 88% yield). 1H NMR 
(ppm) in DMSO-d6: 8.88 (8H, s, β-pyrrole, 9.04 (8H, d, pyH), 8.56 (8H, d, ArH), 8.36 (8H, d, 
ArH), 8.19 (8H, d, pyH), 4.87 (8H, s, CH2), 4.38 (12H, s, CH3), 3.04 (12H, s, CH3), -2.93 (2H, 
br, NH). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 416 (302,100), 512 (14,500), 546 (6000), 
588 (4400), 642 (2400). ESI-MS(m/z): [M + 4H]+4 = 352.6199; calcd for [M+4H]4+ = 352.6177. 
[T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (7). Porphyrin 7 was synthesized from its non-alkylated 
precursor (synthesized by treating a suspension of TPPSO2Cl (0.22 g, 0.22 mmol) in acetonitrile 
(20 mL) with N,N,N'',N''-Et4-dien (0.199 g, 0.93 mmol) in acetonitrile (10 mL) at RT). The 
resulting suspension became a solution when stirred overnight, and the solvent was then removed 
by rotary evaporation. The residue was recrystallized from dichloromethane and hexane as 
purple crystals (0.35 g, 93% yield). 1H NMR (ppm) in CDCl3: 8.79 (8H, s, β-pyrrole), 8.36 (8H, 
d, ArH), 8.28 (8H, d, ArH), 3.55 (16H, t, CH2), 2.84 (16H, t, CH2), 2.67 (32H, m. CH2), 1.12 
(48H, m, CH3), -2.84 (2H, br, NH). The non-alkylated precursor (0.13 g) was alkylated by using 
iodoethane (5 mL) instead of iodomethane in the procedure above, and 7 was obtained as the 
chloride salt (0.115 g, 89% yield) as described above. 1H NMR (ppm) in DMSO-d6: 8.95 (8H, s, 
β-pyrrole), 8.51 (16H, d, ArH), 4.0 (16H, t, CH2), 3.68 (16H, t, CH2), 3.48 (48H, s. CH2), 1.32 
(72H, m, CH3), -2.84 (2H, br, NH). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 416 (320,000), 
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512 (15,500), 546 (6600), 588 (5100), 642 (2700). ESI-MS(m/z): [M + 4H]+4 = 492.7939; calcd 
for [M+4H]4+ = 492.8223. 
[Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6). A solution of 6 (0.05 g, 0.032 
mmol) in methanol (10 mL) was treated with copper(II) acetate (0.64 mg, 0.032 mmol) in MeOH 
(5 mL). The solution was allowed to stir at RT for about 1 h. Completion of the reaction was 
indicated by UV/vis spectroscopy, with the four Q bands of the free base (λ = 512, 546, 588, 642 
nm) collapsing to one peak (λ = 538 nm). The volume of the reaction mixture was reduced to ~1 
mL, and acetone was added to precipitate the compound as a red powder (0.045 g, 88% yield). 
1H NMR (ppm) in DMSO-d6: 8.99 (8H, br, pyH), 8.12 (8H, br, pyH), 4.80 (8H, br, CH2), 4.35 
(12H, s, CH3), 2.95 (12H, br, CH3). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 414 (364,400), 
538 (1740). 
[Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7). This compound was synthesized and 
isolated as for Cu(II)6 above from (0.05 g, 0.022 mmol) of 7; yield = 0.039 g (76%), UV-vis 
(methanol) λmax (ε) [nm (M-1cm-1)]: 414 (449,000), 538 (21,600).  
[Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6). A solution of porphyrin 6 (0.05 g, 
0.032 mmol) in dichloromethane (10 mL) was treated with a solution of zinc acetate (0.035 g, 
0.16 mmol in methanol, 2 mL). The solution was stirred at RT for 2 h, after which a small 
sample of the reaction mixture that was analyzed by visible spectroscopy indicated that the metal 
insertion was complete, with the four Q bands of the free base (λ = 514, 549, 590, 643 nm) 
collapsing to two peaks (λ = 556, 596 nm). The dichloromethane was removed by rotary 
evaporation, and the purple precipitate that formed was collected on a filter and washed with 
methanol to remove the excess of zinc acetate, affording the zinc complex of the precursor of 
porphyrin 6 (0.033 g, 63% yield). 1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole, 8.64 (8H, 
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d, pyH), 8.46 (8H, d, ArH), 8.28 (8H, d, ArH), 7.46 (8H, d, pyH), 4.55 (8H, d, CH2), 2.93 (12H, 
s, CH3). The general method of alkylation described above afforded Zn(II)6 as a purple powder 
(0.035 g, 93% yield). 1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole, 9.03 (8H, d, pyH), 
8.50 (8H, d, ArH), 8.33 (8H, d, ArH), 8.20 (8H, d, pyH), 4.87 (8H, d, CH2), 4.38 (12H, d, CH3), 
2.94 (12H, s, CH3). UV-vis (methanol) λmax (ε) [nm (M-1cm-1)]: 424 (388,100), 556 (14,600), 
596 (5,900). 
3.3 Results  
3.3.1 Synthesis. The use of various metal salts to metallate porphyrins containing a secondary 
sulfonamide generally produced insoluble materials. The fact that sulfonamides are known to 
coordinate to metal ions through both the sulfonyl oxygen and the deprotonated sulfonamide 
nitrogen44,45 led us to investigate the synthesis of the porphyrins containing a tertiary 
sulfonamide group. Utilizing the N-Me group in place of the dissociable NH group allowed us to 
prepare porphyrins that are very soluble in organic solvents; this property permitted successful 
alkylation and metallation of the porphyrins. The cationic porphyrins ([T(R2R1NSO2Ar)P]X4/8) 
(Figure 3.3) were characterized by mass spectrometry (ESI), UV-vis (methanol), and 1H NMR 
spectra (in DMSO-d6). 
The Cu(II) complexes of the cationic porphyrins (Figure 3.3) were characterized by visible 
spectroscopy, and the Zn(II) complexes were characterized by both 1H NMR and visible 
spectroscopy. Upon Cu(II) insertion into [T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (6) to form 
[Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6), the Soret band maximum (λSo) was blue 
shifted by 3 nm for 6 and the number of Q bands decreased from four to one, results consistent 
with reported observations for other copper porphyrins, such as CuTMAP.46,47 Zn(II) insertion 
into 6 to form [Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6) produced a 10 nm red shift 
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of λSo, and the number of Q bands decreased from four to two; both features have been observed 
previously with other zinc porphyrins.47,48 
3.3.2 Solution Studies with No DNA Present. Values of λSo and molar absorptivity at that 
wavelength (εSo) are summarized for several new porphyrins and for Cu(II)TMAP in Table 3.1. 
All solution studies employed 7.5 µM porphyrin and pH 7.0, unless stated otherwise. Compared 
to the λSo at 410 nm of an aqueous red solution of Cu(II)6 (no added salt), λSo was shifted 
slightly to 406 nm and 403 nm in 10 and 100 mM NaCl solutions, respectively, and εSo decreased 
(Table 3.1). A similar comparison of aqueous Zn(II)6 showed decreases in εSo, but λSo did not 
change with salt concentration (Table 3.1). The molar absorptivity of 6, Cu(II)6 and Zn(II)6 in 
10 mM NaCl increased with added methanol at least up to 50% methanol. This absorbance 
increase is attributable to the dissociation of porphyrin aggregates.  
Table 3.1. Visible Spectroscopic Data for [T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (6), Cu(II)6, 
Zn(II)6, and Cu(II)TMAP 
porphyrin a λSob (10-5 × εSo)c 
 in H2O 
λSob (10-5 × εSo)c 
 in 10 mM NaCl 
λSob (10-5 × εSo)c 
in 100 mM NaCl 
λSob (10-5 × εSo)c 
 in methanol 
6 413 (1.5) 412 (1.1) 404 (0.9) 415 (3.0) 
Cu(II)6 410 (2.0) 406 (1.6) 403 (1.1) 414 (3.6) 
Zn(II)6 423 (2.9) 423 (1.8) 423 (1.5) 424 (3.9) 
Cu(II)7 414 (3.1) 414 (2.3) 409 (2.2) 414 (4.4) 
Cu(II)TMAP 411 (2.8) 411 (2.8) 411 (2.6) 412 (2.9) 
a 7.5 μM porphyrin. b nm. c M-1 cm-1. 
 
The greater width and lower molar absorptivity of the Soret band of Cu(II)6 compared to that 
of Cu(II)TMAP [Cu(II)6: 410 nm, full width at half-maximum (fwhm) = 22 nm, εSo = 2.0 × 105 
M-1cm-1 vs. Cu(II)TMAP: 411 nm, fwhm = 16 nm, εSo = 2.8 × 105 M-1cm-1] in aqueous solution 
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indicate that Cu(II)6 aggregates significantly. Likewise, Zn(II)6 has fwhm = 14 nm and εSo = 2.9 
× 105 M-1cm-1, suggesting that the axial water on Zn as well as other effects of a five-coordinate 
geometry on the porphyrin structure disfavor stacking. These results suggest that the new 
cationic porphyrins, even at 7.5 µM, undergo appreciable aggregation and that the aggregated 
(stacked) Cu(II) porphyrins have relatively blue-shifted Soret bands. 
3.3.3 SDS Studies. The λSo and εSo values of Cu(II)6 in the presence and absence of SDS 
(Figure 3.4) are summarized in Table 3.2. During the first hour after a 1.5 mM stock solution of 
Cu(II)6 was added to 1 M SDS to make a 7.5 µM solution, the spectra recorded with time 
(Figure 3.4) indicated that two forms of the porphyrin were present initially: one form with a 
blue-shifted λSo at 399 nm and the other form with a red-shifted λSo at 416 nm (when compared 
to λSo at 410 nm in water). The facts that the 399 nm Soret band converted completely to the 416 
nm Soret band after 12 h and that the intensity of this 416 nm band was high (Figure 3.4) 
indicate that Cu(II)6 is stacked in water and slowly destacks in 1 M SDS.  
To test this interpretation, the concentrated stock solution of Cu(II)6 was diluted to 15 µM. 
Equal volumes of this dilute solution and a 2 M SDS solution were mixed, producing final 
concentrations of 1 M SDS and 7.5 µM Cu(II)6. The absorption spectrum recorded immediately 
shows only the red-shifted 416 nm band (Figure 3.4). This intense band is very similar to the 
band observed in the experiment described in the previous paragraph. These observations are 
consistent with a high degree of aggregation of Cu(II)6 in water, especially at high 
concentrations, and with SDS causing disaggregation of Cu(II)6. (When the Cu(II)6 is less 
stacked, the Soret band is red shifted.) 
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Table 3.2. Visible Spectroscopic Data for [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Cu(II)6) in H2O and 1 M SDS at pH 7.0a 
time  
λSob (10-5 × εSo)c 
H2O 
λSob (10-5 × εSo)c 
1 M SDS 
5 min 410 (2.0) 416 (1.6), 399 (1.0) 
10 min  416 (2.1), 399 (1.1) 
30 min  416 (2.4), 399 (1.0) 
1 h  416 (2.5), 399 (1.0) 
12 h  416 (3.8) 
a 7.5 μM porphyrin. b nm. c M-1 cm-1.  
 
Figure 3.4. Visible spectrum monitored with time of 7.5 µM [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6) in 1 M SDS. Also shown are the spectrum in water and that in 
1 M SDS but prepared with a dilute solution of the porphyrin (spectrum a, red dashed line). 
 
When a 1.5 mM stock solution of Cu(II)6 was added to 0.1 M SDS to make a 7.5 µM solution, 
the spectrum recorded with time (Supporting Information, Figure B.11) indicated that both the 
399 nm and 416 nm bands were present, suggesting coexistence of two forms. The two bands 
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remained even after 12 h. This fact suggests that, in contrast to 1 M SDS, 0.1 M SDS does not 
cause complete disaggregation of the stacked positively charged porphyrin cation. SDS has 
negative charge, favoring stacking (aggregation) and hydrophobic character, favoring de-
stacking. Evidently, the hydrophobic capacity of 0.1 M SDS is not sufficient to offset the effect 
of the negative charge. 
3.3.4 DNA-Binding Studies. Several methods were used to evaluate DNA binding. We 
assessed how the Soret band position and intensity changed on DNA addition. Hypochromicity 
(%H) is defined here as [(Ao – As)/Ao] × 100%, where Ao and As are the absorbance values at λSo 
in the absence and presence of CT DNA, respectively (a negative %H indicates 
hyperchromicity). Because both CT DNA and the free porphyrin have no CD band in the visible 
region, the only CD signal observed in this region is the induced CD signal of the bound 
porphyrins. Viscosity measurements are also useful because intercalation of a cation into DNA 
has a measurable effect on solution flow properties.20 A fixed concentration (75 µM) of 
sonicated CT DNA was maintained as the concentration of several porphyrins in 100 mM NaCl 
was increased (Figure 3.5). The SRV increased with addition of the intercalating 
Cu(II)TMPyP(4). For Cu(II)TMAP the SRV first increased slightly at low R, but leveled off after 
R = 0.15. The addition of Cu(II)6, Zn(II)6, or Cu(II)7 to CT DNA caused changes in SRV 
similar to those observed for the non-intercalating Cu(II)TMAP (Figures 3.5 and B.1). Viscosity 
experiments were used to determine if Cu(II)6 binds DNA competitively with Cu(II)TMpyP(4). 
At different R values (0.025, 0.1, 0.2 and 0.3) with equimolar amounts of the two porphyrins, the 
SRV values found (1.08, 1.12, 1.25 and 1.35) were smaller than the respective values (1.16, 1.46, 
1.62 and 1.74) for Cu(II)TMpyP(4) alone, Figures 3.5 and B.1. 
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Figure 3.5. Plot of SRV vs. R for the addition of metalloporphyrins to solutions of CT DNA (75 
µM, 100 mM NaCl, pH 7.0). 
 
DNA Binding of [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6). The Cu(II)6–CT 
DNA visible studies are summarized in Table 3.3. After addition of CT DNA, the spectrum of 
Cu(II)6 exhibited two Soret components. The red-shifted component (at 420 nm) in both 10 mM 
and 100 mM NaCl solutions (Table 3.3 and Figures 3.6 and B.2) is indicative of an unstacked 
bound form. As more CT DNA was added (as R changed from 0.25 to 0.005), the intensity of the 
long-wavelength component increased at the expense of the shorter-wavelength component. 
Hyperchromicity of the Soret band indicates unstacking of Cu(II)6. 
The overall shape of the CD spectrum of Cu(II)6 was independent of NaCl concentration. The 
binding of Cu(II)6 to CT DNA for all R values induced a CD spectrum with a positive feature at 
~415 nm (+exc) and a weak negative feature (-s) at ~433 nm (Table 3.4 and Figures 3.7 and 
B.3). The intensity of the positive band increased with increasing CT DNA concentration 
(decreasing R), while that of the negative feature decreased. At R = 0.005 in 10 mM NaCl the 
CD signal of Cu(II)6 with CT DNA reached its maximum value (molar ellipticity ([Θ]) = 4.9 × 
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104 deg cm2 dmol-1). These results and similar data for 100 mM NaCl are consistent with non-
stacking or weakly stacking outside binding. 
 
Figure 3.6. Effect of CT DNA on the visible spectrum of [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
 
Table 3.3. Visible Spectroscopic Data for [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Cu(II)6) in the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λSob 10-5 × εSoc Δλb (%H) λSob 10-5 × εSoc Δλb (%H) 
0 406 1.6  403 1.1  
0.25 404 1.2 -2 (25) 403 1.0 0 (9) 
 420 1.3 14 (19) 420 1.2 17 (-9) 
0.05 404 1.1 -2 (31)    
 420 1.6 14 (0) 420 1.4 17 (-27) 
0.01 404 1.0 -2 (38)    
 420 1.6 14 (0) 420 2.2 17 (-100) 
0.005 404 1.0 -2 (38)    
 420 1.8 14 (-13) 420 2.4 17 (-118) 
a 7.5 μM porphyrin. b nm. c M-1 cm-1. 
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Table 3.4. Effect of NaCl Concentration on the CD Spectrum of [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6) in the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λ+excb 10-4×[Θ]+excc λ-sb 10-4×[Θ]-sc λ+excb 10-4×[Θ]+excc λsb 10-4×[Θ]-sc 
0.25 413 2.3 433 –1.2 412 1.9 433 –0.5 
0.05 414 3.2 433 –0.7 416 3.8 434 –0.2 
0.01 415 3.6 433 –0.6 417 4.3 434 –0.5 
0.005 416 4.9 433 –0.3 414 2.3 434 –0.2 
a 7.5 μM porphyrin. b nm. c deg cm2 dmol-1. 
 
Figure 3.7. CT DNA-induced CD spectra of [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Cu(II)6, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
 
DNA Binding of [Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6). Addition of CT 
DNA to a solution of Zn(II)6 in 10 mM and 100 mM NaCl solutions caused a 3 nm red shift in 
λSo at all R values (Table B.1). At the lowest DNA concentration, only small changes in Soret 
band intensity in both 10 mM and 100 mM NaCl solutions were observed (Table B.1 and Figures 
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B.6 and B.7). At the highest DNA concentration (R = 0.005), significant hyperchromicity was 
observed in 10 mM (%H = -61) and 100 mM (%H = -87) NaCl solutions (Table B.1 and Figures 
B.4 and B.5). At low R values, an induced CD signal (+exc at ~420 nm) was observed (Table 
B.2 and Figures B.6 and B.7). As for Cu(II)6, these results are consistent with non-stacking or 
weakly stacking outside binding. 
DNA Binding of [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7). Addition of CT DNA to 
Cu(II)7 caused 7 and 11 nm red shifts of λSo in 10 mM and 100 mM NaCl solutions, respectively 
(Table 3.5). At the highest concentration of DNA (R = 0.005), hyperchromicity was observed 
(Table 3.5 and Figures B.8 and B.8). An induced CD signal (+exc at ~415 nm, -s at ~430 nm) 
was observed upon addition of CT DNA (Table 3.6). The intensity of these features generally 
decreased with an increase in DNA concentration (Table 3.6 and Figures 3.9 and B.9). As for 
Cu(II)6, these results are consistent with non-stacking or weakly stacking outside binding. 
 
Table 3 5. Visible Spectroscopic Data for [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7) in 
the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λSob 10-5 × εSoc Δλb (%H) λSob 10-5 × εSoc Δλb (%H)
0 414 2.3  409 2.2  
0.25 421 2.0 7 (13) 420 2.4 11 (-9) 
0.05 421 2.2 7 (4) 420 2.8 11 (-27) 
0.01 421 2.4 7 (-4) 420 3.0 11 (-36) 
0.005 421 2.7 7 (-17) 420 3.2 11 (-46) 
a 7.5 μM porphyrin. b nm. c M-1 cm-1. 
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Figure 3.8. Effect of CT DNA on the visible spectrum of [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 
(Cu(II)7, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
 
Table 3.6. Effect of NaCl Concentration on the CD Spectrum of 
[Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7) in the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λ+excb 10-4 × 
 [Θ]+exc 
λ-sb 10-4 × 
 [Θ]-sc 
λ+excb 10-4 × 
 [Θ]+exc 
λsb  10-4 × 
 [Θ]-sc 
0.25 414 3.9 428 –3.0 414 2.1 430 –1.5 
0.05 415 2.6 430 –0.7 414 1.2 430 –0.7 
0.01 415 1.8 429 –0.9 414 1.5 430 –0.5 
0.005 415 1.6 429 –0.8 419 0.8 436 –0.5 
a 7.5 μM porphyrin. b nm. c deg cm2 dmol-1. 
 
DNA-Binding Studies of Porphyrins with Different Peripheral Groups. The λSo of 
solutions of both 1 ([T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4) and 5 ([T(N-Mepy-2-
CH2(CH3)NSO2Ar)P]Cl4) in 10 mM NaCl was at 414 nm (Table B.3). The addition of CT DNA 
at a low DNA concentration (R = 0.25) to 1 and 5 led to red-shifted and blue-shifted (5 nm) 
bands and hypochromicity. At the higher DNA concentration (R = 0.005), the same two bands 
were observed (%H = 52 and 7 for 1 and %H = 54 and 15 for 5, Table B.3). The binding of CT 
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DNA to both porphyrins induced a positive CD feature (Table B.4). As more CT DNA was 
added (as R changed from 0.25 to 0.005), the intensity of these positive features increased (Table 
B.4). Visible and CD spectral changes for 4 ([T(Me3NCH2CH2(H)NSO2Ar)P]Cl4) in 10 mM 
NaCl (Tables B.3 and B.4) were similar to those for 1 and 5. The spectral features of the 
porphyrins described in this subsection are consistent with a combination of weakly stacked and 
unstacked outside binding rather than with intercalation. 
 
 
Figure 3.9. CT DNA-induced CD spectra of [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7, 
7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
3.3.5 Fluorescence Spectroscopy. The fluorescence spectrum of the metal-free porphyrin, 
[T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (6), in 10 mM NaCl shows two emission maxima at 656 
nm [Q(0,0) band] and at ~700 nm [Q(0,1) band] (Figure 3.10); the band assignment follows that 
used for other porphyrins.49 The two bands shifted (656 nm band slightly, ~700 nm band 
significantly), and the intensity decreased significantly (by 34% and ~60%, respectively, Figure 
3.10) upon the addition of a small amount of DNA (R = 0.25). The decrease in fluorescence 
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intensity of 6 is attributed to the proximity of the neighboring porphyrins, which are self-stacked 
when bound to DNA.50 Further addition of CT DNA led to increases in intensity. The final value 
(R = 0.005) was ~1.2 times those found before DNA addition. We attribute these changes to 
conversion of the unbound porphyrin aggregates initially present first to bound aggregates 
(Figure 3.2, right) and then to the bound monomer form at high DNA concentration (Figure 3.2, 
middle).50  
 
Figure 3.10. Effect of CT DNA on the fluorescence spectrum of [T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (6, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
 
3.4 Discussion  
Our primary interests were to determine how the new water-soluble cationic porphyrins and 
metalloporphyrins prepared in this work bound to DNA, either as intercalators or outside-
binders, and to use the results to gain further insight into important features that favor 
intercalation of cationic porphyrins. Experimental evidence useful for determining if a porphyrin 
intercalates and our evidence establishing that the new porphyrins do not intercalate will be 
discussed first. Next we discuss the factors that our work indicates are important for intercalation 
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of known porphyrin intercalators. Finally, we shall discuss briefly the nature of the DNA outside 
binding of the new porphyrins.  
3.4.1 Experimental Criteria for Porphyrin Intercalation into DNA. Experimental 
observations indicating intercalative binding include changes in the Soret region of spectra, 
namely, a large red shift (~15 nm), a large hypochromicity (~30%) and a negative induced CD 
signal. These spectroscopic parameters tend to vary over a narrower range than those found for 
outside binders (see below). Perhaps the most characteristic spectral feature is the negative 
induced CD signal; typical magnitudes found are about -5 × 104 (deg cm2/dmole).5,31,37,38,51 
However, perhaps the best procedure to assess DNA binding mode is to measure solution 
reduced viscosity (SRV). Porphyrins known to intercalate (e.g., Cu(II)TMpyP(4)52) increase the 
SRV of DNA solutions.31  
3.4.2 Evidence That New Porphyrins Are Not Intercalators. No increase in DNA solution 
viscosity was observed for Cu(II)6, Zn(II)6, and Cu(II)7 (Figures 3.5 and B.1). The SRV values 
of Cu(II)6, Zn(II)6, and Cu(II)7 were comparable to that of Cu(II)TMAP, a non-intercalator.53 
The absence of an increase in SRV demonstrates that these new porphyrins are outside binders. 
At the same ratio of total Cu(II) porphyrin to DNA, lower SRV values were found in the 
presence of both [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 and Cu(II)TMpyP(4) than in the 
presence of Cu(II)TMpyP(4) alone (Figure 3.5). This finding indicates that [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 competes for DNA with Cu(II)TMpyP(4), which has a DNA binding 
constant of ~107 M-1.54 Therefore, because all the new porphyrins are similar, we expect that all 
are tight outside binders to DNA, and we turn our attention to comparing the features of the new 
porphyrins vs intercalating porphyrins in order to identify important features for intercalation. 
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3.4.3 Properties of Porphyrins Favoring Intercalation. On the basis of our past work and 
that of others,1,19-21,29,52,55,56 we can conclude, as mentioned above, that the porphyrin peripheral 
groups should be N-alkyl pyridinium groups and that the porphyrin core of the 
metalloporphyrins with these groups need to lack axial ligands (e.g., Cu(II)TMpyP(4)) or have 
dissociable axial ligands (e.g., Ni(II)TMpyP(4)).1,19,22,56 In general, the length of the N-alkyl 
group does not appear to be important;22,31-34,57,58 however, the N-alkylpyridinium group must 
link to the porphyrin core via the 4- or 3- position of the pyridyl ring (not via the 2- position). 
This latter requirement has three implications: First, and most important, this requirement 
indictates that a relatively planar structural unit involving the pyridinium group and the adjacent 
portion of the porphyrin ring must be achieved. Second, the overall electronic nature of the 
directly attached pyridinium group and the porphyrin core appear to be important. Third, and less 
obvious, the separation between the charged nitrogens of the pyridinium groups may need to fall 
within a required range. These distances can be shorter (~6.5 Å) for TMpyP(2). The latter two 
aspects can be assessed with the results from our current work.  
A recent paper contained a comparison of TMpyP(4) and its analogue with a 4-phenylene 
group inserted between the N-methylpyridinium group and the porphyrin core (B-TMpyP(4), 
Figure 3.1).59 The latter compound does not intercalate. In TMpyP(4) the distances between the 
N’s of the N-Mepy groups are 11 Å (cis) and 16 Å (trans), whereas for B-TMpyP(4) these 
distances between the N’s of the 4-C6H4–N-Mepy groups are 19 Å (cis) and 27 Å (trans). This 
comparison suggests both that the separation between the charged nitrogens needs to be smaller 
and that, as mentioned above, the pyridinium group needs to be directly attached to the porphyrin 
core. The recent work of the McMillin laboratory showing that triD4 (Figure 3.1) intercalates 
indicates that a separation of 16 Å allows intercalation. This separation corresponds somewhat to 
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the cis distance in B-TMpyP(4). McMillin et al. showed that when bulk is present cis to the 
pyridinium groups (MetriD4), such larger porphyrins do not intercalate as well the original 
smaller porphyrin.38 The 4-C6H4–N-Mepy group is large and projects out in a rigid manner. 
Other relatively large pyridinium porphyrins that intercalate have cis pyridinium groups with 
flexible N-alkyl substituents,22,31 and this flexibility might allow the alkyl group to adopt an 
orientation that does not inhibit intercalation. In contrast, we believe that the rigid 4-C6H4–N-
Mepy groups of B-TMpyP(4) do not allow the meso peripheral groups to avoid the steric clashes. 
Unlike B-TMpyP(4), the [T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 porphyrins studied here are 
quite conformationally flexible. The various conformations can place the pyridinium groups in 
positions covering a range of distances from 9 Å (cis) to 25 Å (trans). These distances 
encompass those in pyridinium porphyrins for which intercalation has been found. However, the 
new porphyrins do not intercalate. This finding refines further the requirements for a porphyrin 
to be an intercalator and indicates that direct attachment of the pyridinium group to the porphyrin 
core is a very favorable and probably necessary feature for intercalation to occur. We believe the 
steric and electronic features of the combined pyridinium group and adjacent portions of the 
porphyrin core facilitate intercalation. 
3.4.4 Stacking of Cationic Porphyrins under Aqueous Conditions. In the absence of DNA, 
many porphyrins undergo self-stacking in water.39,60-64 The Soret bands of the face-to-face (H) 
and edge-to-edge (J) type stacked porphyrins are respectively blue shifted and red shifted.60,63 
The H-type stacking involves considerable overlap of the porphyrin cores, whereas J-type 
stacking can be viewed as a slippage of the porphyrin cores so that there is less overlap.60 The 
electronic spectra are also influenced by the way the porphyrins align with respect to each other 
because alignment influences the relative orientation of the transition moments.63 It was not our 
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objective to analyze in depth this very complicated stacking process. Rather, our goal was to 
determine qualitatively the relative importance of stacking for the unbound porphyrin because 
stacking influences the electronic spectra, and understanding this influence is useful in assessing 
spectral changes accompanying binding.  
For types of cationic porphyrins usually studied, self-stacking upon DNA binding is normally 
accompanied by hypochromicity, broadening, and/or a shift in λSo.4-7,20,29,33 Self-aggregation of 
cationic porphyrins is believed to be responsible for the large hypochromicities (50-65%) 
observed in high salt concentrations.29,33,39 From data in previous studies29,61 the spectral changes 
indicate that TMAP and trans-P(4) in the presence of salt exist as H- and J-type aggregates, 
respectively.  
3.4.5 Properties of the New Cationic Porphyrins in the Absence of DNA. We investigated 
the behavior of selected new porphyrins under aqueous conditions. The addition of NaCl to a 
solution of [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6) affected the Soret band, 
causing a blue shift, a broadening, and a decrease in the intensity (%H = 70 at 3.0 M NaCl, 
Figure B.10). These changes in the visible spectrum indicate that Cu(II)6 undergoes substantial 
self-stacking and that the aggregates are of the H-type. Even in water, Cu(II)6 gives evidence for 
stacking and the stacking increases under the low salt conditions used here. The literature 
indicates TMpyP(4) exists as the monomer in water even in the presence of inorganic salts.24,65 
Indeed, we compared aqueous and 200 mM NaCl solutions of TMpyP(4) and found that the 
Soret band (421 nm) did not shift and there was little change in intensity (%H = 3). In the same 
type of experiment but with Cu(II)6 the Soret band showed a blue shift (9 nm) and %H = 45. 
Thus, Cu(II)6 has a greater propensity to stack than TMpyP(4). 
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Addition of SDS to a solution of Cu(II)6 produced a visible spectrum with two Soret bands at 
399 nm and 416 nm. At low SDS concentration (0.1 M) the two bands were observed even after 
12 h (Figure B.11). After 12 h in a 1 M solution of SDS the blue-shifted Soret band at 399 nm 
converted completely to the 416 nm band (red-shifted by 4 nm, an indication of a J-type 
aggregate). The intensity of this band increased with time (%H = -90 after 12 h, Figure 3.4). For 
TMpyP(4) at neutral pH, SDS produced no spectral shifts and thus the aggregate type could not 
be assigned as H- or J-type.62  
The Soret band of octacationic [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7) in water (λSo 
= 414 nm) was much sharper than that of Cu(II)6, indicating that Cu(II)7 is less aggregated than 
Cu(II)6 in water. Upon addition of salt, the Soret band of Cu(II)7 became less intense and 
broader, and these effects increased with increasing salt (Figure B.12). These characteristics 
indicate that Cu(II)7 undergoes self-stacking with an increase in salt concentration. At 3.0 M 
NaCl, the %H value of 57 is less than that of Cu(II)6. All results indicate that (because of its high 
charge) stacking of Cu(II)7 is lower than that of  Cu(II)6. 
In aqueous 10 and 100 mM NaCl, the solution conditions used here for DNA binding studies, 
the Soret band of Cu(II)6, Cu(II)7 and also Zn(II)6 (Figure 3.3) gave evidence for aggregation 
(Table 3.1). Upon DNA addition (see below), the Soret bands of these porphyrins shifted to the 
red and sharpened. The significant hyperchromicity and the red shift of the Soret bands are 
indicative of porphyrin binding to DNA as non-self-stacking outside binders.21,28,31,66 Such 
changes must be assessed in the context of the degree of aggregation with stacking of the 
unbound porphyrin.  For example, the extent of the hyperchromicity on DNA binding is less for 
Cu(II)7 than for Cu(II)6 because Cu(II)7 is already less self-stacked than Cu(II)6 prior to DNA 
binding. Thus, the DNA-bound Cu(II)7 is not stacked (see below). 
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3.4.6 Outside Binding to DNA by Porphyrins. Porphyrins that induce no increase in the SRV 
of linear DNA are outside binders. The type of outside binding can be evaluated by observation 
of features of the induced CD signal. In addition, the Soret region of the visible spectrum 
undergoes changes. Because outside binding depends on a number of variables such as salt, ratio 
of porphyrin to the DNA, DNA base pair composition, etc., and because there can be 
combinations of co-existing outside binding modes, simple spectral signatures are difficult to 
define and categorize. In addition, because self-stacking often occurs and the self-stacking can 
itself change with the various conditions, it is not a simple matter to define precisely the binding. 
To illustrate the effects on CD and Soret spectra on porphyrin outside binding to DNA, we 
consider three limiting cases (Figure 3.2, middle and right), namely no self-stacking with the 
porphyrin core close to the DNA, no self-stacking with the core somewhat further and tumbling 
anisotropically, and extensive self-stacking. 
Each of the three cases gives a distinct induced CD signal. A relatively unstacked outside-
bound porphyrin will typically have a non-conservative positive CD signal with an intensity for 
[Θ] = ~1 × 105 deg cm2 dmol-1.21,31 One system with this type of binding is TMpyP(4)–[poly(dA-
dT)]2.21,31 We believe that TMpyP(2) is an example of a porphyrin that exhibits tumbling 
anisotropically. No appreciable induced CD signal was observed.21 Conservative CD signals (in 
some cases strong) are indicative of outside binding with self-stacking.4,5,30,33,35-37,67 Although the 
negative and positive features for the conservative signal detected are often not much stronger 
than the single prominent feature of an unstacked porphyrin, porphyrins with tentacle arms (e.g., 
TθOPP) offer an example of extensive self-stacking on DNA with both positive and negative 
features [Θ] having an absolute magnitude ten times greater than normal, with values of ~106 deg 
cm2 dmol-1.33  
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The Soret band is also useful for assessing stacking. As mentioned above, hyperchromicity is 
most reliably indicative of outside-bound unstacked porphyrins. Previously studied porphyrins 
(Mn(III)TMpyP(4) and Co(III)TMpyP(4)) showed small red shifts (5 nm) of the Soret band and 
significant hyperchromicity with CT DNA (-30% and -27%, respectively).21 Outside binding 
with porphyrin stacking produces variable effects on the Soret band. A moderate (9 nm) red shift 
of λSo, along with less than 30% hypochromicity4,5 has been observed, but a large (25-30 nm) red 
shift29 with large (~60%) hypochromicity  has also been observed.29,30,33,34,67  
[Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6) and [Zn(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6). Visible and CD spectroscopic results for Cu(II)6 and 
Zn(II)6 are consistent with both being non-stacking outside binders. After addition of CT DNA 
to Cu(II)6 and Zn(II)6, a red-shifted Soret band component was evident.  Large 
hyperchromicities (Table 3.3) of up to -118% for Cu(II)6 were observed. At all R values, a 
positive induced CD band (Figures 3.7 and B.3) for Cu(II)6 was observed at ~416 nm, indicative 
of outside binding. Likewise, Zn(II)6 exhibited a positive CD band (Figures 3.6 and 3.7), a red 
shift (3 nm) and hyperchromicity (%H as large as -87) of the Soret band (Table 3.1). We 
conclude that both Cu(II)6 and Zn(II)6 are non-stacking outside binders. 
Another method for assessing binding mode is fluorescence. Porphyrins exhibit reduced 
fluorescence intensity at high R followed by increase in fluorescence intensity as R decreases. 
However, Cu(II)6 does not have usable fluorescence intensity. Because the metal-free porphyrin, 
[T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (6), exhibits spectral features on addition of CT DNA 
similar to those found for Cu(II)6, we studied 6. The fluorescence intensity of 6 first decreased 
and then increased as R decreased (Figure 3.10), another finding indicating that non-stacking 
outside binding at low R.33,50 In view of the similar structures and visible spectral behavior of 6 
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and Cu(II)6, the fluorescence data support the other results indicating that Cu(II)6 is a non-self-
stacking outside binder. 
[Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7). Cu(II)7 is also a non-stacking outside 
binder as evidenced a small red shift (7–11 nm) and (except at high R and low salt) 
hyperchromicity of the Soret band (Table 3.5 and Figures 3.8 and B.8). The highest 
hyperchromicity observed for Cu(II)7 (%H = -46) was much lower than that of Cu(II)6 and 
Zn(II)6 because the unbound Cu(II)7 is not significantly self-stacked. For the Cu(II)7-DNA 
adduct at R = 0.005 (100 mM), the magnitude of εSo (3.2 × 105 M-1 cm-1) is typical of a non-
stacking outside binder.  
Other Porphyrins. [T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4 (1) and [T(N-Mepy-2-
CH2(CH3)NSO2Ar)P]Cl4 (5) have N-Mepy groups similar to those in TMpyP(2), but unlike 
TMpyP(2), their interaction with CT DNA led to a red shift (8 nm) of the Soret band, 
hyperchromicity, and a positive CD feature  (Tables B.3 and B.4). These results indicate that 1 
and 5 are non-stacking outside binders. The Soret band of TMpyP(2) was unaffected by 
interaction with CT DNA, and no hyperchromicity or CD signal was observed.21 Because the N-
Mepy groups of TMpyP(2) are close to the porphyrin core, steric hindrance between the N-Me 
group and the pyrrole protons prevents the pyridinium group from rotating to become coplanar 
with the porphyrin core, thus hindering intercalation.21 However, we suggest that another effect 
of the N-Mepy groups linked via the 2- position in TMpyP(2) is to keep the porphyrin core from 
interacting tightly with DNA. In this situation, we believe that the porphyrin is tumbling 
anisotropically (Figure 3.2). Compared to TMpyP(2), the N-Mepy groups of [T(N-Mepy-2-
CH2(H)NSO2Ar)P]Cl4 and [T(N-Mepy-2-CH2(CH3)NSO2Ar)P]Cl4 are far from the porphyrin 
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core and thus do not inhibit the porphyrin core from approaching the DNA closely. We propose 
proximity is needed for a CD signal to be induced.  
3.5 Conclusions 
[Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6), [Zn(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6), and [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7) are 
non-stacking outside binders with CT DNA, as shown by viscometric studies and by the positive 
induced CD band and hyperchromicity in the Soret region. The decrease in SRV in the 
competitive viscosity studies reveals that [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 competes 
with CuTMpyP(4) in DNA binding. In general, the outside-binding mode is similar in both 10 
and 100 mM NaCl. Furthermore, the metal does not influence binding mode, and 6 binds to CT 
DNA in a similar fashion as Cu(II)6.  
Most of these new porphyrins contain the same 4-substituted N-Mepy group as in TMpyP(4) 
and in several other known intercalating porphyrins. However, the N-Mepy group in the new 
porphyrins is not directly attached to the porphyrin ring. The lack of such direct attachment 
means that the porphyrin ring is more electron rich than that of TMpyP(4), but studies with 
TθF4TAP have shown that electron-poor porphyrin rings do not lead to intercalation.32 Our 
results on new porphyrins having 4-substituted N-Mepy groups that can have separations similar 
to those in intercalating porphyrins indicate that spacing is not the deciding factor. This finding, 
along with results on porphyrins with N-Mepy groups linked at the 2-position, let us conclude 
that direct attachment of the N-alkylpyridinium groups to the porphyrin ring in such a way that 
the N-alkylpyridinium group can become nearly coplanar with the porphyrin ring is necessary for 
intercalation to occur. 
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Our current results with [T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 and its derivatives showing 
that these are outside binders without self-stacking indicate that their behavior is unlike that of 
TθOPP (another porphyrin with an electron-rich core). TθOPP is an outside binder to DNA 
exhibiting substantial self stacking.33 We attribute the difference in stacking propensity (which 
we view as a matter of degree, differing in the relative abundance of stacked vs unstacked bound 
porphyrin) to subtle differences involving the interaction of the charged groups with the DNA 
and also perhaps other interactions such as hydrogen bonding. We note, however, that the new 
porphyrins with secondary and tertiary sulfonamide groups bind to DNA in a similar manner. 
Thus, any role of the sulfonamide in hydrogen bonding would be as an H-bond acceptor by the 
sulfonamide oxygen atoms.  
These new porphyrins have various charged groups, but the differences do not affect binding 
mode. When TMpyP(4) interacts with AT rich regions of DNA as an a non-stacking outside 
binder, its fluorescence behavior (decrease at high R and increase at low R) is similar to that of 6. 
Thus the porphyrin rings of these two rather different porphyrins probably are positioned relative 
to DNA in a very similar manner. 
The same characteristic binding and spectral changes found for new porphyrins with 4-
substituted N-Mepy groups were also found for [T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4 and [T(N-
Mepy-2-CH2(CH3)NSO2Ar)P]Cl4. These latter contain N-Mepy groups attached at the 2-position 
as in TMpyP(2), a porphyrin that does not exhibit spectral changes upon DNA binding.21 Our 
findings indicate that the porphyrin ring of the new porphyrins is close to the DNA when bound 
in a non-stacking manner, as shown in Figure 3.2. In turn, we conclude that TMpyP(2) tumbles 
anisotropically, with the porphyrin ring on average farther from the DNA than the porphyrin ring 
of other porphyrins when these bind outside of DNA (Figure 3.2). 
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CHAPTER 4. NEW PORPHYRINS BEARING NEGATIVELY CHARGED 
PERIPHERAL GROUPS LINKED BY SULFONAMIDE BOND TO THE PHENYL 
GROUP OF TETRA PHENYL PORPHYRIN CORE FOR VIRUCIDAL ACTIVITY 
 
4.1 Introduction 
The human immunodeficiency virus (HIV) epidemic continues to have enormous human 
health consequences. Every 6 seconds, a new person is infected by the virus and every 10 
seconds another person dies as a result of AIDS or associated opportunistic infection. 1 Recent 
studies toward vaccine development have yielded promising results, but a vaccine capable of 
preventing HIV-1 and HIV- 2 infections is not yet available. The complexity inherent to the viral 
life cycle and the added problem of a high mutation rate, which leads to the development of 
resistance to antiviral drugs, warrant a greater effort toward the discovery and development of 
alternative methods to prevent HIV transmission. Sexual transmission plays a predominant role 
in the spread of HIV infection, and approaches to prevent such transmission are urgently needed.  
One promising approach receiving increasing attention is the development of 
microbicides which, when applied topically, can prevent viral infection. These compounds could 
directly interact with HIV virions to decrease or prevent infectivity, thus providing a defense 
against sexual transmission of the virus. Current clinical trials with the most promising anti-HIV 
microbicides employ mostly polymeric sulfonates.2 A number of retroviral agents are already on 
the market, but these are expensive and studies have shown the virus is resistant to them and 
have toxic effect. 3 These factors prompted our research group to focus on small molecules that 
will inhibit entry of the virus into the cell. There have been a number of reports on the antiviral 
activity of phthalocyanines (1) against HIV.4,5 The photoinactivation of viruses by diamagnetic 
porphyrins and phthalocyanines has been studied by Horowitz.6 Photoactivation involves 
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absorption of light by a compound with resulting production of free radicals and singlet oxygen. 
Porphyrins and metalloporphyrins have also been shown to have antiviral activity against HIV. 
 
Previous studies indicated that some porphyrins inhibit the interaction between the virus 
envelope protein and its receptors.2 We have shown4,7 also that porphyrins block infection by 
HIV-1 and that this activity appears to be a result of an interaction with the envelope protein. 
Most of these compounds that were active in blocking HIV-1 were sulfonated. In other studies8 
sulfonated porphyrins (2) and some natural porphyrins (3) were found to be active against pox 
virus. The sulfonamide –SO2NH– group occurs in numerous biologically active compounds, 
which include antimicrobial drugs, saluretics, carbonic anhydrase inhibitors, insulin-releasing 
sulfonamides, antithyroid agents and a number of other agents with biological activities.9 
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Amprenavir is an example of a sulfonamide compound that was introduced in the market in 1999 
as an HIV protease inhibitor, in spite of the success of this drug it has some shortcomings, 
including gastrointestinal side effects and long term metabolic disturbances.10 The aim of my 
research is to introduce one or more sulfonamide group into different porphyrin derivatives. 
 
 
5,10,15,20-tetraphenylporphyrin (H2TPP) 
Porphyrins are readily synthesized from pyrrole and aromatic aldehyde derivatives. This 
porphyrin H2TPP (4) have aromatic groups at the meso position, hydrogen substituents on the 
pyrrole rings, the central N have NH and are organic soluble. Water- soluble porphyrins based in 
sulphonic groups have been prepared by direct sulfonation with strong sulfuric acid 11,12 
Formation of the sulfonic acid derivative limits us from adding other groups to these porphyrins 
because the only way to form the sulfonamide is by first making the sulfonyl chloride of the 
porphyrin. Recently Gonsalves et al.13 synthesized a 5,10,15,20-tetra(4-
chlorosulfonylphenyl)porphyrin (5) from the parent compound 5,10, 15,20-tetraphenylporphyrin 
(4) by using chlorosulfonic acid. The chlorosulfonyl compound 5 may be converted into 
derivatives with a variety of nucleophiles so as to give, for example, the free sulfonic acid, a 
sulfonamide, or a sulfonate ester.14 The work described here involves preparation of the 
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chlorosulfonyl porphyrins 5 and 7, and condensation of different amines with 5 to form 
sulfonamide derivatives of the porphyrin and some metal complexes. 
 
4.2 Experimental Section 
4.2.1 Materials and Methods. All compounds used in the synthetic chemistry were 
purchased from Aldrich. 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (TClSO2PP, 5) was 
synthesized by a known method, and the chemical shifts of the NMR spectrum in CDCl3 
matched the reported values.13  
 All 1H NMR spectra were recorded on either a 300 MHz or a 400 MHz Bruker NMR 
spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference. Mass spectra for samples dissolved in methanol were obtained at the Mass 
Spectrometry Facility at LSU on a Hitachi MS-8000 3DQ LC-ion trap ESI mass spectrometer. 
Electronic absorption spectra were recorded with a Cary 3 spectrophotometer.  1H NMR 
spectra were recorded for DMSO-d6 and CDCl3 solutions on a Bruker 300 MHz or 400 MHz 
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spectrometer.  Peak positions are relative to TMS. All NMR data were processed using the 
XWINNMR and Mestre-C softwares. 
4.2.2 Sulfonation of the Benzylamine Derivatives. (a) Benzylamine (0.046 mmol, 5 
mL) was placed into a 250 mL round-bottomed flask; the flask was placed in an ice bath, and 
fuming H2SO4 (12.5 mL, 0.242 mmol) was added very slowly.12  The mixture was left stirring 
for 6 h in a steam water bath, then removed and left stirring at room temperature overnight. 
HPLC water (50 mL) was added cautiously to the reaction mixture, and immediately a white 
precipitate formed, which was vacuum filtered and washed several times with absolute alcohol 
and dried under vacuum to yield 4-(aminomethyl)benzenesulfonic acid (15); yield, 87.5 mg, ~ 
90%.  The purity of the compound was checked by NMR spectroscopy.  1H NMR (ppm) in D2O: 
7.8 (2H, d, ArH); 7.64 (2H, d, ArH); 4.20 (2H, s, CH2). 
(b) Trifluoroacetic acid anhydride (TFAA) (30 mL, 0.21mol) was added to conc. H2SO4 
(10 g, 0.1 mol) with cooling (ice water) in a dry atmosphere and stirred for 3 h, after which 
complete dissolution of H2SO4 was achieved; the solution was light brown. 3-iodobenzylamine 
(0.1 mol, 23.3g) was added dropwise to the cooled solution, and this solution was heated at 
reflux for 10 min.15 Water was added dropwise with cooling (ice water).The yellowish 
precipitate was washed with absolute ethanol several times to remove trifluoroacetic acid 
(TFA),filtered and dried under vacuum to yield 4-(aminomethyl)-2-iodobenzenesulfonic acid 
(16) yield, 45 mg, ~ 62%.  The purity of the compound was checked by NMR spectroscopy. 1H 
NMR (ppm) in DMSO-d6: 8.99 (8H, s, β-pyrrole), 8.56 (8H, d, ArH);  8.37 (8H, d, ArH); 7.72 
(8H, d, ArH; 7.48 (8H, d, ArH); 4.40 (8H, s, CH2); -2.87 (s, 2H, NH). 
5,10,15,20-tetra(4-sulfonamidophenyl)porphyrin (8): Ammonia (conc. 35% w/V; 25 
mL) was added to 5; (100 mg, 0.099 mmol) in dichloromethane (25 mL) and stirred for 1 h at 
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room temperature The precipitate formed was collected by filtration to give the crude 
sulfonamide. This solid was washed with dichloromethane, crystallized from 
acetone/dichloromethane (1:1) and dried under vacuum to give the solid 5,10,15,20-tetra(4-
sulfonamidophenyl)porphyrin (8), yield 45 mg, 48.8%. The purity of 8 was checked by NMR 
spectroscopy.  1H NMR (ppm) in DMSO-d6): δ 8.83 (8H, s,β-pyrrole), 8.41 (8H, d, ArH); 8.27 
(8H, d, ArH); 7.51 (4H, br, NH); -2.97 (s, 2H, NH).  
5,10,15,20-tetra(4-isopropylsulfonamidophenyl)porphyrin (9): Isopropylamine (28.96 
mg, 0.49mmol) was added to 5 (100 mg, 0.099 mmol) in chloroform (25 mL); the mixture was 
left stirring at room temperature for 48 h. The solution was evaporated to dryness and the 
compound was recrystallized from CHCl3/MeOH (90:10); yield, 65 mg, 60%.  The purity of 
5,10,15,20-tetra(4-isopropylsulfonamidophenyl)porphyrin (9) was checked by NMR 
spectroscopy. 1H NMR (ppm) in DMSO-d6: 8.804 (8H, s,β-pyrrole), 8.42 (8H, d J = 8.1 Hz, 
ArH); 8.22 (8H, d J = 8.4 Hz, ArH); 3.56(4H, m CH); 1.14(24H, d, J = 6.6Hz, CH3); -2.97 (s 2H, 
NH).  
5,10,15,20-tetra(4-phenylsulfonamidophenyl)porphyrin (10): Aniline (46.09 mg, 
0.495mmol) was added 5 (100 mg, 0.099 mmol) in chloroform (25 mL)  The reaction mixture 
was left stirring at room temperature for 4 h and was then concentrated by rotary evaporation. 
With dichloromethane as the eluent, the resulting solid was passed through a silica gel column. 
The collected fraction was concentrated and the solution treated with n-hexane to induce 
recrystallization; yield, 37 mg, 30%. The purity of 5,10,15,20-tetra(4-
phenylsulfonamidophenyl)porphyrin (10) was checked by NMR spectroscopy. 1H NMR (ppm) 
in DMSO-d6: 10.50 (4H,br,NH); 8.65 (8H, s, β-pyrrole), 8.35 (8H, d, ArH), 8.14 (8H, d, ArH), 
7.44 (20H, m, ArH), -3.09 (s, 2H, NH). 
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5,10,15,20-tetra(4-toluinylsulfonamidophenyl)porphyrin (11): p-toluidine (158 mg, 
1.47 mmol) was added to 5 (100 mg, 0.099 mmol) in chloroform (25 mL), pyridine (10 mL) was 
also added and the resulting solution heated at reflux for 24 h. After it had cooled to room 
temperature, the solution was washed with 10% HCl.  The organic layer was separated and 
washed with cold distilled water until the pH of the washing water was neutral. The organic 
phase was dried over anhydrous sodium sulfate and evaporated to dryness. The final product that 
precipitated from chloroform, was vacuum filtered and vacuum dried; Yield, 30mg, ~24% The 
purity of 5,10,15,20-tetra(4-toluinylsulfonamidophenyl)porphyrin (11) was checked by NMR 
spectroscopy.  1H NMR (ppm) in CDCl3: 8.63 (8H, s, β-pyrrole), 8.19 (8H, d, ArH), 8.13 (8H, d, 
ArH), 7.27 (8H, d, ArH), 7.16 (8H, d, ArH), -2.97 (s, 2H, NH). 
5,10,15,20-tetra(4-{3'-iodobenzyl}sulfonylamidophenyl)porphyrin (12): 3-
Iodobenzylamine (230.64 mg, 0.99 mmol) was added to 5 (100 mg, 0.099 mmol) in dry 
acetonitrile (25 mL).  The reaction mixture was left stirring at room temperature for 4h. The 
suspension was filtered, and the residue was washed several times (3 x 15 mL) with ethyl acetate 
and left in the filter to dry; yield, 120 mg, 67%. The purity of the compound 5,10,15,20-tetra(4-
{3′-iodobenzyl}sulfonylamidophenyl)porphyrin (12) was checked by NMR spectroscopy. 1H 
NMR (ppm) in DMSO-d6: 8.65 (8H, s, β-pyrrole), 8.63 (4H,b,NH), 8.40 (8H, d, ArH), 8.21 (8H, 
d, ArH), 7.81 (4H, s, ArH), 7.72 (4H, d, ArH), 7.45(4H, d, ArH), 7.23 (4H, m, ArH), 4.34 (8H, s, 
CH2), -2.98 (s, 2H, NH).  
5,10,15,20-tetra(4-{3'-fluorobenzyl}sulfonylamidophenyl)porphyrin (13): 3-
Fluorobenzylamine (227.7 mg, 0.99 mmol) was added to 5 (100 mg, 0.099 mmol) in dry 
acetonitrile (25 mL). The reaction mixture was left stirring at room temperature for 4 h. There 
were some precipitate at the end of the reaction which was filtered, washed with ethyl acetate 
 91
and the residue was left in the filter to dry; yield, 95 mg, 71%.  The purity of 5,10,15,20-tetra(4-
{3′-fluorobenzyl}sulfonylamidophenyl)porphyrin (13) was checked by NMR spectroscopy.  1H 
NMR (ppm) in DMSO-d6: δ 8.79 (8H, s β-pyrrole), 8.65 (4H, b, NH), 8.38 (8H, d, ArH), 8.19 
(8H, d, ArH), 7.44 (4H, d, ArH), 7.26(12H, m, ArH), 4.40 (8H, s, CH2), -3.0 (s, 2H, NH). 
5,10,15,20-tetra(4-benzylsulfonamidophenyl)porphyrin (14): Benzylamine (42.4 mg, 
0.395 mmol) was added to 5 (50 mg, 0.049 mmol) in dry acetonitrile (25 mL). The reaction 
mixture was left stirring at room temperature for 4 h. The reaction mixture was filtered, and the 
residue washed with ethyl acetate. The filtrate was evaporated to dryness; yield, 38 mg, 76%.  
The purity of 14 was checked by NMR spectroscopy. 1H NMR (ppm) in DMSO-d6: 8.81 (8H, s, 
β-pyrrole), 8.63 (4H, br, NH), 8.37 (8H, d, ArH), 8.19 (8H, d, ArH), 7.40 (20H, m, ArH), 4.35 
(8H, s, CH2), -3.00 (s, 2H, NH). 
5,10,15,20-tetra(4-{p-sulfonbenzyl}sulfonylamidophenyl)porphyrin (15): 4-
(aminomethyl)benzenesulfonic acid (65.5 mg, 0.35 mmol) was added to 5 (70 mg, 0.069 mmol) 
in dry acetonitrile (5 mL), and anhydrous K2CO3 (70 mg, 0.5 mmol) Anhydrous methanol (1 
mL) was also added, and the mixture was sealed and left stirring at room temperature for 12 h. 
The reaction mixture was filtered to give a reddish powder. The red powder was left to dry on 
the filter paper before purifying as follows: small amount of the residue was dissolved in a 
minimal volume of HPLC water and passed through a Sephadex LH20 column. With methanol 
as an eluant, a red fraction was collected, concentrated and acetone added to recrystallize; Yield, 
45 mg, 62%. The purity of 5,10,15,20-tetra(4-{p-sulfonbenzyl}sulfonylamidophenyl)porphyrin 
(15) was checked by NMR spectroscopy.  1H NMR (DMSO-d6): δ 8.91 (8H, s, β-pyrrole), 8.48 
(8H, d, ArH); 8.29 (8H, d, ArH); 7.64 (8H, d, ArH; 7.40 (8H, d, ArH); 4.32 (8H, s, CH2); -2.87 
(s, 2H, NH). ESI-MS(m/z): [M-4H]4- = 401.53. Calcd for [M - H]4- = 401.94. 
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5,10,15,20-tetra(4-{3′-iodosulfonbenzyl}sulfonylamidophenyl)porphyrin 16: 4-
(aminomethyl)-3-iodobenzenesulfonic acid (82.1 mg, 0.245 mmol) was added to 5 (50 mg, 0.049 
mmol) in dry acetonitrile (5 mL), and anhydrous K2CO3 (33.8 mg, 0.245 mmol). Anhydrous 
methanol (1 mL) was also added and the mixture was sealed and left stirring at room temperature 
for 12 h. The reaction mixture was filtered and the residue was left to dry on the filter paper and 
then further purification of the residue was carried out as follows: 
A small amount of the residue was dissolved in a minimal volume of HPLC water and 
passed through a Sephadex LH20 column.  With methanol as an eluant, the red fraction was 
collected, concentrated, and treated with acetone to induce crystallization; yield, 71.6 mg, 67%. 
The purity of 5,10,15,20-tetra(4-{3′-iodosulfonbenzyl}sulfonylamidophenyl)porphyrin 16 was 
checked by NMR spectroscopy and 1H NMR (ppm) in DMSO-d6: 8.82 (8H, s, β-pyrrole), 8.38 
(12H, d, ArH and NH), 8.17 (8H, d, ArH), 7.83 (4H, s, ArH), 7.75 (4H, d, ArH), 7.59 (4H, d, 
ArH), 4.79 (8H, s, CH2), -2.98 (s, 2H, NH). 
5,10,15,20-tetra(4-{3′-fluorosulfonbenzyl}sulfonylamidophenyl)porphyrin 17: 4-
(aminomethyl)-3′-fluorobenzenesulfonic acid (55.6 mg, 0.245 mmol) was added to 5 (50 mg, 
0.049 mmol) in dry acetonitrile (5 mL), and anhydrous K2CO3 (33.8 mg, 0.245 mmol). 
Anhydrous methanol (1 mL) was also added and the mixture was sealed and left stirring at room 
temperature for 12 h. The reaction mixture was filtered and the residue was left to dry on the 
filter paper and then further purification of the residue was carried out as follows: 
A small amount of the residue was dissolved in a minimal volume of HPLC water and 
passed through a Sephadex LH20 column.  With methanol as an eluant, the red fraction was 
collected, concentrated, and treated with acetone to induce crystallization; yield, 51.2 mg, 61%. 
The purity of 5,10,15,20-tetra(4-{3′-fluorosulfonbenzyl}sulfonylamidophenyl)porphyrin 17 was 
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checked by NMR spectroscopy and 1H NMR (ppm) in DMSO-d6): δ 8.79 (8H, s, β-pyrrole), 
8.50(4H, t, NH), 8.47 (8H, d, ArH), 8.18 (8H, d, ArH), 7.24 (4H, s, ArH), 7.17(4H, m, ArH), 
4.82 (8H, s, CH2), -2.98 (s, 2H, NH). ESI-MS(m/z): [M-4H]4- = 419.52. Calcd for [M - H]4- = 
419.93. 
5,10,15,20-tetra(4-{1′sulfonaphthalene-N-5′-amino-
ethyl}sulfonamidophenyl)porphyrin (18): 5-(2-aminoethylaminonaphthalene sulfonic acid 
(148.2 mg, 0.49 mmol) was added to 5 (100 mg, 0.098 mmol) in dry acetonitrile (5 mL), and 
anhydrous K2CO3 (68 mg, 0.49 mmol) Anhydrous methanol (1 mL) was also added and the 
mixture was sealed in a pressure proof flask and left stirring at room temperature for 12 h. The 
reaction mixture was filtered to give a brown solid that was dried before purifying. The brown 
residue was dissolved in a minimal volume of HPLC water and passed through a Sephadex 
LH20 column. With methanol as an eluant, the red fraction was collected, concentrated and 
treated with acetone to induce recrystallization; yield, 73 mg, ~ 70%. The purity of 5,10,15,20-
tetra(4-{1′sulfonaphthalene-N-5′-amino-ethyl}sulfonamidophenyl)porphyrin (17) was checked 
by NMR spectroscopy. 1H NMR (ppm) in DMSO-d6: 8.82 (8H, s, β -pyrrole), 8.46 (8H, ArH), 
8.31 (8H, d, ArH), 8.26 (4H,b,NH), 8.20 (8H, dd, ArH), 7.94 (4H, d, ArH), 7.32 (8H, dd, ArH), 
6.56 (4H, d, ArH), 6.16 (s, 2H, NH), 3.40 (16H, s, CH2), -2.99 (s, 2H, NH). ESI-MS(m/z): [M-
4H]4- = 480.58. Calcd for [M - H]4- = 480.04. 
Cu(II)-5,10,15,20-tetra(4-{p-sulfonylbenzyl}sulfonylamidophenyl)porphyrin: 
5,10,15,20-tetra(4-{p-sulfonylbenzyl}sulfonylamidophenyl)porphyrin (15) (100 mg, 0.058 
mmol) was dissolved in water (5 mL) and treated with 0.11 mmol of CuO; the reaction mixture 
was left stirring at room temperature for 12 h.  The reaction was followed b y UV-vis 
spectroscopy and stopped after the Q band had shifted from 515 nm to 539 nm.(Figure 3.6) The 
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solution was filtered through 20 μm filter and the filtrate concentrated by rotary evaporation and 
passed through a cationic exchange column (Na+ form to remove excess copper). The fraction 
collected was evaporated to dryness and the compound dried under vacuum. 
5,10,15,20-tetra(4-{p-sulfonbenzyl}sulfonamidophenyl)porphyrinPd(II): 5,10,15,20-
tetra(4-{p-sulfonbenzyl}sulfonamidophenyl)porphyrin (15)(50 mg, 0.029 mmol) was suspended 
in an acetate buffer (pH 4 – 5) solution containing potassium tetrachloropalladate ( 47.33 mg, 
0.145 mmol) and the solution was heated at reflux for 1 to 2 h until the green solution changed 
color to orange. The solution was concentrated using a rotary evaporator. Ethanol was added and 
the solution was filtered to remove sodium acetate. The solution was evaporated to dryness and a 
small amount of water added to dissolve the residue; this solution was then passed through a 
cationic exchange column (Na+) to exchange the potassium ions with sodium ions. The solution 
was evaporated to dryness to yield the Pd2+ derivative of porphyrin. UV-vis spectroscopy in 
water (Soret band at 408 nm and Q-band at 523 nm). The purity of the Pd(II) 5,10,15,20-tetra(4-
{p-sulfonbenzyl}sulfonamidophenyl) porphyrin was checked by NMR spectroscopy. 1H NMR 
(ppm) in DMSO-d6: 8.86 (8H, s, β-pyrrole), 8.43 (8H, d, ArH), 8.27 (8H, ArH), 7.64 (8H, ArH), 
7.40 (8H, d, ArH), 4.32 (8H, s, CH2). 
4.3 Results and Discussion 
Chlorosulfonic acid in Scheme 4.1 readily protonates the porphyrin ring of 5,10,15,20-
tetraphenylporphyrin (4), thereby deactivating the pyrrolic positions and directing electrophilic 
substitution to any meso aryl groups which may be present. The advantage of chlorosulfonation 
over sulfonation using concentrated sulfuric acid is that the initially formed chlorosulfonyl 
compounds are easily isolated from the reaction medium because they are insoluble in water but 
soluble in organic solvents. The chlorosulfonyl group can easily be hydrolyzed to its water 
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soluble by-product by heating 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (5) at reflux in 
water for 12 h.  
 
Scheme 4.1. Chlorosulfonation of 5,10,15,20-tetraphenylporphyrin (4) and 5,10,15,20-
tetrabiphenylporphyrin (6). 
 
The 1H NMR spectrum of the parent compound 4 in DMSO-d6 (Figure 4.1) has four 
peaks assigned to the pyrrolic protons, the m-, p-, and o- protons and the inner NH protons. 
There was a downfield shift of the chlorosulfonyl phenyl group  compared to the signals in the 
parent compound 4 (~0.19ppm) and an upfield shift of the m-proton.(~0.05ppm) In addition, the 
p-H signal was missing, as expected from chlorosulfonation at the para position of the parent 4. 
1H NMR spectroscopy of 5 (Figure 4.2) in DMSO-d6 showed clearly that the compound was 
successfully synthesized. Because the porphyrin is symmetric, it should have only three peaks, a 
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singlet assigned to eight pyrrolic protons and two doublets, each assigned to the meso aryl group 
eight ortho protons and eight meta protons. 
 
Figure 4.1. 1H NMR spectrum for 5,10,15,20-tetraphenylporphyrin (4). 
 
 
Figure 4 .2. 1H NMR, spectrum for 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (5). 
 
The chlorosulfonyl compound 5 was reacted with a series of amines, to give the 
sulfonamide derivative of the porphyrin. Scheme 4.2 depicts the porphyrin sulfonamide 
derivatives synthesized.  
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Scheme 4.2. porphyrin sulfonamide derivatives synthesized 
 
The products of the reaction of the chlorosulfonyl compound 5 with amines (Scheme 4.2) 
were assessed by 1H NMR spectra in different solvents. The reaction of 5 with aqueous ammonia 
hydroxide (35%) was used as a model for the synthesis of the rest of the sulfonamides. The 
reaction was successful and it yielded~90% of the 5,10,15,20-tetra(4-
sulfonamidophenyl)porphyrin (15) and ~10% of the hydrolyzed derivative of compound (5). 
This was confirmed by 1H NMR spectra (Figure 4.3) of the product in DMSO-d6, which had a 
set of two peaks for the phenyl protons corresponding to the two compounds formed. The 
chemical shift of the pyrrolic protons was not affected by the sulfonamide group, but there was a 
downfield shift (~0.24ppm) of the phenyl signal (o- and m-) due the electron-withdrawing effect 
of the sulfonamide group compared to the phenyl signals of compound 5 (Figure 4.3).  
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Figure 4.3. 1H NMR, spectrum for 5,10,15,20-tetra(4-sulfonamidophenyl)porphyrin (15). 
For all the compounds synthesized the porphyrin peaks and the NH signal of the 
sulfonamide had approximately the same chemical shifts (pyrrolic signals ~8.82 ppm, phenyl 
signals ~8.40 ppm and 8.21 ppm and the sulfonamide NH signal at ~8.63 ppm) which were 
characteristic and aided in confirming the synthesis of the sulfonamide compound. 
Attempts to chlorosulfonate the sulfonamide derivative 14 at different temperatures (-10 
to 10 oC) failed and led to cleavage of the sulfonamide bond.16 
Reaction of compound 5 with amines with electron-withdrawing groups was not 
successful and resulted mainly in hydrolysis of the porphyrin to its sulfonic acid derivative. The 
electron-withdrawing groups especially at the o- and p- position of the aryl amines decrease the 
basicity of the amine. However, the conditions of the reaction of the chlorosulfonyl compound, 
5, with benzylamine derivatives with sulfonic acid groups were optimized. In particular, 4-
(aminomethyl)benzenesulfonic acid and 5 reacted to give the 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl)porphyrin. (15) Figure 4.4 shows the 1H NMR spectrum of the 
compound. 
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Figure 4.4. 1H NMR, spectra for 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl)porphyrin. 
 
Metallation of the 5,10,15,20-tetra(4-{p-sulfobenzyl}sulfonylamidophenyl) porphyrin 
(15) with potassium tetrachloropalladate was confirmed by both NMR spectroscopy and UV-vis 
spectroscopy. 1H NMR spectra showed that the inner NH signals of the porphyrin were missing, 
as the NH’s were replaced by the metal ion (Figure 4.5); UV-vis spectra showed that the Soret 
414 nm band of 15 had shifted to 408 nm, while the Q-bands typical of free base porphyrin (515 
nm, 530 nm, 582 nm, 637 nm) had collapsed to one band at 523 nm(Figure 4.6). 
 
 
Figure 4.5. 1H NMR, spectra for 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl)porphyrin Pd(II). 
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Figure 4.6. Absorption spectrum of 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl)porphyrin Free base (green), Pd(II) (blue) and Cu(II) (pink), 
derivative. 
 
Also, copper metallation was successfully carried under the same conditions Figure 4.6 
shows the UV-spectrum of the 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl)porphyrin Cu(II). Also the tetra(4-
sulfonatobiphenyl)porphyrin was metallated to its copper (II) compound. Figure 4.7 shows the 
UV-spectrum of the Cu(II) compound.  
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Figure 4.7. Absorption spectra of tetra(4-sulfonatobiphenyl)porphyrin (TBPS4) and its copper 
derivative, showing both the Soret band and the Q-bands. 
 
The antiviral activity against Equine Herpesvirus Type 1 of 5,10,15,20-tetra(4-{p-
sulfobenzyl}sulfonylamidophenyl) porphyrin Cu(II) is under study. 
 
Figure 4 8. Structures of porphyrins studied and porphyrin synthesized. 
 
Previous studies have shown that certain porphyrins show antiviral activity against HIV 
and in some cases virucidal activity. Among these porphyrins the natural porphyrin (Protophyrin, 
hematoporphyrin) and metallloporphyrins have been shown to have acitivity aginst HIV in the 
micromolar range in such antiviral assays. Also other synthetic porphyrins namely the sulfonated 
derivatives of the tetraphenylporphyrin have also been shown to be active against HIV-1, HSV-1 
and HSV-2. In other studies the metalloderivatives without axial ligands (TPPS4 and its Cu 
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chelate) had the highest activity against HIV-1 (Figure 4.8). Sulfonated derivatives of TPP with 
halogen groups at different position (2, 6-difluoro-meso-tetraphenylporphine and its copper 
chelate, and sulfonated porphyrin with one chloro at the fourth position were shown to inhibit the 
HIV virus. Sulfonated tetranaphthyl porphyrin (TNaPS) and tetra-anthracenyl porphyrin 
(TAnthPS) were also found to be very active against HIV-1 virus. TNaPS (Figure 4.8) was 
showed higher activity against pox virus and HIV-1 virus.8,7 This suggests that modified 
porphyrins with extended structure would be more active against the different viruses.Another 
class of compounds which is related to the porphyrins are the sulfonated pthalocyanines and its 
copper chelate which previously have shown activity against HIV-1.4,7  
For virucidal activity one important characteristic is that the agent should be not 
phototoxic. Previous studies have shown that the different porphyrins with paramagnetic metals 
[Cu(II), Fe(III)] in its core had the highest activity against HIV-1. Porphyrins synthesized in this 
proposal are expected to have better virucidal activity against HIV-1 and other related viruses 
since they are related structurally to the already studied porphyrin compounds. The porphyrin 
synthesized has more advantages over the already studied ones since it has a sulfonamide group 
in addition to the sulfonic acid groups which is found in numerous biologically active 
compounds, which includes antimicrobial drugs and also its an extended molecule.. Amprenavir 
is an example of a sulfonamide compound that was introduced in the market in 1999 as a HIV 
protease inhibitor.10 
4.4 Conclusion 
Reaction of the 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (5) with a series of 
amines was successful and confirmed by 1H NMR spectroscopy. From 1H NMR spectra of all the 
compounds synthesized it was observed that at least 90% of the target compounds were present 
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while 10% was the product of hydrolysis of compound 5. Attempts to separate the hydrolysis 
compound from the target compound failed. Conditions for coupling amines with sulfonic acid 
groups at different positions were optimized. Metallation of the sulfonamide porphyrin 
derivatives with Cu2+, Pd2+ was successful and afforded excellent yields. 
4.5 Current and Future Work 
 
Current work involves the purification of the sulfonamide porphyrin derivatives since 
from the 1H NMR spectroscopy the compound contains 10% of the hydrolyzed compound. More 
reactions of 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin (5) with amines with different 
substituents especially electron withdrawing groups preferably halogenated groups at different 
positions will be carried. Also conjugation of 5,10,15,20-tetra(4-
chlorosulfonylbiphenyl)porphyrin (7) with different amines will be done. Other porphyrins such 
as acyl chloride derivative of 5,10,15,20-tetraphenylporphyrin will be synthesized and its 
conjugations with different amines studied. All the compounds synthesized will be provided to 
virologist for testing against several viruses.  
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CHAPTER 5. SYNTHESIS OF PORPHYRIN DERIVATIVES WITH APPENDED 
PLATINUM MOIETIES 
 
5.1 Introduction 
Cis-dichlorodiammineplatinum(II) (cisplatin) remains one of the most widely used 
anticancer drugs for treatment of testicular and ovarian cancer.1 Platinum drugs, such as cisplatin 
and carboplatin, nonselectively penetrate fast-growing tissues, leading to severe side effects (e.g. 
nausea, myelosuppression, nephrotoxicity and ototoxicity) that limit the dose that can be applied 
to patients.2,3 These strong side effects may be reduced by selective delivery of cisplatin in the 
tumor tissue compared to the normal tissue.4 It is also known that the effectiveness of Pt(II) 
antitumor drugs can be improved by linking the reactive platinum functionality to DNA binding 
agents, such as acridine,5-8 anthraquinones,9,10 and other intercalators.11-13 
Selective delivery of the anti-tumor drug to the tumor tissue may be achieved by 
incorporating a carrier group that can target tumor cells with high specificity. Porphyrins are 
known to have the ability to localize selectively in a wide variety of tumors.14,15 Porphyrin-based 
compounds possess good photochemical, photophysical, and biological properties that make 
them highly desirable for medical applications.16 Porphyrins have also been used widely for 
photodynamic therapy and fluorescence imaging, which are based on the preferential uptake and 
retention of the porphyrins by tumor tissues.17-21 Promising results have been published by 
Brunner et al., who synthesized porphyrin-platinum conjugates by utilizing carboxylic acid 
groups on the natural porphyrin as ligands for the platinum moiety. The antitumor activity of 
these compounds revealed a double therapeutic effect on inhibition of cell growth by the 
cytotoxic platinum effect and the phototoxic porphyrin effect.22-26  
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Conjugating a platinum moiety onto a porphyrin can possibly lead to selective delivery of 
the drug into tumor tissues. Furthermore, the photoactivity of the porphyrin can be applied as in 
photodynamic therapy. Studies have identified a cationic 5,10,15-tri(N-methyl-4-
pyridiniumyl)porphyrin-platinum conjugate with greater antitumor activity than cisplatin and 
with a greater tumor-localizing effect (tumor/muscle ratio > 2) than carboplatin.27 
Simple dinuclear compounds that are cationic and which can exist as both cis and trans 
isomers have displayed anti-tumor activity.28 Farrell and co-workers have reported that dinuclear 
cationic trans complexes (which utilize as linkers the naturally available polyamines, spermine 
and spermidine) are very active substances that overcome cisplatin resistance in L1210 murine 
leukemia cells in vitro.29 The additional positive charges assure a high affinity for DNA. A 
trinuclear platinum complex, BBR 3464, is in phase II clinical trials as a chemotherapeutic drug 
for treatment of ovarian and lung cancer.30,31 Recently, five tetrapyridylporphyrin 
areneruthenium (II) derivatives and a p-cymeneosmium and two 
pentamethylcyclopentadienyliridium and rhodium analogues were analyzed as potential 
photosensitizing chemotherapeutic agents by Schmitt and co-workers.32 The ruthenium 
analogues were found to exhibit excellent phototoxicity towards melanoma cells when exposed 
to laser light.32 Cellular uptake and localization microsocopy studies revealed that the ruthenium 
and the rhodium analogues accumulated in the melanoma cell cytoplasm in granular structures 
different from lysosomes.32 
We describe here the synthesis of a new family of Pt(II) complexes of 
tetraphenylporphyrin derivatives bearing polyamine ligands linked to the para position of the 
phenyl group through a sulfonamide group to bind Pt(II) moiety. The porphyrin ligands used 
(Scheme 5.1) in this study are 5,10,15,20-tetra(4-
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[aminoethylaminoethylsulfonamidophenyl])porphyrin (Porphyrin-4(SO2NHdien)) and 
5,10,15,20-tetra(4-[diaminodiethylaminoethylsulfonamidophenyl])porphyrin (Porphyrin-
4(SO2NHtren). Porphyrin-4(SO2NHdien) afforded 5,10,15,20-tetra(4-
[dichloroPt(II)aminoethylaminoethyl)sulfonamidophenyl])porphyrin (Porphyrin-
4((SO2NHdien)Pt(II)Cl2), complex whereas Porphyrin-4(SO2NHtren) gave 5,10,15,20-tetra(4-
[chloroPt(II)diaminodiethylaminoethyl)sulfonamidophenyl])porphyrin Chloride ([Porphyrin-
4((SO2NHtren)Pt(II)Cl)]4Cl) (Figures 5.1 and 5.2). 
Scheme 5.1. Synthesis of [2-(2-amino-ethylamino)ethyl]carbamic acid tert-butyl ester 
(dien mono Boc) and {2-[(2-aminoethyl)-(2-tert-butoxycarbonylaminoethyl)amino]ethyl}-
carbamic acid tert-butyl ester (tren bis Boc) 
 
5.2 Experimental Section  
5.2.1 Materials and Methods. Diethylenetriamine (dien), tris(2-aminoethyl)amine (tren) 
and Di-tert-butyl dicarbonate (Boc2O) were obtained from Aldrich (Scheme 5.1). 5,10,15,20-
tetra(4-chlorosulfonylphenyl)porphyrin (TPPSO2Cl (1), Scheme 5.2) was synthesized by a 
known method and the chemical shift of the 1H NMR spectrum in CDCl3 matched the reported 
value.33 Cis-Pt(Me2SO)2Cl2 was prepared as described in the literature.34 
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All 1H NMR spectra were recorded on either a 300 MHz or a 400 MHz Bruker NMR 
spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference. All NMR data were processed with Mestre-C software. 
Mass spectra were obtained at the Mass Spectrometry Facility at Louisiana State 
University, Baton Rouge, LA, on a Bruker ProFlex III MALDI-TOF and Hitach M8000 ESI 
mass spectrometer. The compounds were dissolved in dichloromethane or chloroform using 
dithranol as the matrix and in methanol for ESI MS. 
5.2.2 Synthesis of [2-(2-Aminoethylamino)ethyl]carbamic Acid tert-Butyl Ester 
(dien mono Boc) and {2-[(2-Aminoethyl)-(2-tert-butoxycarbonylaminoethyl)amino]ethyl}-
carbamic Acid tert-Butyl Ester (tren bis Boc). Dien mono Boc and tren bis Boc were 
synthesized by a slight modification of Krapcho’s method (Scheme 5.1).35 A solution of Boc2O 
(5 mmol, 50 mL of dioxane) was added dropwise over the course of about 2 h to a solution of 
dien or tren (20 mmol, 50 mL of dioxane). The reaction mixture was stirred at RT for 24 h. The 
dioxane was completely removed under vacuum, and water (50 mL) was added. The product was 
extracted into CH2Cl2 (3 × 50 mL), and the solvent was removed under rotary evaporation.  
[2-(2-Aminoethylamino)ethyl]carbamic Acid tert-Butyl Ester (dien mono Boc). The 
general method described above with dien (2.1 g, 20 mmol) yielded dien mono Boc (3.9 g, 56%). 
1H NMR (ppm) in CDCl3: 4.48 (1H, br, NHBoc), 3.35 (2H, d, CH2), 2.18-3.28 (6H, m, CH2), 
1.43 (9H, s, t-butyl). 
{2-[(2-Aminoethyl)-(2-tert-butoxycarbonylaminoethyl)amino]ethyl}-carbamic Acid 
tert-Butyl Ester (tren bis Boc). The general method described above with tren (2.9 g, 20 mmol) 
yielded tren bis Boc (1.75 g, 43%).1H NMR (ppm) in CDCl3: 5.28 (2H, br, NHBoc), 3.18 (2H, d, 
CH2), 2.73 (2H, t, CH2), 2.46-2.58 (6H, m, CH2), 1.45 (18H, s, t-butyl). 
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The oils thus obtained were used to synthesis the porphyrin ligands as in Scheme 5.2. 
Scheme 5.2. Porphyrin ligands synthesized in this study  
 
 
5.2.3 Synthesis of 5,10,15,20-tetra(4-[N-tert-
butyloxycarbonyldiethylenetriaminylsulfonamido]phenyl)porphyrin (2) and 5,10,15,20-
tetra(4-[N-bistert-
butyloxycarbonyldiaminodiethylaminoethylsulfonamidophenyl]porphyrin (3). To a solution 
of porphyrin 1 (Scheme 5.2, 0.1 g, 0.1 mmol) in anhydrous dichloromethane (20 mL) was added 
a solution of dien mono Boc or tren bis Boc (0.5 mmol, 10 mL of dichloromethane). The reaction 
mixture was stirred at room temperature for 12 h. The reaction mixture was washed with water 
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(3 × 10 mL) to remove the unreacted amine. The organic phase was dried over anhydrous 
Na2SO4 and the solvent was removed under vacuum. The final compounds were precipitated 
from dichloromethane/hexane.  
5,10,15,20-tetra(4-[N-tert-
butyloxycarbonyldiethylenetriaminylsulfonamido]phenyl)porphyrin (2): The general 
method described in Scheme 5.2 with dien mono Boc (0.1 g) produced porphyrin 2 (0.18 g, 
81%). 1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole), 8.45 (8H, d, ArH), 8.24 (8H, d, 
ArH), 6.75 (8H, br, NHBoc), 3.12 (8H, t, CH2), 3.01 (8H, q, CH2), 2.70 (8H, t, CH2), 2.57 (8H, 
q, CH2), 1.31 (36H, s, t-butyl), -2.96 (2H, br, NH). 
5,10,15,20-tetra(4-[N-bistert-
butyloxycarbonyldiaminodiethylaminoethylsulfonamidophenyl])porphyrin (3): The general 
method described above with tren bis Boc (0.17 g) yielded porphyrin 3, Scheme 5.2 (0.16 g, 
95%) 1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole), 8.44 (8H, d, ArH), 8.26 (8H, d, 
ArH), 7.83 (4H, br, NH-sulfonamide), 6.79(8H, br, NHBoc), 3.15 (8H, t, CH2), 2.96 (16H, q, 
CH2), 2.59 (8H, t, CH2), 2.50 (8H, t, CH2), 1.32(72H, s, t-butyl), -2.96 (2H, br, NH). 
5.2.4 General Procedure for Removal of the Boc-protecting Group  
Method A: Following a published procedure,36 TFA (2 mL) was added to porphyrin 2 or 
3 and the final solution was stirred at room temperature for 5 min. TFA was evaporated under 
reduced pressure; the residue was triturated and washed with ethyl acetate (3 × 5 mL) to give a 
green powder. 
Method B: A suspension of porphyrin 2 or 3 in HCl/dioxane (4 M, 5 mL) was stirred at 
room temperature for 30 min. The reaction mixture was dried under vacuum. The residue (green 
solid) was then washed with diethyl ether, collected on a filter paper and dried under vacuum. 
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5,10,15,20-tetra(4-[aminoethylaminoethylsulfonamidophenyl])porphyrin (2a): 
Method B with 0.05 g of porphyrin 2 yielded a green precipitate of porphyrin 2a, Scheme 5.2 
(0.068 g, 88% yield). 1H NMR (ppm) in DMSO-d6: 8.85 (8H, s, β-pyrrole), 8.45 (8H, d, ArH), 
8.25 (8H, d, ArH), 7.97 (4H, br, NH-sulfonamide), 7.79 (24H, br, NH3+), 3.32 (8H, t, CH2), 2.94 
(16H, t, CH2), 2.73 (24H, t, CH2), -2.95 (2H, br, NH). 
5,10,15,20-tetra(4-[diaminodiethylaminoethylsulfonamidophenyl])porphyrin (3a): 
Method B with 0.05 g of porphyrin 3 yielded a green precipitate of porphyrin 3a, Scheme 5.2 
(0.041 g, 87% yield). 1H NMR (ppm) in DMSO-d6: 8.89 (8H, s, β-pyrrole), 8.49 (8H, d, ArH), 
8.41 (4H, br, NH-sulfonamide), 8.29 (20H, ArH and NH3+) 3.34 (16H, t, CH2), 3.29 (16H, t, 
CH2), -2.97 (2H, br, NH). 
5.2.5 Synthesis of Porphyrin-Platinum(II) Complexes 
Synthesis of Porphyrin-4((SO2NHdien)Pt(II)Cl2) (4, Figure 5.1): A suspension of cis-
Pt(Me2SO)2Cl2 (0.148 g, 0.352 mmol) in methanol (10 mL) was treated with porphyrin 2a (0.11 
g, 0.070 mmol) in methanol (10 mL), and the reaction mixture was stirred at 50 oC overnight. 
The brown solid that precipitated was collected on a filter, washed with diethyl ether and dried 
under vacuum; yield, 0.05 g, (31%). 1H NMR (ppm) in DMSO-d6: 8.87 (8H, s, β-pyrrole), 8.47 
(8H, d, ArH), 8.27 (12H, d, ArH and NH), 7.11(4H, br, NH), 6.17 (8H, br, NH2), 3.3 (32H, br, 
CH2), -2.97 (2H, br, NH). 
Synthesis of [Porphyrin-4((SO2NHtren)Pt(II)Cl)]4Cl (5, Figure 5.2): A suspension of 
cis-Pt(Me2SO)2Cl2 (0.06 g, 0.144 mmol) in methanol (10 mL) was treated with porphyrin 3a 
(0.05 g, 0.029 mmol) in methanol (10 mL), and the reaction mixture was stirred at 50 oC 
overnight. The brown solid that precipitated was collected on a filter, washed with diethyl ether 
and dried under vacuum; yield, 0.045 g (62.5%). 1H NMR (ppm) in DMSO-d6: 8.88 (8H, s, β-
 112
pyrrole), 8.48 (8H, d, ArH), 8.41(4H, t, NH-sulfonamide), 8.32 (8H, d, ArH), 5.75 (8H, br, NH2), 
5.47 (8H, br, NH2), 3.69(8H, t, CH2), 3.43 (8H, t, CH2), 3.31 (16H, br, CH2), 2.96 (8H, t, CH2), -
2.96 (2H, br, NH). 
 
Figure 5.1. Porphyrin-4((SO2NHdien)Pt(II)Cl2) (4). 
5.3 Results and Discussion 
Starting from the easily synthesized 5,10,15,20-tetra(4-chlorosulfonylphenyl)porphyrin33 
and reaction of different polyamines that were Boc-protected (Scheme 5.1), new porphyrins 
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containing sulfonamide groups with multidentate ligands (Scheme 5.2) were synthesized. The 
Boc-protected amines were obtained following previously published procedures35 (Scheme 5.1), 
and their 1H NMR spectra in CDCl3 are shown in Figures 5.3 and 5.4.  
 
 
Figure 5.2. [Porphyrin-4((SO2NHtren)Pt(II)Cl)]4Cl (5). 
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Figure 5.3. 1H NMR spectrum of dien mono Boc in CDCl3. 
 
 
Figure 5.4. 1H NMR spectrum of tren bis Boc in CDCl3. 
 
The porphyrin Boc-protected compounds synthesized (2 and 3, Scheme 5.2) are soluble 
in organic solvents (chloroform, dichloromethane) and the Boc groups are easily cleaved in 
quantitative yield by using TFA at room temperature.36 The deprotected porphyrin conjugates, 2a 
and 3a, were soluble in water, methanol and DMSO. The porphyrin-ligands were analyzed by 1H 
NMR spectroscopy in DMSO-d6 (Figures 5.5 and 5.6). The 1H NMR spectra of the protected 
porphyrin-ligand showed the resonance of the sulfonamide NH protons (7-8.5 ppm) and of the 
 115
amide NH of the Boc-protected groups at ~6.8 ppm (Figures 5.5 and 5.6). The signal of the 
methyl groups of the tert-butyl group observed at ~1.3 ppm confirmed the synthesis of the 
protected porphyrin ligands. Removal of the protecting group of 2 and 3 was confirmed by 1H 
NMR spectroscopy; the disappearance of the methyl signal of the tert-butyl group and 
appearance of a broad peak at ~7.5 ppm for the protonated primary amine groups confirmed the 
cleavage of the tert-butyl groups. Further confirmation was obtained by addition of D2O to the 
NMR sample of the deprotected porphyrin ligands, whereupon the broad signal of the primary 
amines disappeared because of exchange with D2O. 
5.3.1 1H NMR Characterization of Porphyrin-Pt(II) Complexes 
Porphyrin-Pt(II) conjugates (Figures 5.1 and 5.2) were prepared by treating the 
deprotected porphyrin ligands (Porphyrin-4(SO2NHdien) and Porphyrin-4(SO2NHtren)) 
dissolved in methanol with cis-Pt(Me2SO)2Cl2 at 50 °C for 12 h. The porphyrin-Pt(II) conjugates 
precipitated, and the precipitate was washed with methanol to remove the excess of cis-
Pt(Me2SO)2Cl2 and the unchanged porphyrin ligand. All the porphyrin-Pt(II) conjugates were 
soluble only in DMSO and were analyzed by 1H NMR spectroscopy in DMSO-d6 (Figures 5.5 
and 5.6). 
Porphyrin-4((SO2NHdien)Pt(II)Cl2) (4). Soon after Porphyrin-
4((SO2NHdien)Pt(II)Cl2) (Figure 5.1) was dissolved in DMSO-d6, one major and one minor set 
of NH signals were observed, and only one set of the porphyrin signals was observed. The minor 
set of signals (upfield) disappeared after ~5 min. One set of the NH signals (upfield) belongs to 
Porphyrin-4((SO2NHdien)Pt(II)Cl2) while the major set (downfield) belongs to the solvated 
species [Porphyrin-(4((SO2NHdien)Pt(II)(Me2SO)Cl]4+. The minor set did not appear upon 
addition of [Et4N]Cl. Similar results were observed with Pt(DNSH-dienH)Cl2 (DNSH-dienH = 
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N-(2-((2-aminoethyl)amino)ethyl)-5-(dimethylamino)naphthalene-1-sulfonamide).37 The 1H 
NMR signals of 4 compared to those of the deprotected porphyrin derivative (2a) are not 
significantly affected upon platinum binding to the Porphyrin-4(SO2NHdien (2a), indicating that 
the porphyrin moiety is far from the platinum. The presence of the sulfonamide N3H signal 
(Figure 5.5) is an indication that N1 and N2 participate in the binding to Pt(II) but N3 does not.  
 
Figure 5.5. Selected region of the 1H NMR spectrum of the protected porphyrin-ligand (2) 
(bottom) and of Porphyrin-4((SO2NHdien)Pt(II)Cl2) (4) (top) in DMSO-d6.  
 
The presence of the sulfonamide N3 signal in the 1H NMR spectrum of 4 is an indication 
that the Porphyrin-4(SO2NHdien) ligand acts as a bidentate ligand (central N2 and terminal N1) 
(Figure 5.1). There are two signals of the terminal amino groups (N1H) of 4 (5.36-5.47 ppm), 
and they are comparable to the shifts of Pt(DNSH-dienH)Cl2  (5.23-5.34 ppm) observed 
previously.37 The shift (6.57 ppm) of N2H in 4 is comparable to that of Pt(DNSH-dienH)Cl2 
(6.27 ppm) reported previously.37 The sulfonamide N3H signal of 4 (8.26 ppm) is comparable 
(8.22 ppm) to that of Pt(DNSH-dienH)Cl2.37 In general all the NH signals were slightly 
downfield (~ 0.05 ppm) as compared to the NH shifts of the previously reported (Pt(DNSH-
dienH)Cl2)37 arising from the electron-withdrawing effect of the porphyrin.  
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[Porphyrin-4((SO2NHtren)Pt(II)Cl)]4Cl (5). [Porphyrin-4((SO2NHtren)Pt(II)Cl)]4Cl 
(Figure 5.2) was prepared by treating cis-Pt(Me2SO)2Cl2 with porphyrin 3a. In DMSO-d6 the 1H 
NMR signals of the porphyrin are not significantly affected by Pt binding (Figure 5.6). Upon 
dissolution of 5 in DMSO-d6 one major and one minor set of NH signals were observed (Figure 
5.6). The minor set of the NH signals (downfield shifted) was for the solvated species 
[Porphyrin-4((SO2NHtren)Pt(II)(Me2SO-d6)]8+ and only 10% of this solvated species was 
formed; the major set arises from the unsolvated species ([Porphyrin-
4((SO2NHtren)Pt(II)Cl)]4Cl). The presence of the sulfonamide N3H signal confirmed that the 
desired structure formed. Similar results were observed with [Pt(DNSH-tren)Cl]Cl, which can be 
used as a model of 5.37 Previous studies from our laboratory revealed that the presence of the 
alkyl group on the central N2 decreases DMSO solvolysis. 
 
Figure 5.6. Selected region of the 1H NMR spectrum of the protected porphyrin-ligand (3) 
bottom) and [Porphyrin-4((SO2NHtren)Pt(II)Cl)]4Cl (5) (top) in DMSO-d6. 
 
5.4 Conclusions and Future Work 
The Porphyrin-4(SO2NHdien) and Porphyrin-4(SO2NHtren) ligands act as bidentate and 
tridentate ligands for platinum (II) complexes, respectively. The sulfonamide NH signal was 
found to be diagnostic in confirming the synthesis of the porphyrin-platinum conjugates. The 
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synthesized compounds will be submitted for testing for anticancer activity. Derivatives of the 
compounds can be prepared in order to improve their solubility in water. 
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CHAPTER 6. SYNTHESIS OF PROTOPORPHYRIN IX POLYAMINE CONJUGATES 
APPENDED WITH PLATINUM MOIETIES 
 
6.1 Introduction 
Cis-dichlorodiammineplatinum(II) (cisplatin), as one of the leading metal-based drugs, is 
widely used in the treatment of various forms of cancer.1 However, its clinical usefulness has 
been limited by severe side effects, such as nephrotoxicity, gastrointenstinal toxicity, ototoxicity 
and neurotoxicity.2,3 Extensive efforts have been made to overcome the drawbacks of cisplatin to 
develop cisplatin analogues having equivalent or better antitumor activity and less toxicity. One 
of the strategies for designing new platinum antitumor compounds is to combine the 
chemotherapeutic agent (platinum compounds) with proper carrier groups that target selectively 
the tumor cells. 
Porphyrins have been used effectively in the photodynamic treatment of tumors over a 
decade and play an important role in fluorescence imaging, both based on the preferential uptake 
and retention of the porphyrins in tumor tissues.4-7 Porphyrins are known to accumulate 
selectively in tumor tissues, while platinum complexes such as cisplatin and carboplatin 
penetrate unselectively into all fast-growing tissues, giving rise to the known side effects.8,9 
Studies dealing with the combination of the useful properties of the platinum containing 
preparations and porphyrins resulted in the synthesis of a number of compounds representing 
platinum complexes (covalent conjugates) with protoporphyrin, hematoporphyrin, tetraphenyl 
porphyrin derivatives and with zinc phthalocyanines.10-18 A study of the effect of the conjugates 
to the living cells showed an additive effect of the porphyrin photodynamic activity and platinum 
cytotoxic acitivity.10,19,20 Porphyrin platinum conjugates already synthesized are of the natural 
porphyrin (hematoporphyrin), in which the platinum(II) moiety is attached to the propionic acid 
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side chains out of the porphyrin macrocycle. In previous studies involving conjugation of the 
carboxylic acid side chains of hematoporphyrin with the platinum compounds, only one platinum 
compound per porphyrin was synthesized. Herein, we describe a different approach to the 
synthesis of Pt(II) complexes. In this study the carboxylic acid groups of protoporphyrin (IX) 
were conjugated with different amines, which acted as ligands for platinum(II) compounds. As a 
result, in our system each protoporphyrin ligand synthesized contains two platinum compounds. 
6.2 Experimental Section 
6.2.1 Materials and Methods. 2,18-dipropionic-3,8,13,17-tetramethyl-7,12-
divinylporphyrin (PP, 1) (Frontier), 1–hydroxybenzonitrile (HOBt), 2-(1H-benzonitriazole-1-yl)-
1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU), N,N-diisopropylethylamine (DIEA) and 
N,N– dimethylformide (DMF) from Aldrich, [2-(2-Amino-ethylamino)-ethyl]-carbamic acid tert-
butyl ester (dien mono Boc) and {2-[(2-Amino-ethyl)-(2-tert-butoxycarbonylamino-ethyl)-
amino]-ethyl}-carbamic acid tert-butyl ester (tren bis Boc) were synthesized as described in 
Chapter 4, and the chemical shifts of the 1H NMR spectra in CDCl3 matched the reported values. 
cis-Pt(Me2SO)2Cl2 was prepared as described in the literature.  
All 1H NMR spectra were recorded on either a 300 MHz or a 400 MHz Bruker NMR 
spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference. All NMR data were processed with Mestre-C software. 
Mass spectra were obtained at the Mass Spectrometry Facility at Louisiana State 
University, Baton Rouge, LA, on a Bruker ProFlex III MALDI-TOF and Hitach M8000 ESI 
mass spectrometer. The compounds were dissolved in dichloromethane or chloroform using 
dithranol as the matrix and in methanol for ESI MS. 
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Scheme 6.1. Synthesis of polyamine PPIX conjugatesa 
 
a Reagents and conditions: (i) PP (1.1 equiv), polyamine (2.2 equiv), TBTU (2.2), HOBt 
(2.2 equiv), DIEA (7.7 equiv), DMF, RT, 24 h; (ii) CF3COOH, RT, 30 min.  
 
6.2.2 General Synthesis of Porphyrin Conjugates. A solution of 1 (0.1g, 0.36 mmol) in 
2.0 mL dry DMF was treated with DIEA (0.28g, 2.18 mmol), TBTU (0.23g, 0.72 mmol) and 
HOBt (0.098g, 0.36 mmol), followed by 0.64 mmol of the respective amine in 0.5 mL of DMF. 
The reaction mixture was stirred at RT for 24 h, diluted with 10 mL of ethyl acetate, and washed 
with water (5 × 10 mL). The organic layer was collected and dried over anhydrous Na2SO4, 
filtered, and the solvent evaporated under vacuum. The porphyrin conjugates were isolated by 
column chromatography on silica gel by eluting with CHCl3/EtOH, 90:10 + 5% TEA. 
2,18-Bis[tertbutoxycarbonyldiethlenetriaminyl-N-amidoethyl]-3,8,13,17-
tetramethyl-7,12-divinylporphyrin (2): The general method described above with PP (0.1 g) 
and dien mono Boc (0.13 g) yielded porphyrin 2 (0.12 g, 35%), 1H NMR (ppm) in DMSO-d6: 
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10.30, 10.23 (4H, s, meso-H), 8.49 (2H, dd, CH-vinyl), 7.86 (2H, br, -NHCO), 6.50 (2H, d, CH2-
vinyl), 6.42 (2H, br, NHBoc), 6.22 (2H, d, CH2-vinyl), 4.33 (4H, br, COCH2), 3.72 (6H, d, CH3-
β-pyrrole), 3.62 (6H, d, CH3-β-pyrrole), 3.06(10H, s, CH2-proto and CH2-dien), 2.76 (2H, s, NH-
dien), 2.35 (8H, d, CH2-dien), 1.30 (18H, CH3-Boc), -3.95 (2H, s, NH-pyrrole). MS (MALDI) 
m/z: [M + H]+ = 933.708, calcd for [M + H]+ = 933.563. 
2,18-Bis[di-tertbutoxycarbonyldiaminodiethylaminoethyl-N-amidoethyl]-3,8,13,17-
tetramethyl-7,12-divinylporphyrin (3): The general method described above with PP (0.1 g) 
and tren bis Boc (0.22 g) yielded porphyrin 3 (0.28 g, 65%). 1H NMR (ppm) in DMSO-d6: 10.29, 
10.24, 10.23, 10.21 (4H, s, meso-H), 8.49 (2H, dd, CH-vinyl), 7.85 (2H, br, -NHCO), 6.48 (2H, 
d, CH2-vinyl), 6.42 (2H, br, NHBoc), 6.22 (2H, d, CH2-vinyl), 4.33 (4H, br, COCH2), 4.03 (6H, 
d, CH3-β-pyrrole), 3.72 (6H, d, CH3-β-pyrrole), 3.04(8H, s, CH2-proto and CH2-tren), 2.69 (12H, 
s, CH2-tren), 2.18 (8H, d, CH2-tren), 1.26 (36H, CH3-Boc), -3.94 (2H, s, NH-pyrrole). MS 
(MALDI) m/z: [M + H]+ = 1220.527, calcd for [M + H]+ = 1220.579. 
Deprotection was accomplished in quantitative yield by using trifluoroacetic acid (TFA) 
(2 mL) at RT for 30 min, followed by evaporation of TFA and washings with diethyl ether. 
Porphyrins 2a and 3a were obtained as green powders.  
2,18-Bis[aminoethylaminoethyl-N-amidoethyl]-3,8,13,17-tetramethyl-7,12-
divinylporphyrin (PP-2(CONHdien), 2a): 1H NMR (ppm) in DMSO-d6: 1H NMR (ppm) in 
DMSO-d6: 10.34, 10.31, 10.28 (4H, s, meso-H), 9.46 (2H, s, NH-dien), 8.49 (2H, dd, CH-vinyl), 
8.43 (2H, br, NHCO),8.31 (6H, br, NH3), 6.47 (2H, d, CH2-vinyl), 6.24 (2H, d, CH2-vinyl),4.41 
(4H, br, COCH2), 3.66 (12H, d, CH3 β-pyrrole), 3.49(6H, d, CH2-proto and CH2-dien), 3.36 
(10H, m, CH2-proto and CH2-dien ), 3.16 (6H, d, CH2-dien), -3.95 (2H, s, NH-pyrrole). ESI-
MS(m/z): M+ = 732.4669, calcd for M+ = 732.4586. 
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2,18-Bis[diaminodiethylaminoethyl-N-amidoethyl]-3,8,13,17-tetramethyl-7,12-
divinylporphyrin (PP-2(CONHtren), 3a): 1H NMR (ppm) in DMSO-d6: 10.37, 10.29, 10.26 
(4H, s, meso-H), 8.53 (2H, dd, CH-vinyl), 7.92 (2H, br, NHCO), 7.62 (12H, br, NH3), 6.47 (2H, 
d, CH2-vinyl), 6.24 (2H, d, CH2-vinyl), 4.36 (4H, br, COCH2), 3.75 (6H, d, CH3 β-pyrrole), 3.64 
(6H, d, CH3 β-pyrrole), 3.06 (12H, s, CH2-proto and CH2-tren), 2.58 (8H, s, CH2-tren), 2.35 (8H, 
s, CH2-tren), -3.95 (2H, s, NH-pyrrole). ESI-MS(m/z): M+ = 818.5310, calcd for M+ = 818.5431.  
 
6.2.3 Synthesis of the Platinum Complexes of the Porphyrin Polyamine Conjugates. 
A suspension of cis-Pt(Me2SO)2Cl2 (43.7 mg, 0.1 mmol) in methanol (20 mL) was treated with 
the polyamine PP conjugates 2a and 3a, (0.025 mmol), and the reaction mixture was heated at 50 
oC overnight. The product precipitated in the course of the reaction; the brown suspension was 
concentrated to 5 mL and the product removed by filtration and washed with water, diethyl ether 
and dried under vacuum to yield the desired platinum complexes PP-2((CONHdien)Pt(II)Cl2) 
and [PP-2((CONHtren)PtCl)]2Cl, which were characterized by 1H NMR spectroscopy. 
PP-2((CONHdien)Pt(II)Cl2) (4). The general method described above with 2a (20 mg) 
afforded 4 (Figure 6.1) as a purple solid (15 mg, 47% yield). 1H NMR (ppm) in DMSO-d6: 
10.36, 10.27, 10.24 (4H, s, meso-H), 8.57 (2H, dd, CH-vinyl), 8.20 (2H, s, NHCO), 6.70 (2H, br, 
NH-dien), 6.49 (2H, d, CH2-vinyl), 6.26 (2H, d, CH2-vinyl), 5.92 (4H, br, NH2), 4.39 (4H, br, 
COCH2), 3.79 (6H, d, CH3 β pyrrole), 3.67 (6H, d, CH3 β pyrrole), 3.12 (4H, t, CH2-Proto), 2.86 
(4H, CH2-dien), 2.65 (4H, CH2-dien), 2.26 (8H, CH2-dien), -3.79 (2H, s, NH-pyrrole).  
[PP-2((CONHtren)PtCl)]2Cl (5). The general method described above with 3a (25 mg) 
afforded 5 (Figure 6.1) as a brown solid (22 mg, 69% yield). 1H NMR (ppm) in DMSO-d6: 
10.39, 10.31, 10.25 (4H, s, meso-H), 8.58 (2H, dd, CH-vinyl), 8.27 (2H, s, NHCO), 6.47 (2H, d, 
CH2-vinyl), 6.24 (2H, d, CH2-vinyl), 5.52 (4H, br, NH), 5.16 (4H, br, NH), 4.35 (4H, br, 
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COCH2), 3.76 (6H, d, CH3 β pyrrole), 3.65 (6H, d, CH3 β pyrrole), 3.24 (12H, t, CH2-proto and 
CH2-diene), 3.10 (8H, t, CH2-tren), 2.97 (4H, t, CH2-tren), 2.85 (8H, m CH2-tren), -3.82 (2H, s, 
NH-pyrrole).  
 
 
Figure 6.1. PP-Pt(II) complexes synthesized in this study. 
 
6.3 Results and Discussion 
Polyamines with Boc-protected groups (Scheme 6.1) were selectively synthesized by 
following Krapcho’s method. The Boc-protecting group can be removed easily by treating with 
TFA or a solution of 4 M HCl/dioxane. The synthesis of PP-polyamine conjugates 2 and 3 was 
carried out by reaction of the carboxylic acid groups of PP with the primary amine group of dien 
mono boc or tren bis Boc in the presence of DIEA, TBTU and HOBt in DMF. After purification 
by silica column chromatography (eluent: CHCl3/EtOH, 90:10 + 5% TEA), protected polyamine 
PP conjugates 2 and 3 were obtained in 35% and 48% yields, respectively. 1H NMR spectra of 2 
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and 3 in DMSO-d6 confirmed the synthesis of the PP-polyamine conjugates (2 and 3), as the 
signal of the hydroxyl group at ~12.0 ppm was missing and additional peaks of the amide 
(NHCO) protons were observed (Figures 6.2 and 6.3). PP-polyamine conjugates (2 and 3) were 
further confirmed by MS MALDI (Figures 6.4 and 6.5), which gave the expected peaks. After 
cleavage of protecting groups (Boc), the expected compounds 2a and 3a were obtained in 
quantitative yields and confirmed by 1H NMR spectroscopy and mass spectrometry. Treatment 
of the crude deprotected polyamine PP conjugates with cis-Pt(Me2SO)2Cl2 in methanol afforded 
the PP-platinum complexes (Figure 6.1).  
 
 
Figure 6.2. 1H NMR region of PPIX (a), 2 (b) and 4 (c) in DMSO-d6. 
 
PP polyamine conjugates and their platinum complexes were characterized by 1H NMR 
spectroscopy in DMSO-d6, and their chemical shifts compared to those of PP in the same solvent 
(Figures 6.2 and 6.3). The 1H NMR spectra of the porphyrin diacid showed the resonance of two 
inner pyrrole protons at -4.18 ppm as a singlet. The resonance of the meso protons appeared at 
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10.4 – 10.2 ppm as three singlets in a 2:1:1 ratio. Upon conjugation of the polyamines to the PP 
diacid groups, the OH peak at 12.30 ppm disappeared, and the amide NH was observed between 
7.85 – 8.0 ppm for the two PP-polyamine conjugates (2 and 3). The presence of the methyl 
groups of the tert-butyl groups at ~1.3 ppm confirmed successful conjugation of the polyamines 
to the PP diacid groups. 
 
 
Figure 6.3. 1H NMR region of of PPIX (a), 3 (d) and 5 (e) in DMSO-d6. 
 
There was a general downfield shift of the PP proton signals of the PP-polyamine 
conjugates as compared to the parent porphyrin PP diacid. Removal of the Boc-protecting groups 
was confirmed by 1H NMR spectroscopy (disappearance of the methyl signals of the tert-butyl 
group and the appearance of the protonated amine groups of the ligands) and ESI-MS, which 
gave one parent peak of the expected mass (see Experimental Section). 
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Figure 6.4. MS MALDI spectrum for 2,18-bis[tertbutoxycarbonyldiethlenetriaminyl-N-
amidoethyl]-3,8,13,17-tetramethyl-7,12-divinylporphyrin (2). 
 
Cis-Pt(Me2SO)2Cl2 was treated with the PP-polyamine conjugate (2a and 3a) (Scheme 1) 
dissolved in methanol at 50 °C for 12 h. The PP-platinum complexes (4 and 5) precipitated and 
were collected by filtration and then washed with methanol to remove the excess of cis-
Pt(Me2SO)2Cl2 and any unreacted ligand. All the PP-platinum complexes synthesized were 
soluble only in DMSO.  
6.3.1 1H NMR Characterization of PP-Pt(II) Complexes 
PP-2((CONHdien)Pt(II)Cl2) (4). Under the conditions used cis-Pt(Me2SO)2Cl2 and PP-
2(CONHdien) formed PP-(dien-Pt)22Cl2 , with PP-2(CONHdien) acting as a bidentate ligand 
(central N2 and terminal N1) (Figure 6.1). Evidence of this conclusion is the presence of an 
amide signal N3H in the 1H NMR signal (Figure 6.2) at a shift close to that of the free PP-
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2(CONHdien). Soon after dissolving 4 in DMSO-d6, one major and one minor set of NH signals 
were observed. The extra set of signals disappeared after ~5 min. Based on a previous study by 
Christoforou et al.,21 the minor set of signals was assigned to the dichloride complex and the 
other set assigned to the monosolvated species, in which only one chloride ligand is replaced by 
DMSO. 
 
 
Figure 6.5. MS MALDI spectrum for 2,18-Bis[ditertbutoxycarbonyldiaminodiethylaminoethyl-
N-amidoethyl]-3,8,13,17-tetramethyl-7,12-divinylporphyrin (3). 
 
[PP-2((CONHtren)PtCl)]2Cl (5). Similarly, under the conditions used, the reaction of 
cis-Pt(Me2SO)2Cl2 and PP-2(CONHtren) formed [PP-2((CONHtren)PtCl)]2Cl, with PP-
2(CONHtren) acting as a tridentate ligand (central N2 and two terminal N1) (Figure 6.1). The 
presence of the amide N3H signal (8.5 ppm) confirmed formation of the desired compound 
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(Figure 6.3). The primary amine N2H signals had shifts close to those of related compounds 
studied previously.21 Unlike for PP-2((CONHdien)Pt(II)Cl2), upon dissolving [PP-
2((CONHtren)PtCl)]2Cl in DMSO, no solvolysis species were observed. This unusual behavior 
was also observed in a related compound, [Pt(DNSH-tren)Cl]Cl, in which only 10% of the 
solvolysis species was observed; the explanation given was that the presence of an alkyl group 
on the central N decreases DMSO solvolysis.21  
6.4 Conclusion and Future Work 
We synthesized protoporphyrin IX containing polyamine ligands (PP-2(CONHdien) and 
PP-2(CONHtren)) that acted as bidentate and tridentate ligands towards platinum (II) complexes, 
respectively. The synthetic method developed in this work is useful and versatile for conjugating 
other useful ligands to the protoporphyrin IX. This in turn will provide protoporphyrin IX 
ligands that can bind different metal fragments with medicinal application.  
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CHAPTER 7. CONCLUSIONS 
 
Novel synthetic methodology for preparing porphyrins and their metal derivatives having 
sulfonamide link was developed. In general the sulfonamide group provided a versatile way to 
expand porphyrin utility. However, it was necessary to employ a tertiary sulfonamide because 
otherwise intractable species would be formed. The sulfonamide link can also be used in 
bioconjugation of useful molecules to the porphyrin.  
We achieved the synthesis of pyridyl porphyrins that contained either a secondary or 
tertiary sulfonamide group. Since sulfonamide groups are known to bind metals, replacing the 
dissociable proton of the sulfonamide group with a methyl group simplified the synthesis of the 
metalloporphyrin. Coordinating the pyridyl group with methylcobaloxime unit allowed us to 
estimate the pKa of the pyridyl groups of T(N-py-4-CH2(CH3)NSO2Ar)P) and of TpyP(4) to be 
close to that of pyridine. 
We were able to convert sulfonamide expanded porphyrins bearing pyridyl groups to 
cationic porphyrins. Most of these new porphyrins contain the same 4-substituted N-
methylpyridinium group (N-Mepy) as in TMpyP(4) and in several other known intercalating 
porphyrins. However, the N-Mepy group in the new porphyrins is not directly attached to the 
porphyrin ring. The interaction studies of these cationic porphyrins with calf thymus DNA 
showed that they are outside binders without self stacking in contrast to what is observed with 
TMpyP(4) which is a known intercalator. Our results on new porphyrins having 4-substituted N-
Mepy groups that can have separations similar to those in intercalating porphyrins indicate that 
spacing is not the deciding factor for intercalation into CT DNA. This finding, along with results 
on porphyrins with N-Mepy groups linked at the 2-position, leads us to conclude that direct 
attachment of the N-alkylpyridinium groups to the porphyrin ring in such a way that the N-
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alkylpyridinium group can become nearly coplanar with the porphyrin ring is necessary in order 
for intercalation to occur. 
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APPENDIX A. SUPPLEMENTARY MATERIAL FOR CHAPTER 2 
Table A.1. Selected Bond Distances (Å), Angles (deg) of the Methylcobaloxime moieties in 
[CH3Co(DH)2]4TpyP(4) (9) 
[CH3Co(DH)2]4TpyP(4) (9) 
Co(1)–Neq 1.883(4) Co(2)–Neq 1.882(4) 
Co(1)–Neq 1.883(4) Co(2)–Neq 1.883(4) 
Co(1)–Neq 1.885(4) Co(2)–Neq 1.887(5) 
Co(1)–Neq 1.887(4) Co(2)–Neq 1.892(5) 
Co(1)–Nax 2.055(4) Co(2)–Nax 2.079(4) 
Co(1)–C(29) 2.002(5) Co(2)–C(38) 1.999(5) 
N(4)–Co(1)–C(29) 177.5(2) N(4)–Co(2)–C(3) 179.4(2) 
 
Table A.2. 1H NMR Shifts (ppm) of Porphyrina Signals 
compound Hβb m-H o-H H3,5 (py) H2,6 (py) NCH3 -NH 
T(N-py-2-CH2(H)NSO2Ar)P (2) 8.80 8.36 8.18    -2.99
T(N-py-4-CH2(H)NSO2Ar)P (3) 8.76 8.36 8.19 7.43 8.60  -3.01
T(N-py-2-CH2(CH3)NSO2Ar)P (4) 8.90 8.47 8.25   2.99 -2.94
T(N-py-4-CH2(CH3)NSO2Ar)P (5) 8.92 8.51 8.30 7.46 8.65 2.93 -2.92
a 5 mM in DMSO-d6. b β -pyrrole. 
 
Table A.3. Selected 1H NMR Shifts (ppm) of [CH3Co(DH)2]4TpyP(4) (9) 
signals observed after addition of 3,5-luta 
Compound Hβb -NH 
[CH3Co(DH)2]4TpyP(4) 8.87, 8.77, 8.76 -3.04, -3.01, -2.97, 
-2.94, -2.92 
a 5 mM in CDCl3. b β -pyrrole 
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Figure A.1. ORTEP drawing of T(N-py-2-CH2(CH3)NSO2Ar)P (4) with 50% ellipsoids. 
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Figure A.2. ORTEP drawing of [CH3Co(DH)2]4Zn(II)TpyP(4) (11) with 50% ellipsoids. 
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Figure A.3. Emission spectra of [CH3Co(DH)2]4T(N-py-4-CH2(CH3)NSO2Ar)P (6) (5.0 μM) in 
CH2Cl2 with increasing amounts (6 : pyridine ratio)  
of 4-CNpy (excitation wavelength 420 nm). 
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Figure A.4. Emission spectra of [CH3Co(DH)2]4TpyP(4) (9) (5.0 μM) in CH2Cl2 with increasing 
amounts (9 : pyridine ratio) of 4-CNpy (excitation wavelength 420 nm). 
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APPENDIX B. SUPPLEMENTARY MATERIAL FOR CHAPTER 3 
 
Figure B.1. Plot of SRV vs. R for the addition of metalloporphyrins to solutions of CT DNA (75 
µM, 100 mM NaCl, pH 7.0). 
 
Figure B.2. Effect of CT DNA on the visible spectrum of [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6, 7.5 µM) at various R values (100 mM NaCl, pH 7.0). 
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Figure B.3. CT DNA-induced CD spectra of [Cu(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4  
(Cu(II)6, 7.5 µM) at various R values (100 mM NaCl, pH 7.0). 
 
 
Figure B.4. Effect of CT DNA on the visible spectrum of [Zn(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
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Figure B.5. Effect of CT DNA on the visible spectrum of [Zn(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6, 7.5 µM) at various R values (100 mM NaCl, pH 7.0). 
 
 
 
Figure B.6. CT DNA-induced CD spectra of [Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Zn(II)6, 7.5 µM) at various R values (10 mM NaCl, pH 7.0). 
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Figure B.7. CT DNA-induced CD spectra of [Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Zn(II)6, 7.5 µM) at various R values (100 mM NaCl, pH 7.0). 
 
 
Figure B.8. Effect of CT DNA on the visible spectrum of 
[Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7, 7.5 µM) at various R values (100 mM NaCl, 
pH 7.0). 
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Figure B.9. CT DNA-induced CD spectra of [Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7, 
7.5 µM) at various R values (100 mM NaCl, pH 7.0). 
 
 
 
Figure B.10. Effect of NaCl concentration on the visible absorption spectrum of [Cu(II)T(N-
Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6, 7.5 µM in water). 
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Figure B.11. Visible spectrum monitored with time of [Cu(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Cu(II)6, 7.5 µM) in 0.1 M SDS. The spectrum in water (dark blue) is 
also shown. 
 
 
Figure B.12. Effect of NaCl concentration on the visible absorption spectrum of 
[Cu(II)T(Et3NCH2CH2)2NSO2Ar)P]Cl8 (Cu(II)7, 7.5 µM in water). 
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Table B.1. Visible Spectroscopic Data for [Zn(II)T(N-Mepy-4-CH2(CH3)NSO2Ar)P]Cl4 
(Zn(II)6) in the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λSob 10-5 × εSoc Δλb (%H) λSob 10-5 × εSoc Δλb (%H)
0 423 1.8  423 1.5  
0.25 426 1.7 3 (6) 426 1.7 3 (-13) 
0.05 426 2.0 3 (-11) 426 2.0 3 (-33) 
0.01 426 2.5 3 (-39) 426 2.3 3 (-53) 
0.005 426 2.9 3 (-61) 426 2.8 3 (-87) 
a 7.5 µM porphyrin. b nm. c M-1 cm-1. 
 
 
Table B.2. Effect of NaCl Concentration on the CD Spectrum of [Zn(II)T(N-Mepy-4-
CH2(CH3)NSO2Ar)P]Cl4 (Zn(II)6) in the Presence of CT DNA at pH 7.0a 
10 mM NaCl 100 mM NaCl 
R λ+exc b 10-4× [Θ]+excc λ-sb 10-4 ×[Θ]-sc λ+excb 10-5×[Θ]+excc λsb 10-4 ×[Θ]-sc 
0.25 415 2.2 430 -1.2 415 2.2 430 -0.8 
0.05 420 2.7 434 -0.5 412 0.9   
0.01 420 2.4 437 -0.03 420 1.3   
0.005 420 1.7   421 1.4   
a 7.5 µM porphyrin. b nm. c deg cm2 dmol-1. 
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Table B.3. Visible Spectroscopic Data for [T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4 (1), 
[T(Me3NCH2CH2(H)NSO2Ar)P]Cl4 (4), and [T(N-Mepy-2-CH2(CH3)NSO2Ar)P]Cl4 (5) in the 
Presence of CT DNA at pH 7.0a 
 1 4 5 
R λSob (10-5 × εSo)c Δλb (%H) λSob  (10-5 × εSo)c Δλb (%H) λSob (10-5 × εSo)c Δλb (%H)
0 414 (2.7)  414 (2.8)  414 (2.6)  
0.25 409 (1.2) -5 (56) 408 (1.2) -6 (57) 409 (1.3) -5 (50) 
 422 (1.4) 8 (48) 422 (1.1) 8 (61) 422 (1.5) 8 (42) 
0.005 409 (1.3) -5 (52) 408 (1.1) -6 (61) 409 (1.2) -5 (54) 
 422 (2.5) 8 (7) 422 (2.4) 8 (14) 422 (2.2) 8 (15) 
a 7.5 µM porphyrin, 10 mM NaCl. b nm. c M-1 cm-1. 
 
Table B.4. CD Spectral Data for [T(N-Mepy-2-CH2(H)NSO2Ar)P]Cl4 (1), 
[T(Me3NCH2CH2(H)NSO2Ar)P]Cl4 (4), and [T(N-Mepy-2-CH2(CH3)NSO2Ar)P]Cl4 (5) in the 
Presence of CT DNA at pH 7.0a 
 1 4 5 
R λ+exc b 10-4 × [Θ]+excc λ+exc b 10-4 × [Θ]+excc λ+exc b 10-4 × [Θ]+excc 
0.25 422 1.5 424 1.8 418 2.6 
0.005 422 4.7 418 3.6 418 4.9 
a 7.5 µM porphyrin, 10 mM NaCl. b nm. c deg cm2 dmol-1. 
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